{"id":3572,"date":"2017-01-19T17:00:49","date_gmt":"2017-01-19T17:00:49","guid":{"rendered":"https:\/\/www.wma.net\/wp-content\/uploads\/2016\/11\/wmj19.pdf"},"modified":"2017-01-19T17:00:49","modified_gmt":"2017-01-19T17:00:49","slug":"wmj19-2","status":"inherit","type":"attachment","link":"https:\/\/www.wma.net\/fr\/publications\/world-medical-journal\/wmj19-2\/","title":{"rendered":"wmj19"},"author":2,"comment_status":"open","ping_status":"closed","template":"","meta":[],"acf":[],"description":{"rendered":"<p class=\"attachment\"><a href='https:\/\/www.wma.net\/wp-content\/uploads\/2016\/11\/wmj19.pdf'>wmj19<\/a><\/p>\n<p>No. 3, September 2008<br \/>\nEditor in Chief<br \/>\nDr. P\u0113teris Apinis<br \/>\nLatvian Medical Association<br \/>\nSkolas iela 3, Riga, Latvia<br \/>\nPhone +371 67 220 661<br \/>\npeteris@nma.lv<br \/>\neditorin-chief@wma.net<br \/>\nCo-Editor<br \/>\nDr. Alan J. Rowe<br \/>\nHaughley Grange, Stowmarket<br \/>\nSu\ufb00olk IP143QT, UK<br \/>\nCo-Editor<br \/>\nProf. Dr. med. Elmar Doppelfeld<br \/>\nDeutscher \u00c4rzte-Verlag<br \/>\nDieselstr. 2, D-50859 K\u00f6ln, Germany<br \/>\nAssistant Editor Velta Poz\u0146aka<br \/>\nwmj-editor@wma.net<br \/>\nJournal design and<br \/>\ncover design by J\u0101nis Pavlovskis<br \/>\nCover painting : impressions on a wall<br \/>\nin northern Somalia, dated back to over<br \/>\n3000 years. A cover picture is selected as a<br \/>\nmoral support of WMA for Somalian people<br \/>\nand physicians<br \/>\nLayout and Artwork<br \/>\nThe Latvian Medical Publisher \u201cMedic\u012bnas<br \/>\napg\u0101ds\u201d, President Dr. Maija \u0160etlere,<br \/>\nHospit\u0101\u013cu iela 55, Riga, Latvia<br \/>\nPublisher<br \/>\nThe World Medical Association, Inc. BP 63<br \/>\n01212 Ferney-Voltaire Cedex, France<br \/>\nPublishing House<br \/>\nDeutscher-\u00c4rzte Verlag GmbH,<br \/>\nDieselstr. 2, P.O.Box 40 02 65<br \/>\n50832 K\u00f6ln\/Germany<br \/>\nPhone (0 22 34) 70 11-0<br \/>\nFax (0 22 34) 70 11-2 55<br \/>\nBusiness Managers J. F\u00fchrer, D. Weber<br \/>\n50859 K\u00f6ln, Dieselstr. 2, Germany<br \/>\nIBAN: DE83370100500019250506<br \/>\nBIC: PBNKDEFF<br \/>\nBank: Deutsche Apotheker &#8211; und \u00c4rztebank,<br \/>\nIBAN: DE28300606010101107410<br \/>\nBIC: DAAEDEDD<br \/>\n50670 K\u00f6ln, No. 01 011 07410<br \/>\nAt present rate-card No. 3 a is valid<br \/>\nThe magazine is published quarterly.<br \/>\nSubscriptions will be accepted by<br \/>\nDeutscher \u00c4rzte-Verlag or<br \/>\nthe World Medical Association<br \/>\nSubscription fee \u20ac 22,80 per annum (inkl.<br \/>\n7%MwSt.). For members of the World Medical<br \/>\nAssociation and for Associate members the<br \/>\nsubscription fee is settled by the membership<br \/>\nor associate payment. Details of Associate<br \/>\nMembership may be found at the World<br \/>\nMedical Association website www.wma.net<br \/>\nPrinted by<br \/>\nDeutscher \u00c4rzte-Verlag<br \/>\nK\u00f6ln, Germany<br \/>\nISSN: 0049-8122<br \/>\nDr. J\u00f3n SN\u00c6DAL<br \/>\nWMA President<br \/>\nIcelandic Medicial Assn<br \/>\nHlidasmari 8<br \/>\n200 Kopavogur<br \/>\nIceland<br \/>\nDr. Kazuo IWASA<br \/>\nWMA Vice-Chairman of Council<br \/>\nJapan Medical Assn<br \/>\n2-28-16 Honkomagome<br \/>\nBunkyo-ku<br \/>\nTokyo 113-8621<br \/>\nJapan<br \/>\nDr. Otmar KLOIBER<br \/>\nWMA Secretary General<br \/>\n13 chemin du Levant<br \/>\nFrance 01212 Ferney-Voltaire<br \/>\nFrance<br \/>\nDr. Yoram BLACHAR<br \/>\nWMA President-Elect<br \/>\nIsrael Medical Assn<br \/>\n2 Twin Towers<br \/>\n35 Jabotinsky Street<br \/>\nP.O. Box 3566<br \/>\nRamat-Gan 52136<br \/>\nIsrael<br \/>\nDr. Eva NILSSON-<br \/>\nB\u00c5GENHOLM<br \/>\nWMA Chairperson of the Medical<br \/>\nEthics Committee<br \/>\nSwedish Medical Assn.<br \/>\nP.O. Box 5610<br \/>\n11486 Stockholm<br \/>\nSweden<br \/>\nDr. Guy DUMONT<br \/>\nWMA Chairperson of the Associate<br \/>\nMembers<br \/>\n14 rue des Tiennes<br \/>\n1380 Lasne<br \/>\nBelgium<br \/>\nDr. Nachiappan ARUMUGAM<br \/>\nWMA Immediate Past President<br \/>\nMalaysian Medical Assn.<br \/>\n4th Floor, MMA House<br \/>\n53000 Kuala Lumpur<br \/>\nMalaysia<br \/>\nDr. J\u00f6rg-Dietrich HOPPE<br \/>\nWMA Treasurer<br \/>\nBundes\u00e4rztekammer<br \/>\nHerbert-Lewin-Platz 1<br \/>\n10623 Berlin<br \/>\nGermany<br \/>\nDr. Mukesh HAIKERWAL<br \/>\nWMA Chairperson of the Finance<br \/>\nand Planning Committee<br \/>\n58 Victoria Street<br \/>\nWilliamstown, VIC 3016<br \/>\nAustralia<br \/>\nDr. Edward HILL<br \/>\nWMA Chairperson of Council<br \/>\nAmerican Medical Assn<br \/>\n515 North State Street<br \/>\nChicago, ILL 60610<br \/>\nUSA<br \/>\nDr. Jos\u00e9 Luiz GOMES DO<br \/>\nAMARAL<br \/>\nWMA Chairperson of the Socio-<br \/>\nMedical-A\ufb00airs Committee<br \/>\nAssocia\u00e7ao M\u00e9dica Brasileira<br \/>\nRua Sao Carlos do Pinhal 324<br \/>\nBela Vista, CEP 01333-903<br \/>\nSao Paulo, SP<br \/>\nBrazil<br \/>\nDr. Karsten VILMAR<br \/>\nWMA Treasurer Emeritus<br \/>\nSchubertstr. 58<br \/>\n28209 Bremen<br \/>\nGermany<br \/>\nWorld Medical Association O\ufb03cers, Chairpersons and O\ufb03cials<br \/>\nO\ufb03cial Journal Of The World Medical Association<br \/>\nOpinions expressed in this journal \u2013 especially those in authored contributions \u2013 do not necessarily re\ufb02ect WMA policy or positions<br \/>\nwww.wma.net<br \/>\n75<br \/>\nWe are occasionally faced with the question: What is the role of the<br \/>\nphysician? Is it to care for the individual patient, or does the physi-<br \/>\ncian\u2019s responsibility extend to include the health of the whole nation<br \/>\nor even the entire planet?<br \/>\nSome of my colleagues have expressed the view that a national<br \/>\nmedical association\u2019s task does not extend to the medical care for<br \/>\nthe whole nation. In their opinion, that responsibility belongs to<br \/>\nthe government or an agency of the government, or to society as a<br \/>\nwhole; the doctor\u2019s job is to care for his or her patients. Although<br \/>\nthis latter statement is true, our professional medical education puts<br \/>\nus in the position to be the best guarantors of public health. I hold<br \/>\nphysicians in very high regard as specialists who invest and synthe-<br \/>\nsize their energy, knowledge and experience in the total care of their<br \/>\npatient.<br \/>\nHowever, each physician\u2019s mission is broader than the care of in-<br \/>\ndividual patients, just as the mission of every national professional<br \/>\nsociety extends beyond the inhabitants of the country. The mission<br \/>\nof the physician, the national medical organization, and the World<br \/>\nMedical Association should also be the health of society as a whole.<br \/>\nBecause no one else has a grasp of the issues, only the doctors and<br \/>\ntheir professional associations can e\ufb00ectively deal with the health of<br \/>\nthe general population.<br \/>\nThe health of the population worldwide could be dramatically im-<br \/>\nproved by paying attention to a few basic concepts: adequate nutri-<br \/>\ntion, su\ufb03cient exercise, clean water and air, primary and secondary<br \/>\nprophylaxis against disease, access to medication, access to quali\ufb01ed<br \/>\nmedical personnel, improvement in physical and mental well-being<br \/>\nand eradication of harmful behaviors such as smoking, alcoholism<br \/>\nand the use of drugs.<br \/>\nToday, inspired by the Olympic Games in Beijing and the Declara-<br \/>\ntion of Helsinki Conference in S\u00e3o Paolo, I would like to discuss<br \/>\nthe importance of exercise in the improvement and maintenance of<br \/>\ngood health.<br \/>\nWe were enthralled by the incredible new Olympic stadiums in<br \/>\nChina, the spectacular opening and closing ceremonies and the<br \/>\nworld-class competition of athletes in Beijing.While winning a gold<br \/>\nmedal is a signi\ufb01cant achievement, participation in the competition<br \/>\nis even more important. We should encourage all to participate in<br \/>\nphysical activity even if they have no chance of winning a medal.<br \/>\nChina provides a good example by the large number of people of<br \/>\nall ages who practice Tai Chi every day as a means to physical and<br \/>\nspiritual well-being. Athletics can inspire as a spectator sport, but it<br \/>\nshould be a reality in the everyday life of all people.<br \/>\nThe Declaration of Helsinki Conference took place in S\u00e3o Paolo,<br \/>\nBrazil in August 2008. Each conference participant took something<br \/>\naway from this meeting. For me, the most striking insight was the<br \/>\none I gained during several very early mornings in a park. I was not<br \/>\nthe only person running. Many thousand people, primarily 40- to<br \/>\n60-year-olds, were also running, alone or in lively groups. I now<br \/>\nunderstand why Brazilian athletes are the trend-setters in soccer,<br \/>\nvolleyball and athletics worldwide: they simply love to exercise, and<br \/>\nthey continue to exercise all their lives.<br \/>\nMy proposal is simple. The World Medical Association and each<br \/>\nnational medical association should undertake to promote at least<br \/>\nsome daily exercise and physical training in every individual, young<br \/>\nand old.<br \/>\nSenior sports should also be included in a nation\u2019s public health<br \/>\nprogram. In the world literature there are reports of research stud-<br \/>\nies showing that regular, daily exercise at a su\ufb03ciently high level<br \/>\nof intensity (including activity in an anaerobic regimen) can bring<br \/>\nabout a noticeable improvement in health status, increase in muscle<br \/>\nmass,amelioration of coordination disturbances,and stabilization of<br \/>\nthe heart and circulatory system. Exercise programs in 80 to 90 year<br \/>\nold patients can save on resources that would otherwise be spent in<br \/>\nthe health or social services Furthermore, exercise is the best way<br \/>\nto combat the worldwide epidemic of obesity and the sharply in-<br \/>\ncreased incidence of type 2 diabetes.<br \/>\nAt the moment there is no clear strategy internationally to pro-<br \/>\nmote exercise in older people. Senior sports enjoy prestige in only a<br \/>\nfew countries. In Scandinavian countries, for example, the sport of<br \/>\norientation attracts many people at retirement age, who then start<br \/>\ntraining in earnest, attend training camps in mountainous regions,<br \/>\nand go to training camps in the winters in southern Europe. It is<br \/>\ntime for us to \ufb01nd recognition for senior sports championships equal<br \/>\nto those enjoyed by youths and 20- to 30-year-olds. Most resources<br \/>\nare invested in youth sports, on the assumption that these young<br \/>\npeople will then mature into adults who love to exercise. However,<br \/>\nelderly people should also be encouraged to participate in sporting<br \/>\nactivities, consistent with their abilities.<br \/>\nOur goal in promoting good health is su\ufb03cient exercise and optimal<br \/>\nnutrition for every person, regardless of age.<br \/>\nEditorial<br \/>\nP\u0113teris Apinis, M.D.<br \/>\nEditor-in-Chief of the World Medical Journal<br \/>\n76<br \/>\nThe 179th<br \/>\nCouncil met in Divonne-les-<br \/>\nBains, France 15-17th<br \/>\nMay 2008 under the<br \/>\nchairmanship of Dr. Edward Hill.<br \/>\nOpening the meeting the Chair called on<br \/>\nDr. Ishii, member of Council and Secretary<br \/>\nGeneral of the Confederation of Medi-<br \/>\ncal Associations in Asia and Oceania, who<br \/>\nspoke of the mortality, injury and devasta-<br \/>\ntion caused by the earthquake in China<br \/>\nand the cyclone in Myanmar. This raised<br \/>\nhuge challenges in the Region. The Chair,<br \/>\nechoing these remarks, also referred to the<br \/>\ne\ufb00ects of armed con\ufb02ict and violence on<br \/>\nhuman health. In particular he referred<br \/>\nto the tragedy a\ufb00ecting the family of Prof<br \/>\nBartov, member of council. He then read a<br \/>\nletter written on behalf of Council to Pro-<br \/>\nfessor Bartov and Council stood in silent<br \/>\ntribute to those who had lost their lives in<br \/>\nthe earthquakes and the victims of natural<br \/>\ndisasters, war and violence.<br \/>\nThe President, Dr. Sn\u00e6dal reported that he<br \/>\nhad he had visited a number of NMAs, re-<br \/>\nferring in particular to a successful meeting<br \/>\non Communicable diseases in Taiwan and<br \/>\nto the enormous problems facing NMAs<br \/>\nin Sub-Saharan Africa. He continued by<br \/>\nspeaking of meetings which he, with others,<br \/>\nhad attended in Ethiopia and Uganda on<br \/>\nHuman Health Resources and the concept<br \/>\nof Task Shifting ( also being considered by<br \/>\nthe WMA working group). Task shifting<br \/>\nwas very important as it removes tasks from<br \/>\nmedicine to others. The other health pro-<br \/>\nfessions had also recognised that this had<br \/>\nimplications for them. Others important<br \/>\nissues would be referred to in the Report of<br \/>\nthe Secretary General.<br \/>\nDr. Otmar Kloiber, Secretary General, re-<br \/>\nported that the sta\ufb00 increases would fa-<br \/>\ncilitate increased WMA representation and<br \/>\nadvocacy at political level. He was grateful<br \/>\nto the AMA for facilitating the appoint-<br \/>\nment of Clarisse Delorme, a Human Rights<br \/>\nlawyer, as the Advocacy Adviser. There had<br \/>\nbeen a lot of activity on Task Shifting (TS).<br \/>\nTask Shifting While this seemed shocking at<br \/>\n\ufb01rst,it was nevertheless necessary to address<br \/>\nthe problem of areas where the Physician\/<br \/>\nPopulation ration was down to 1 : 50000-<br \/>\nmeaning that the sick had no chance of<br \/>\nseeing a physician. In these extraordinary<br \/>\ncircumstances there was a compelling need<br \/>\nto act. On the other hand WHO and do-<br \/>\nnor organisations gave the impression of<br \/>\nconsidering Task Shifting as a general con-<br \/>\ncept widely applicable to dealing with all<br \/>\n179th<br \/>\nWMA Council Meets<br \/>\nPresidium of 179th<br \/>\nWMA Council<br \/>\nDelegates of the Council by the Divonne-les-Bains Palace<br \/>\n77<br \/>\nhealthcare human resource problems. They<br \/>\ndon\u2019t view this concept as only applicable to<br \/>\npoor countries with human health resource<br \/>\ndeprived areas, but rather it could be used<br \/>\nas a tool to solve the problems of Health<br \/>\ncare systems in developed and rich coun-<br \/>\ntries. They are looking at countries, nota-<br \/>\nbly in the west such as the USA and UK,<br \/>\nwho have already started Task Shifting, etc.<br \/>\nThese countries don\u2019t have to face the sort of<br \/>\nshortages experienced by African countries.<br \/>\nLast year and this we have had a chance to<br \/>\nin\ufb02uence a Task Shifting policy document,<br \/>\nand point out that this is primarily for ad-<br \/>\ndressing the problems of shortages of hu-<br \/>\nman resources. In Addis Ababa we learnt<br \/>\nthat the African Ministers of Health were<br \/>\nnot aware of the western proposal of Task<br \/>\nShifting. Dr.Kloiber referring to the Kam-<br \/>\npala meeting said that the Health Profes-<br \/>\nsions requested but, were given no opportu-<br \/>\nnity for, direct in\ufb02uence on policy as there<br \/>\nwas no open discussion of the prepared<br \/>\ndocument, but simply information on what<br \/>\nwas planned. The Declaration of Kampala*<br \/>\noutlined the importance of Task Shifting,<br \/>\nbut pressure by the WHPA resulted in the<br \/>\ninclusion of the President of WMA in a<br \/>\nclosed ministerial round and some modi-<br \/>\n\ufb01cation of the \ufb01nal document to recognise<br \/>\nthe needs for health professionals.<br \/>\nTuberculosis Sta\ufb00 member Dr. Julia Seyer<br \/>\nin charge of MDR-TB project, reported<br \/>\nto council that for some years WMA had<br \/>\nbeen working with the Stop TB Alliance<br \/>\nand commented that the provision of theo-<br \/>\nretical knowledge as to how to teach about<br \/>\nTuberculosis on-line should help this cam-<br \/>\npaign. Together with the ICN, WMA was<br \/>\nengaged in workshops on the training and<br \/>\non healthcare workers\u2019 safety guidelines<br \/>\nin managing tuberculosis. She referred on<br \/>\nagreement signed on the previous day and<br \/>\nthe plan for the second phase of the project<br \/>\nand its enlargement (including China, Rus-<br \/>\nsia and India). She would like to extend the<br \/>\non-line course to a CD-ROM and a Hand-<br \/>\nbook. Concerning the training of trainers\u2019<br \/>\ncourses on education in learning styles,<br \/>\nthere was cooperation with the World Eco-<br \/>\nnomic Forum who had a toolkit for working<br \/>\nin countries such as China (where Tuber-<br \/>\nculosis is stigmatised), addressing the prob-<br \/>\nlems of how to diagnose, treat and manage<br \/>\ntuberculosis. Referring to ethics in relation<br \/>\nto tuberculosis, she highlighted the right of<br \/>\nsociety to enforce Tuberculosis control.<br \/>\nTobacco \/Alcohol Dr. Kloiber then referred to<br \/>\nthe new approach to Tobacco developed in<br \/>\nCopenhagen where WMA were invited to<br \/>\nwork on Legal controls.NMAs had selected<br \/>\nthe issues of education and communication<br \/>\nin Tobacco Control and also on limiting<br \/>\nexposure to tobacco smoke.The WMA had<br \/>\nco-sponsored a seminar on Tobacco control<br \/>\nat the EFMA\/WHO annual meeting in Tel<br \/>\nAviv and WMA would host a side event at<br \/>\nthe World Health Assembly on \u201cFocuss-<br \/>\ning Opportunities for Tobacco Cessation\u201d.<br \/>\nResponding to a question from India on<br \/>\ncollaboration he stressed that there would<br \/>\nbe more opportunities for NMA involve-<br \/>\nment in the projects new phase. Turning to<br \/>\nAlcohol which was now before the World<br \/>\nHealth Assembly, the recommendation<br \/>\nbefore the Assembly included a direction<br \/>\nthat the Secretary General should cooper-<br \/>\nate with the Alcohol industry.In view of the<br \/>\nlobbying by the industry this was a matter<br \/>\nof concern.<br \/>\nLeadership The WMA course Leadership<br \/>\nwas held in the autumn together with IN-<br \/>\nSEAD, with 32 participants from all over<br \/>\nthe world. Dr. Kloiber thanked P\ufb01zer for<br \/>\nmaking this course possible.The course was<br \/>\nsuch a success that it would be repeated.<br \/>\nWHPA** The WMA had taken over the<br \/>\nsecretariat of the World Health Professions<br \/>\nAlliance (WHPA) from the International<br \/>\nCouncil of Nurses (ICN) for the next pe-<br \/>\nriod after which it would rotate though the<br \/>\nother professions. WHPA is a very strong<br \/>\n* see page 82<br \/>\n** see more page 95<br \/>\nMeeting \u201eFocussing Oportunities for Tobacco<br \/>\nCessation\u201d in Geneva<br \/>\nFrom the left: Burton Conrod, President FDI; Hiroko Minami, ICN President; John Snaedal,<br \/>\nPresident WMA; Marilyn Mo\ufb00at, President WCPT; Kamal Midha, President FIP<br \/>\n78<br \/>\nalliance of the health professions who found,<br \/>\nto their surprise, that they had a common<br \/>\nexperience in their di\ufb03culties in getting<br \/>\ntheir views to be taken seriously by WHO,<br \/>\nwho considered that their views would be<br \/>\nsectional and partial in the global health<br \/>\n\ufb01eld. The professions who joined together<br \/>\nin this alliance found that this changed the<br \/>\nsituation and the WHPA had been success-<br \/>\nful in presenting a broader collective voice<br \/>\nfrom the health professions. The need for<br \/>\nthis alliance had been enhanced by the pro-<br \/>\nfessions recognising the threats implicit in<br \/>\nTask Shifting.<br \/>\nDr. Kloiber then introduced Ms Clarisse<br \/>\nDelonne, a French Human Rights lawyer<br \/>\nadvising on Advocacy for and by the profes-<br \/>\nsion She reminded council that an approach<br \/>\nhad been made to Paul Hunt the previous<br \/>\nUN Special Rapporteur on Health in Hu-<br \/>\nman Rights.She set out the role of the Rap-<br \/>\nporteur on the Right to Health and the need<br \/>\nto in\ufb02uence the Commission to extend the<br \/>\nmandate of the Commissioner to include<br \/>\nintegrity of health professionals in the man-<br \/>\ndate. WMA has worked extensively with<br \/>\nthe ICN lobbying on extending this role.<br \/>\nA joint statement was being prepared which<br \/>\nwould be sent to the Human Rights Com-<br \/>\nmission requesting that Independence and<br \/>\nIntegrity of health professionals be included<br \/>\nin the Special Rapporteur\u2019s mandate.<br \/>\nIn discussion Dr. Nathanson (BMA) point-<br \/>\ned out that the Special Rapporteur on Tor-<br \/>\nture had an interest in the problems of phy-<br \/>\nsicians in reporting torture and this aspect<br \/>\nshould also be addressed to Mr Nowak with<br \/>\nwhom we could also work.<br \/>\nDr. Wilks (President of the CPME) said<br \/>\nthat the BMA had worked with Paul Hunt<br \/>\nand discussed with him the NMAs\u2019 role<br \/>\nin increasing indices of health. With ref-<br \/>\nerence to Alcohol, Europe had experience<br \/>\nto o\ufb00er. In the European Union they had<br \/>\nbeen able to harness industry in actions on<br \/>\nAlcohol control. The Chair, Dr. Hill, com-<br \/>\nmented that in the USA where the industry<br \/>\ndecided to advise the young on the hazards<br \/>\nof drinking, however, drinking in the young<br \/>\nhad increased in those areas where the in-<br \/>\ndustry was involved.<br \/>\nDr. Letlape considered that WMA needed a<br \/>\nposition on this topic. Dr. Nathanson agree-<br \/>\ning added that alcohol was not as socially ac-<br \/>\nceptable for control action as was Tobacco.<br \/>\nDr. Haikerwall returning to Task Shifting<br \/>\nsaid the trend was towards removing medi-<br \/>\ncal care from Health care.<br \/>\nHuman Rights in Zimbabwe. The Chair<br \/>\nof Council introduced Dr. Paul Chimedza,<br \/>\nPresident of the Zimbabwe Medical As-<br \/>\nsociation (ZiMA) who had been invited to<br \/>\nspeak about the report of health related hu-<br \/>\nman rights and violence in Zimbabwe.<br \/>\nThanking council for the opportunity,<br \/>\nDr. Chimedza said that political tensions<br \/>\nand violence began to rise after the recent<br \/>\nelections in Zimbabwe and that this was be-<br \/>\ning perpetrated by both political parties. He<br \/>\ndenied that any patients had been refused<br \/>\nmedical care on the basis of political a\ufb03li-<br \/>\nation and stated that ZiMA had stressed to<br \/>\nits members that they should report any in-<br \/>\nstances in which they were prevented from<br \/>\ntreating patients. The ZiMA had received<br \/>\nno such reports from its members.<br \/>\nReferring to Harare he said there was no<br \/>\nproblem with the elections but that these<br \/>\narose after the election, when the political<br \/>\ntemperature rose. There had been a lot of<br \/>\nallegations about the profession. He had<br \/>\nreceived e-mails alleging that the Minister<br \/>\nof Health and Dr. Chimedza himself had<br \/>\nbeen involved in political violence and that<br \/>\nthe ZiMA as an organisation was support-<br \/>\ning violence. The allegations came from<br \/>\nthe Zimbabwe Doctors for Human Rights<br \/>\n(ZIDHR). He had met with the Chair-<br \/>\nman of ZiDHR before travelling to the<br \/>\nWMA council meeting in Divonne. Dur-<br \/>\ning this meeting the Chairman of ZiDHR<br \/>\nsaid that they had no evidence to support<br \/>\nthe allegation but had heard rumours.<br \/>\nDr. Chimedza commented that it was sad<br \/>\n\u201cthat a professional organisation could<br \/>\nmake such serious allegations without evi-<br \/>\ndence to support them.\u201d He accepted that<br \/>\nthere was a strained relationship between<br \/>\nZADHR and ZiMA from the time that<br \/>\nZADHR had been denied associate mem-<br \/>\nbership of the ZiMA. This was however<br \/>\nbecause the ZiMA constitution required<br \/>\na\ufb03liates to be speci\ufb01c medical profes-<br \/>\nsional groupings, such as paediatricians<br \/>\netc. ZADHR as a human rights associa-<br \/>\ntion was therefore not eligible for a\ufb03lia-<br \/>\ntion. In fact there had been e\ufb00orts at three<br \/>\nsuccessive ZiMA Congresses to amend the<br \/>\nconstitution to admit ZADHR and they<br \/>\nhad all failed. Despite this ZiMA had been<br \/>\naccommodating to ZADHR whose Chair-<br \/>\nman was a member of the Executive of Zi-<br \/>\nMA\u2019s Mashonaland branch. Dr. Chimedza<br \/>\nstated that ZiMA was against violence of<br \/>\nany kind, perpetrated by anyone. ZiMA<br \/>\nhad resisted being pressurised. In an over-<br \/>\nview of ZiMA\u2019s action he referred to its<br \/>\nSocial Responsibility Programme in which<br \/>\nthere were many actions such as outreach<br \/>\nto rural health centres, including equip-<br \/>\nment provision also funding for furniture<br \/>\nin HIV clinics, provision of drugs and as-<br \/>\nsistance in refurbishing hospitals, such as<br \/>\noperating theatres, as well as engaging in<br \/>\nmany other actions to assist the Zimba-<br \/>\nbwean people.<br \/>\nDr. Nathanson commented that ZiMA was<br \/>\nvulnerable to the sort of allegation referred to<br \/>\nand this was because people were not aware<br \/>\nof its work.It was a good example of how the<br \/>\nWMJ could be used to publicise these activi-<br \/>\nties. Dr. Chimedza felt this would be helpful<br \/>\nand stated that he would request ZiMA Ex-<br \/>\nFrom the left Dr. J. E. Hill,<br \/>\nDr. Paul Chimedza<br \/>\n79<br \/>\necutive to allow a WMA delegation to con-<br \/>\nduct a fact \ufb01nding mission to investigate the<br \/>\nallegations which had been made.This would<br \/>\nalso allow WMA to see the work that ZiMA<br \/>\nis doing, the challenges it faces , and identify<br \/>\nways in which WMA could assist them. Dr.<br \/>\nPlested asked whether in an environment so<br \/>\npolitically violent physicians were at personal<br \/>\nrisk. Dr. Chimedza said this was a major<br \/>\nworry.There was no violence before but after<br \/>\nthe lection.\u201cNone of our member physicians<br \/>\nhad been targeted\u201d. Problems were related to<br \/>\nthe economy.<br \/>\nThe immediate Past President proposed<br \/>\na motion to support such a delegation, to<br \/>\nwhich the Secretary General observed that<br \/>\nthis was unnecessary as it was covered by<br \/>\nthe Resolutions adopted by Council and the<br \/>\nGeneral Assembly in 2007.<br \/>\nDr.Nielsonaskedwhetheritwouldbeappro-<br \/>\npriate for the WMA to call on all physicians<br \/>\nthroughout the world to behave according<br \/>\nto the highest standards of the medical pro-<br \/>\nfession, a suggestion subsequently adopted<br \/>\nby the Council. While indicating that the<br \/>\nAMA would support sending a delegation<br \/>\nto Zimbabwe AMA felt that in would not<br \/>\nbe appropriate to describe such a delegation<br \/>\nas \u201ca fact \ufb01nding mission\u201d.<br \/>\nThe Dr. Nakia informed Council that a<br \/>\nCanadian University had for many years<br \/>\nan infective diseases health group going to<br \/>\nZimbabwe, but had di\ufb03culty recently in<br \/>\ngetting supplies into the country, as well<br \/>\nas concerns about the safety of physicians<br \/>\nand she enquired whether ZiMA would be<br \/>\nable to look into the question of safety for<br \/>\nthese physicians. Dr. Chimedza responded<br \/>\nthat ZiMA did not have the capacity to<br \/>\nguarantee the safety of anyone who was not<br \/>\ndirectly involved in ZiMA programmes and<br \/>\nthat ZiMA had temporarily suspended its<br \/>\nown programmes until violence subsides.<br \/>\nThe Chair of Council reiterated WMA\u2019s wish<br \/>\nto assist ZiMA on issues a\ufb00ecting physicians<br \/>\nand patients and Council adopted a resolu-<br \/>\ntion calling on all physicians to observe the<br \/>\nhighest standards of medical ethics.<br \/>\nMedical Ethics Committee<br \/>\nThe Chair, Dr. Bagenholm welcomed new<br \/>\nmembers of the committee and the minutes<br \/>\nof the last meeting in Copenhagen were ap-<br \/>\nproved.<br \/>\nHelsinki Declaration<br \/>\nMoving to the Declaration of Helsinki revi-<br \/>\nsion, Dr. Bagenholm said that the working<br \/>\ngroup had corresponded, producing a num-<br \/>\nber of drafts and had had a productive meet-<br \/>\ning. She asked Dr. Williams, who had done<br \/>\nmost of the writing, to set out the situation<br \/>\nand outline the most controversial issues.<br \/>\nDr. Williams said that the group were con-<br \/>\nscious of their mandate which was to iden-<br \/>\ntify gaps and to promote the Declaration of<br \/>\nHelsinki (DoH).The group meeting in Hel-<br \/>\nsinki looked at the most controversial sec-<br \/>\ntions, considered suggestions for additions,<br \/>\nbut had sought not to expand but try to<br \/>\ncapitalise the ideas into one or two sentences<br \/>\nand this constituted the agenda.In the report<br \/>\nbefore the committee most of the changes<br \/>\nwere editorial.In considering the vocabulary<br \/>\nit was decided that the best term to be used<br \/>\nfor those submitting to research was \u201cre-<br \/>\nsearch subject\u201d. He then referred to speci\ufb01c<br \/>\nitems setting out the reasons for the group\u2019s<br \/>\ndecisions,mentioning the need to avoid long<br \/>\nsentences and points which needed clari\ufb01ca-<br \/>\ntion. The Chair, Dr. Bagenholm speaking of<br \/>\nthe process, said that there would be a fur-<br \/>\nther revision after the Ethics committee and<br \/>\na workshop in Brazil in September, with a<br \/>\nview to getting a \ufb01nal document to Coun-<br \/>\ncil and submission to the General Assembly<br \/>\nthis year.She reported that an invitation had<br \/>\nbeen received to a WHO meeting in Cairo<br \/>\nof the Eastern and North African Medi-<br \/>\nterranean countries to be coordinated by<br \/>\nthe WHO Cairo O\ufb03ce and UNESCO to<br \/>\ndiscuss \u201cChallenges to Ethics and Medical<br \/>\nResearch\u201dIt was hoped that there could be a<br \/>\nparallel meeting on DoH for WMA mem-<br \/>\nbers and stakeholders.<br \/>\nOpening the discussion Dr. Nathanson<br \/>\n(UK) referred to the use of the word \u201chu-<br \/>\nman\u201d. This was a key issue. It should not be<br \/>\ninterpreted in DoH as including \u201cembryos\u201d.<br \/>\nIn DoH we are talking about humans from<br \/>\nbirth to death. President Sn\u00e6dal thanking<br \/>\nDr. Williams for his work commented that<br \/>\nthe paragraphs appeared to be lengthened,<br \/>\nthey need dividing. Turning to\u201d Research in<br \/>\nChildren\u201d he commented that this subject<br \/>\nhad not been worked on. The alternatives<br \/>\nwere to include it in DoH, or in the Dec-<br \/>\nlarations of Lisbon or Ottawa. Dr. Lemye<br \/>\nrequested that Belgium be included in the<br \/>\nworking group. An amendment which Bel-<br \/>\ngium had submitted appeared not to have<br \/>\nbeen considered. Dr. Bagenholm responded<br \/>\nsaying that all representation were consid-<br \/>\nered in Helsinki and were incorporated as<br \/>\nfar as possible, if appropriate. Dr. Havaux<br \/>\n(Switzerland) considered the document<br \/>\ngenerally to be very satisfactory except the<br \/>\nproblems arising from the DoH in many<br \/>\nlanguages. He expressed great concerns<br \/>\nabout the French translation. It was not<br \/>\nonly a problem of translation but also of<br \/>\nguidance for the French speaking countries.<br \/>\nHe proposed that the documents should<br \/>\nbe circulated in French. Dr. Kloiber agreed<br \/>\nthat we need to change the translations and<br \/>\nasked if some of the four language groups<br \/>\ncould join the editorial group to agree \ufb01nal<br \/>\nversions. Dr. Mot added that France had<br \/>\nalso some similar concerns and had added<br \/>\nthe African French speaking group to their<br \/>\neditorial group.Dr.Collins -Nakai (Canada)<br \/>\nthought there were three areas of concern:<br \/>\naccess of post trial patients,\u2022<br \/>\nuse of placebos,\u2022<br \/>\nDr. John R.Williams, Ph.D.<br \/>\nDr. Eva Nilsson B\u00e4genholm<br \/>\n80<br \/>\nthe current language was too restrictive.\u2022<br \/>\nInformed consent there had been remark-<br \/>\nable developments in the CMA.<br \/>\nDr. Bagenholm, reverting to the topic of<br \/>\nResearch on Children, reported that there<br \/>\nwere comments on this from many NMAs.<br \/>\nDr. Bagenholm opened a discussion on the<br \/>\nproposal on Research in Children reported<br \/>\nthat there had been many comments from<br \/>\nNMAs.When the committee had discussed<br \/>\nDoH it could then decide on how to deal<br \/>\nwith children. It could either be dealt with<br \/>\nin the context of this revision or dealt with<br \/>\nseparately. After recalling that the revision<br \/>\nof DoH was not to include new material,<br \/>\nshe called for expressions of interest in in-<br \/>\ncluding it in DoH. The CMA wanted it<br \/>\nincluded in DoH, using the inclusive term<br \/>\n\u201cvulnerable populations\u201d. Dr. Palve (Fin-<br \/>\nland) felt that the DoH should have a broad<br \/>\napproach \u201cIf we take up any one group why<br \/>\nshould other groups not be taken up? It<br \/>\nwould be better if these were dealt with in<br \/>\nseparate statements\u201d. Dr. Nathanson UK<br \/>\nsaid a lot depended on the timescale. She<br \/>\nrecognised that children were particularly<br \/>\nvulnerable. \u201cWe could use a small addition<br \/>\nto DoH.It was possibly quicker to deal with<br \/>\nit in DoH\u201d.Dr.Nakai (Canada) felt that re-<br \/>\nsearch on children was very important- we<br \/>\ncould use minor amendments to DoH. But<br \/>\nperhaps the WMA should consider amend-<br \/>\nment of the Declaration of Ottawa or in-<br \/>\nclude this topic in a Charter on Children\u2019s<br \/>\nHealth, which could include the proposed<br \/>\nstatement as well as assessment and promo-<br \/>\ntion of children\u2019s health.<br \/>\nDr.Plested (USA) favoured inclusion in the<br \/>\nDoH. The Declaration would be weakened<br \/>\nif we did not include the issue in this semi-<br \/>\nnal document. Prof Spumont (Switzerland)<br \/>\nsaid it was a question of principle. This was<br \/>\nthe sixth revision of Helsinki. It dealt with<br \/>\nthe constitution of research ethics. The<br \/>\nworld and science were changing.If we wish<br \/>\nto preserve the value of the DoH it should<br \/>\nbe limited to principles. It would be bet-<br \/>\nter to link speci\ufb01c declarations\/statements<br \/>\nto the DoH. Having analysed the di\ufb00erent<br \/>\nways in which the DoH has been incor-<br \/>\nporated in legislation, this would be a way<br \/>\nto proceed. Dr. Ishi (Japan) thought it had<br \/>\nbeen agreed that the statement proposed on<br \/>\nResearch in Children should be dealt with<br \/>\nas a separate document and Dr. Letlape<br \/>\n(South Africa)) considered that while there<br \/>\nmight be some amendment, we still needed<br \/>\na speci\ufb01c document. Avv. Wapner (Israel)<br \/>\nfavoured one document \u2013 that of the DoH.<br \/>\nThe proposed statement would dilute the<br \/>\nDoH. The problem was with \u201cvulnerable<br \/>\npopulations\u201d \u2013 children, the elderly, prison-<br \/>\ners etc. President Sn\u00e6dal felt that the issue<br \/>\nof research in children must be addressed.<br \/>\nWe have a proposal, also one on \u201cMaking<br \/>\nmedicines child size\u201d by WHO. WMA had<br \/>\napproved this initiative on research in chil-<br \/>\ndren it would be very expensive to extend<br \/>\nthe DoH. Dr. Letlape felt the DoH should<br \/>\nbe generic; we can\u2019t stop initiatives from<br \/>\noutside. The Paediatric Society would pro-<br \/>\nduce a child friendly version of the DoH.<br \/>\nDr. Parsa Parsi (Germany) supported in-<br \/>\nserting small changes into DoH. Dr. Kumar<br \/>\n(India) called for the inclusion of embryos<br \/>\nin the DoH.<br \/>\nDr. Williams indicated that Dr. Appleyard<br \/>\nhad not proposed alterations in DoH. He<br \/>\nwanted a separate document.This document<br \/>\napplied the principles of DoH to children.<br \/>\nHe also reminded the committee that the<br \/>\nword \u201cassent\u201dnot \u201cconsent\u201dwas in the DoH.<br \/>\nIn Council later, Dr. Bagenholm reported<br \/>\nthat comments on this from NMAs had<br \/>\nbeen received, but the working group had<br \/>\nnot produced any new draft proposals for<br \/>\naction or wording. The options were that<br \/>\nthis should be included in DoH, or that the<br \/>\nDoH be considered to be adequate in this<br \/>\nmatter, that there should be a new state-<br \/>\nment, or that the proposal be combined<br \/>\nwith the Ottawa Declaration.<br \/>\nDr. Plested agreed that the proposal should<br \/>\ngo back to NMAs for their comments on the<br \/>\noptions.Dr.Nathanson said there were many<br \/>\ngood reasons to do this. Do NMAs want a<br \/>\nholistic document or a series of statements?<br \/>\nWe needed to ask the opinion of NMAs.<br \/>\nThe Chair of Council asked what do we do<br \/>\nif we go through a new statement and lose<br \/>\nownership of the document? Dr.Kloiber re-<br \/>\nsponded that we must try to ensure that we<br \/>\njustify our position. We could ask NMAs if<br \/>\nthere was anything in the proposed state-<br \/>\nment which should go in DoH.Dr.Williams<br \/>\nwas worried that this would hold up the re-<br \/>\nvision. He wondered whether the working<br \/>\ngroup could review the proposed statement<br \/>\nand put it in the next version of DoH i.e. he<br \/>\nsuggested that the work group look at this<br \/>\nbefore the next revision of DoH.<br \/>\nThe Council \ufb01nally adopted the following<br \/>\ndecision,<br \/>\nthat the proposed statement on Ethical\u2022<br \/>\nPrinciplesforMedicalResearchonchil-<br \/>\ndren be not accepted as a WMA docu-<br \/>\nment but that the subject of research on<br \/>\nchildren be addressed by WMA in the<br \/>\ncontext of the DoH.<br \/>\nthat the DoH workgroup take into con-\u2022<br \/>\nsideration appropriate issues from the<br \/>\nproposed statement in \ufb01nalising the<br \/>\nnext revision of DoH for broad consul-<br \/>\ntation.<br \/>\nEthics committee further discussion on Hel-<br \/>\nsinki<br \/>\nThe Chair of Ethics committee then com-<br \/>\nmented that the paragraph on disease was very<br \/>\nlong,andneededsomeattentionandalsoasked<br \/>\nDr. Williams what was included in the use of<br \/>\nthe word \u201chumans\u201d. Dr. Williams replied that<br \/>\nsome thought there were important di\ufb00erenc-<br \/>\nes.As long as the word was used as an adjective<br \/>\nit meant \u201cbeing\u201dor \u201ctissue\u201d.When using it as a<br \/>\nnoun it meant \u201cborn subjects\u201d. He noted that<br \/>\nsome had called for a glossary of DoH terms<br \/>\nbut the project had been abandoned. Dr. An-<br \/>\ndrade(Brazil)consideredtheDoH tobeacore<br \/>\ndocument. It should therefore remain a basic<br \/>\ndocument of principles. It deals with the vul-<br \/>\nnerable.The question was who were the most<br \/>\nvulnerable \u2013 for him these were children. He<br \/>\nthought DoH should set standards \u2013 a docu-<br \/>\nment which cannot be ignored. It should be<br \/>\nreadable and consist of primordial principles.<br \/>\nThe de\ufb01nition of \u201chumans\u201d is biological and<br \/>\nthat of \u201cbeing\u201d,philosophical.<br \/>\n81<br \/>\nThe committee then considered the sug-<br \/>\ngested revision document paragraph by<br \/>\nparagraph. In the course of the debate there<br \/>\nwas considerable discussion of the issue of<br \/>\ndealing with principles and the danger of<br \/>\nmaking exceptions was pointed out. When<br \/>\ndealing with the issue of consent and the<br \/>\nemphasis placed on the individual in the<br \/>\nDoH, it was pointed out that this raised<br \/>\nmore than matters of consent. It also raised<br \/>\nthe issue of the balance between issues of in-<br \/>\ndividual concern and issues which were the<br \/>\nconcern of population groups &#8211; the speaker<br \/>\nas a further example posed the question as<br \/>\nto whether individuals have the right in ex-<br \/>\nceptional circumstances to object to the use<br \/>\nof blood taken for one purpose being used<br \/>\nfor another. This question and a number of<br \/>\nothers were referred to the working group.<br \/>\nAfter detailed and lengthy discussion of<br \/>\nthe proposed amendments and other is-<br \/>\nsues the committee agreed to recommend<br \/>\nthat the new draft amended by the working<br \/>\ngroup would be presented to council before<br \/>\nit concluded its meeting and that this be<br \/>\nsent to NMAs and circulated widely for<br \/>\npublic comment. Following the conference<br \/>\nin Brazil, which would include other stake-<br \/>\nholders, a new draft would be prepared for<br \/>\ncouncil and if approved, sent to the General<br \/>\nAssembly in Seoul These recommendation<br \/>\nwere adopted by Council.<br \/>\nStem Cell Research<br \/>\nThe committee engaged in further consider-<br \/>\nation of this draft proposal.There was some<br \/>\ndiscussion concerning con\ufb02ict with national<br \/>\nlaw in some countries.It was agreed that the<br \/>\ndocument, as amended, would be sent out<br \/>\nto NMAs for their views. Council adopted<br \/>\nthis recommendation.<br \/>\nProfessionally led Regulation<br \/>\nThe committee considered a paper on this<br \/>\ntopic which, it was pointed out, arose out of<br \/>\nthe consideration of the Madrid Statement<br \/>\nand new thinking.Dr.Blackmer pointed out<br \/>\nthat the paper had been circulated and the<br \/>\ncomments had mostly been editorial. In the<br \/>\ne\ufb00ort to support professionally led regula-<br \/>\ntion there was, however, a need to recognise<br \/>\nthat there must be some public involvement.<br \/>\nDr. Haikerwall (Australia) stressed that this<br \/>\nwas an important issue. The question was<br \/>\nhow to translate the importance of profes-<br \/>\nsionally led regulation to the public. The<br \/>\nPast President Dr. Letlape, (SouthAfrica)<br \/>\nsaid that the concern for his country, which<br \/>\nmight not apply elsewhere, was that advo-<br \/>\ncacy by physicians for the patient is falling<br \/>\no\ufb00.There was a need to be honest that pro-<br \/>\nfessionalism and advocacy for the patient is<br \/>\ndiminishing. We havn\u2019t kept our duty to so-<br \/>\nciety.The profession needed to be seen to be<br \/>\nthe body appropriate to regulate itself and<br \/>\ntake this responsibility. The Swedish Medi-<br \/>\ncal Association opposed the statement. Self<br \/>\nregulation was important for some NMAs.<br \/>\nFor the SMA this is too much. However,<br \/>\ninvolvement of outside bodies may be good<br \/>\nor not so good, and in this connection refer-<br \/>\nence was made to the varying functioning<br \/>\nof patient associations.The Danish Medical<br \/>\nAssociation agreed with SAMA.It observed<br \/>\nthat Dr.Blackmer had had a di\ufb03cult task In<br \/>\nDenmark and Sweden \u201cwe don\u2019t place much<br \/>\nemphasis on self regulation\u201d and the DMA<br \/>\nwas happy with the authority in Denmark.<br \/>\nWe should try to get a common position.<br \/>\nSir Charles George (BMA) supported self-<br \/>\nregulation, a concept which is being chal-<br \/>\nlenged in the UK.<br \/>\nAfter further discussion it was agreed to<br \/>\nrecommend to Council that a work group<br \/>\nbe established. This recommendation was<br \/>\napproved by Council.<br \/>\nProfessional Autonomy<br \/>\nDuring discussion of a Declaration on Pro-<br \/>\nfessional Autonomy and Clinical Indepen-<br \/>\ndence, a number of speakers pointed out<br \/>\nrelated issues which need addressing and<br \/>\nagreed that these would not be appropriate<br \/>\nfor this document. Dr.Blackmer observed<br \/>\nthat the discussion paper would inevitably<br \/>\nlead to a series of papers. It was agreed that<br \/>\n\u201ccon\ufb02ict of interest\u201dwas not appropriate for<br \/>\nthis document but needed addressing and<br \/>\nthe committee recommended that the pro-<br \/>\nposed statement should go to the General<br \/>\nAssembly in 2008, a recommendation later<br \/>\nagreed by Council, together with a request<br \/>\nthat Dr. Blackmer develop a statement on<br \/>\n\u201ccon\ufb02ict of interest\u201d.<br \/>\nCommon guidelines for physicians and the<br \/>\npharmaceutical industry<br \/>\nFollowing further discussion in committee,<br \/>\nthe Council adopted a recommendation<br \/>\nthat this issue be not pursued but deter-<br \/>\nmined that the working group should de-<br \/>\nvelop a proposal indicating how the WMA<br \/>\nand the Pharmaceutical Industry should<br \/>\ninteract.<br \/>\n1998 policy reviews<br \/>\nContinuing its review of 1998 policies<br \/>\nCouncil accepted that Resolutions on<br \/>\nSIrUS and on Health related Violations<br \/>\nof Human Rights in Kosovo, should be re-<br \/>\nscinded and archived.<br \/>\nIt was recommended and agreed by Council<br \/>\nthat the Ottawa Declaration should un-<br \/>\ndergo a major revision.<br \/>\nConcerning further revision of the statement<br \/>\non Capital punishment, it was reported that<br \/>\nfurther work would be done by the French<br \/>\nand American Medical associations to deal<br \/>\nwith the need for legal wording to satisfy<br \/>\ntranslation and other problems.<br \/>\nDenunciation of Acts of Torture and Cruel<br \/>\nand Degrading Treatment<br \/>\nThe committee considered suggested edito-<br \/>\nrial changes to the statement on Denuncia-<br \/>\ntion of Acts of Torture and Cruel or De-<br \/>\ngrading Treatment, following the request<br \/>\nof the Copenhagen General Assembly that<br \/>\nduplication be removed. After more exami-<br \/>\nnation and an assurance that the suggested<br \/>\nchanges re\ufb02ected the request of the Assem-<br \/>\nbly, Council approved the changes.<br \/>\nDr. Alan J. Rowe<br \/>\n82<br \/>\nWe, the participants at the \ufb01rst Global\u2022<br \/>\nForum on Human Resources for Health<br \/>\nin Kampala, 2-7 March 2008, and repre-<br \/>\nsenting a diverse group of governments,<br \/>\nmultilateral, bilateral and academic in-<br \/>\nstitutions, civil society, the private sector,<br \/>\nand health workers\u2019 professional associa-<br \/>\ntions and unions;<br \/>\nRecognizing the devastating impact that\u2022<br \/>\nHIV\/AIDS has on health systems and<br \/>\nthe health workforce, which has com-<br \/>\npounded the e\ufb00ects of the already heavy<br \/>\nglobal burden of communicable and non-<br \/>\ncommunicable diseases, accidents and<br \/>\ninjuries and other health problems, and<br \/>\ndelayed progress in achieving the health-<br \/>\nrelated Millennium Development Goals;<br \/>\nRecognizing that in addition to the e\ufb00ec-\u2022<br \/>\ntive health system, there are other deter-<br \/>\nminants to health;<br \/>\nAcknowledging that the enjoyment of\u2022<br \/>\nthe highest attainable standard of health<br \/>\nis one of the fundamental human rights;<br \/>\nFurther recognizing the need for immedi-\u2022<br \/>\nate action to resolve the accelerating crisis<br \/>\nin the global health workforce, includ-<br \/>\ning the global shortage of over 4 million<br \/>\nhealth workers needed to deliver essential<br \/>\nhealth care;<br \/>\nAware that we are building on existing\u2022<br \/>\ncommitments made by global and na-<br \/>\ntional leaders to address this crisis, and<br \/>\ndesirous and committed to see immediate<br \/>\nand urgent actions taken;<br \/>\nNow call upon:<br \/>\n1. Government leaders to provide the<br \/>\nstewardship to resolve the health worker<br \/>\ncrisis, involving all relevant stakeholders<br \/>\nand providing political momentum to<br \/>\nthe process.<br \/>\n2. Leaders of bilateral and multilat-<br \/>\neral development partners to provide<br \/>\ncoordinated and coherent support to<br \/>\nformulate and implement comprehen-<br \/>\nsive country health workforce strategies<br \/>\nand plans.<br \/>\n3. Governments to determine the appro-<br \/>\npriate health workforce skill mix and to<br \/>\ninstitute coordinated policies, including<br \/>\nthrough public private partnerships, for<br \/>\nan immediate, massive scale-up of com-<br \/>\nmunity and mid-level health workers,<br \/>\nwhile also addressing the need for more<br \/>\nhighly trained and specialized sta\ufb00.<br \/>\n4. Governments to devise rigorous ac-<br \/>\ncreditation systems for health worker<br \/>\neducation and training, complemented<br \/>\nby stringent regulatory frameworks de-<br \/>\nveloped in close cooperation with health<br \/>\nworkers and their professional organiza-<br \/>\ntions.<br \/>\n5. Governments, civil society, private sec-<br \/>\ntor, and professional organizations to<br \/>\nstrengthen leadership and management<br \/>\ncapacity at all levels.<br \/>\n6. Governments to assure adequate incentives<br \/>\nand an enabling and safe working environ-<br \/>\nment for e\ufb00ective retention and equitable<br \/>\ndistribution of the health workforce.<br \/>\n7. While acknowledging that migration of<br \/>\nhealth workers is a reality and has both<br \/>\npositive and negative impact, countries<br \/>\nto put appropriate mechanisms in place<br \/>\nto shape the health workforce market in<br \/>\nfavour of retention. The World Health<br \/>\nOrganization will accelerate negotia-<br \/>\ntions for a code of practice on the inter-<br \/>\nnational recruitment of health person-<br \/>\nnel.<br \/>\n8. All countries will work collectively to ad-<br \/>\ndress current and anticipated global health<br \/>\nworkforce shortages.Richer countries will<br \/>\ngive high priority and adequate funding to<br \/>\ntrain and recruit su\ufb03cient health person-<br \/>\nnel from within their own country.<br \/>\n9. Governments to increase their own \ufb01-<br \/>\nnancing of the health workforce, with<br \/>\ninternational institutions relaxing the<br \/>\nmacro-economic constraints on their do-<br \/>\ning so.<br \/>\n10. Multilateral and bilateral development<br \/>\npartners to provide dependable,sustained<br \/>\nand adequate \ufb01nancial support and im-<br \/>\nmediately to ful\ufb01ll existing pledges con-<br \/>\ncerning health and development.<br \/>\n11. Countries to create health workforce<br \/>\ninformation systems, to improve re-<br \/>\nsearch and to develop capacity for data<br \/>\nmanagement in order to institutionalize<br \/>\nevidence-based decision-making and<br \/>\nenhance shared learning.<br \/>\n12. The Global Health Workforce Alliance<br \/>\nto monitor the implementation of this<br \/>\nKampala Declaration and Agenda for<br \/>\nGlobal Action and to re-convene this<br \/>\nForum in two years\u2019 time to report-and<br \/>\nevaluate progress.<br \/>\nHuman Resources for Health, Kampala<br \/>\nDeclaration and Agenda for Global Action<br \/>\nWHO Director General addresses the<br \/>\n61st<br \/>\nWorld Health Assembly<br \/>\nDr. Margaret Chan opening her address said<br \/>\n\u201cWe are meeting at a time of tragedy\u201d, ex-<br \/>\npressing her condolences to the millions who<br \/>\nhad lost loved ones,homes and livelihoods in<br \/>\nthe cyclone in Myanmar and the earthquake<br \/>\nin China.Commenting on the great generos-<br \/>\nity shown by the international community in<br \/>\nresponding to crises of this nature,she stressed<br \/>\nthe importance of early warning systems and<br \/>\npreparations to reduce risks in advance.<br \/>\nDr. Chan referred to three global crises<br \/>\nlooming on the horizon, all of which have<br \/>\nhealth e\ufb00ects. The \ufb01rst was Food Security,<br \/>\nin which WHO is part of the \u201chigh level\u201d<br \/>\ntask force. In order to guide priority actions,<br \/>\nWHO identi\ufb01ed 21 \u201chot spots\u201d around the<br \/>\nworld where there are high levels of acute<br \/>\nand chronic under-nourishment? The sec-<br \/>\nond was Climate Change, on which she<br \/>\nelaborated and indicated the draft resolu-<br \/>\ntion before the Assembly which de\ufb01ned<br \/>\nclear WHO responsibilities The third global<br \/>\ncrisis looming is that of Pandemic In\ufb02uenza,<br \/>\nwhere the threat had by no means receded.<br \/>\n\u201cAs with climate change all countries will<br \/>\nbe a\ufb00ected, though in a far more rapid and<br \/>\nsweeping way\u201d.While these events \u201ccould set<br \/>\nback progress in reducing poverty and hun-<br \/>\nger\u201d, the Millennium Health related Goals<br \/>\nHealth \u2013 a global overview<br \/>\n83<br \/>\nreaching the world would vastly increase the<br \/>\nworld\u2019s capacity to cope with these interna-<br \/>\ntional threats.<br \/>\nWith better data and statistical methods<br \/>\nWHO and UNAIDS had been able to<br \/>\nchart the evolution of HIV\/AIDS with<br \/>\ngreater precision. Prevalence had been level<br \/>\nsince 2001 and deaths from AIDS have sig-<br \/>\nni\ufb01cantly declined in the past two years.<br \/>\nReferring to Tuberculosis, Dr. Chan said<br \/>\nthat poor medical practice, which contrib-<br \/>\nutes to the development of drug resistance,<br \/>\nhas continued to be and is a major concern.<br \/>\nMDRTB has now reached the highest level<br \/>\never recorded. \u201cTo allow this form of TB to<br \/>\nbecome widespread would be a set back,a set-<br \/>\nback of epic proportions.\u201d. There had contin-<br \/>\nued to be solid progress in Malaria control.<br \/>\nTurning to immunisation she referred to the<br \/>\nsuccessful Global Immunisation Strategy and<br \/>\nalso spoke of the broad based impact of In-<br \/>\ntegrated Management of Childhood Illness<br \/>\nwhich was now adopted as the principal child<br \/>\nsurvival strategy in 100 countries. Research<br \/>\ncoordinated by WHO had also demonstrated<br \/>\nthat home based treatment of pneumonia in<br \/>\nchildren was as e\ufb00ective as hospital care.<br \/>\nImproving women\u2019s health had proved dis-<br \/>\nappointingly slow, notably in reducing ma-<br \/>\nternal mortality.<br \/>\nIn her comments on non-communicable dis-<br \/>\neases Dr. Chan referred to the \ufb01rst ever Glo-<br \/>\nbal Tobacco Epidemic report launched with<br \/>\nthe Bloomberg Foundation in February and<br \/>\nshe emphasized that tobacco taxes were the<br \/>\nmost powerful tobacco control measures.<br \/>\nIt was the aim to control Neglected Tropi-<br \/>\ncal Diseases by 2015, and she noted that<br \/>\nwe were on the brink of eradicating guin-<br \/>\nea-worm disease. While e\ufb00orts to control<br \/>\npolio in the four remaining countries con-<br \/>\ntinue, she was concerned about a new strain<br \/>\nemerging in Africa.<br \/>\nDr. Chan stressed the need to return to Pri-<br \/>\nmary Health Care in strengthening health<br \/>\ncare systems. Primary Health Care would<br \/>\nbe the subject of the World Health Report<br \/>\nand would be published on the 30th<br \/>\nanniver-<br \/>\nsary of Alma Ata in mid-October.<br \/>\nFinally, speaking about the 60th<br \/>\nyear of the<br \/>\nfoundation of WHO, whose task then was<br \/>\nto restore Health Services in a world devas-<br \/>\ntated by war, she said that the landscape of<br \/>\nPublic Health was now very di\ufb00erent. It is<br \/>\nnow a time of unprecedented global interest<br \/>\nand investment in health,as well as an unprec-<br \/>\nedented challenge. WHO had a clear role in<br \/>\nwhich,amongst the reforms being introduced,<br \/>\nthe Global Management System would con-<br \/>\ntribute to improving WHO e\ufb03ciency and<br \/>\ntransparency in carrying out its role.<br \/>\nVital Report of Global Health Group<br \/>\nFor more than a decade, the concept of<br \/>\n\u201cglobal health\u201d has been widely promoted<br \/>\naround the world. Generally speaking, the<br \/>\nterm refers to health problems that transcend<br \/>\nnational borders and that are best addressed<br \/>\nby cooperative and collective actions.<br \/>\nThe recent pandemics of HIV\/AIDS,SARS,<br \/>\nand avian \ufb02u, as well as the growing health<br \/>\ninequities within and between nations, have<br \/>\nincreased the visibility and popularity of<br \/>\nglobal health. Further, globalization has ac-<br \/>\ncelerated and deepened health interdepen-<br \/>\ndence among societies.In 2000,world leaders<br \/>\ncommitted to the Millennium Development<br \/>\nGoals, (MDGs) \u2013 ambitious development<br \/>\ngoals to be achieved by 2015 \u2013 which speci\ufb01-<br \/>\ncally focused on health and seemed to pro-<br \/>\nmote global health even further.<br \/>\nHowever, many argue that global health ac-<br \/>\ntion is still con\ufb01ned inside the ivory tower<br \/>\nof high-ranking health administrators, or<br \/>\nwithin the major international organiza-<br \/>\ntions. In other words, many recent global<br \/>\nhealth initiatives have actually followed a<br \/>\ntop-down process. Increasing numbers of<br \/>\nhealth actors, while trying to prove their<br \/>\ne\ufb00ectiveness in the local context, have<br \/>\nasked the following questions concerning<br \/>\nglobal health: How do citizens around the<br \/>\nworld perceive the value of global health?<br \/>\nCan global health be integrated into public<br \/>\nlives and values, like the stock markets or<br \/>\noil prices? How can global health be recog-<br \/>\nnized as essential for local health needs?<br \/>\nLocal e\ufb00orts must be taken into consider-<br \/>\nation in the overall broader scope of global<br \/>\nhealth. Donors have been advised to con-<br \/>\nsider how local communities bene\ufb01t from<br \/>\nglobal health activities and how local com-<br \/>\nmunities can possibly recognize the contri-<br \/>\nbutions of these e\ufb00orts. It seems urgent to<br \/>\nre-design the approach to address existing<br \/>\nglobal health challenges. Focusing on lo-<br \/>\ncal communities and players seem to be the<br \/>\nbetter alternative.<br \/>\nThese considerations lead to the rationale of<br \/>\nthe Initiative for a Vital Report on Global<br \/>\nHealth (VRGH 2008) launched on April<br \/>\n8th, 2008, in the European Parliament in<br \/>\nBrussels. The VRGH is unique in the sense<br \/>\nthat its goal is to provide an analysis on how<br \/>\npeople around the world and notably those<br \/>\nliving in the developing countries perceive<br \/>\nAn alternative to better global health<br \/>\nFocusing on local communities and players seem to be the better alternative<br \/>\nFrom the left WHO Director General<br \/>\nDr. Margaret Chan<br \/>\n84<br \/>\nThe international Classi\ufb01cation of Diseases<br \/>\n(ICD) provides a global standard to organ-<br \/>\nise and classify information about diseases<br \/>\nand related health problems. It was devel-<br \/>\noped by the WHO, based on the Interna-<br \/>\ntional List of Causes of Death from 1893<br \/>\nand was printed and published for the \ufb01rst<br \/>\ntime in 1948.<br \/>\nThe actual ICD system provides informa-<br \/>\ntion for the morbidity and mortality sta-<br \/>\ntistics worldwide and is the database for<br \/>\nreimbursement systems, hospital records,<br \/>\nthe general health situation of population<br \/>\ngroups and shows incidences and prevalence<br \/>\nof diseases. The classi\ufb01cation is designed to<br \/>\npromote international comparability in the<br \/>\ncollection, processing, classi\ufb01cation, and<br \/>\npresentation of these statistics.<br \/>\nThe 10th<br \/>\nedition of the ICD has been in use<br \/>\nsince 1994 and will now be updated and<br \/>\nadapted to additional necessities and an in-<br \/>\ncreased IT usage.<br \/>\nWHO reported that the revision process for<br \/>\nICD 10 is not only an update but will also<br \/>\ninclude new information, combines di\ufb00er-<br \/>\nent national and international classi\ufb01ca-<br \/>\ntions, o\ufb00ers di\ufb00erent formats for users and<br \/>\nis will be globally accessible for comments<br \/>\nthrough the internet. The following sum-<br \/>\nmarizes the WHO planning for ICD 11.<br \/>\nThe structure of ICD 11<br \/>\nICD 11 will have a three level approach to<br \/>\no\ufb00er the right information for various users.<br \/>\nThe \ufb01rst level is for the primary care setting,<br \/>\nwhere the focus is on most frequent con-<br \/>\nditions in primary care with broader cat-<br \/>\negories. The second level is for clinical care,<br \/>\nwhich includes more details.The last level is<br \/>\nfor research with standardized detailed cri-<br \/>\nteria and tentative disease labels that are not<br \/>\nyet in o\ufb03cial classi\ufb01cations.<br \/>\nThe information on disease in ICD 11<br \/>\nwill be extended and in comparison to the<br \/>\nICD 10 version where only the disease, the<br \/>\nepidemiology, physiology and pathology is<br \/>\nincluded, now interventions and treatment<br \/>\nguidelines will be incorporated as well.<br \/>\nThe new ICD 11 version will contain all<br \/>\ndi\ufb00erent international and national clas-<br \/>\nsi\ufb01cations (for example WONCA, ICD,<br \/>\nICFD, ICHI) and therefore be the mainly<br \/>\nused classi\ufb01cation.<br \/>\nTo capture all this information and make<br \/>\nthe use easier, the ICD 11 version will be<br \/>\nplaced in a Health Information System and<br \/>\nbene\ufb01t from new IT technology. Through<br \/>\nthe online storage of the data, linkages to<br \/>\nhealth information bases such as population<br \/>\nregistry, insurance systems, and health ser-<br \/>\nvices, can be developed and the direct use<br \/>\nof information for i.e. clinicians, adminis-<br \/>\ntration and health reporting departments<br \/>\nincluding the electronic health record will<br \/>\nbe possible.<br \/>\nThe process of the revision<br \/>\nThe tentative timeline is that in 2010 an<br \/>\nAlpha version of ICD 11 will be prepared.<br \/>\nThat means a draft version will be written.<br \/>\nBy 2011 the Beta version including \ufb01eld tri-<br \/>\nals will be ready and in 2013 the \ufb01nal ver-<br \/>\nsion for public viewing will be available. At<br \/>\nthe WHA in 2014 the ICD 11 will get ap-<br \/>\nproval and will be implemented by 2015.<br \/>\nFor the previous revision process for ICD<br \/>\n10 comments could be handed in only in<br \/>\nthe annual meetings, which gave an advan-<br \/>\ntage to the richer countries. In order to have<br \/>\nan equal balance in receiving comments an<br \/>\nICD revision platform (Hi-Ki) via the In-<br \/>\nternet is implemented to collect comments.<br \/>\nNow everyone is allowed to send comments<br \/>\nand the more comments someone hands in<br \/>\nthe more relevance their comments will get<br \/>\nin future.However the governing body con-<br \/>\nsisting of the Top Advisory Group, the Re-<br \/>\nvision Steering Group and the WHO-FIC<br \/>\ncommittee will \ufb01nally revise all comments.<br \/>\nThe governing body at WHO<br \/>\nA Revision Steering Group will serve as<br \/>\nthe planning and steering authority in the<br \/>\nupdate and revision process and focus on<br \/>\nreviewing the scope of health care diseases<br \/>\nand ensuring that they are consistent with<br \/>\nthe overall structure. They identify users of<br \/>\nthe classi\ufb01cation and address their needs<br \/>\nand de\ufb01ne basic taxonomic and ontological<br \/>\nprincipals.<br \/>\nglobal health. The initiative in collecting<br \/>\nand re\ufb02ecting these perceptions represents<br \/>\na pertinent aim to bring the value of global<br \/>\nhealth to and from the public, and to advise<br \/>\nthe world health decision-makers in forth-<br \/>\ncoming actions.<br \/>\nThe VRGH has been operated by an inter-<br \/>\nactive process,and an online survey has been<br \/>\nlaunched to lead the opinions of global con-<br \/>\ncerns. This multilingual questionnaire has<br \/>\nbeen o\ufb00ered through the internet (http:\/\/<br \/>\nvrgh2008.blogspot.com).<br \/>\nVRGH has been supported by dozens of<br \/>\nglobal health advisers and actors through-<br \/>\nout the world, and a report is expected to be<br \/>\navailable in December, 2008, to commemo-<br \/>\nrate the 60th anniversary of the Universal<br \/>\nDeclaration of Human Rights.<br \/>\nThe VRGH represents an essential and<br \/>\nan important \ufb01rst advanced and more so-<br \/>\nphisticated step toward harmonizing and<br \/>\nstrengthening the global health practices<br \/>\nthat will ultimately bene\ufb01t the health of all<br \/>\npeople globally.<br \/>\nCoordinator:<br \/>\nPr. Peter Chang, MD, MPH, ScD<br \/>\nCo-coordinator:<br \/>\nVincent Rollet , MIR<br \/>\nThe new revision process of the International<br \/>\nClassi\ufb01cation of Diseases<br \/>\n85<br \/>\nThe Topic Advisory Groups (TAG) will<br \/>\nserve as the planning and coordinating ad-<br \/>\nvisory body for speci\ufb01c issues, which are key<br \/>\ntopics in the update and revision process,<br \/>\nnamely Oncology, Mental Health, External<br \/>\nCauses of Injury, Communicable Diseases,<br \/>\nNon-communicable Diseases, Rare Diseas-<br \/>\nes and others to be established. Each TAG<br \/>\nwill determine the number and content ar-<br \/>\neas of the workgroups, identify the mem-<br \/>\nbers and chairs of the workgroups, present<br \/>\nan initial mandate to each workgroup and<br \/>\nestablish procedures for the activities of the<br \/>\nworkgroups. They will also give advice in<br \/>\ndeveloping protocols for and in implement-<br \/>\ning \ufb01eld trials.<br \/>\nFurther information can be found on the<br \/>\ninternet page: http:\/\/www.who.int\/classi\ufb01-<br \/>\ncations\/icd\/en<br \/>\nDr. Julia Seyer<br \/>\nThe Brazilian Medical Association (AMB)<br \/>\nwas honored to host the Work Group<br \/>\nfrom World Medical Association (WMA),<br \/>\nwhich discussed the Review of Declaration<br \/>\nof Helsinki, on August 20th<br \/>\nand 21st<br \/>\n. The<br \/>\nmeeting was held in S\u00e3o Paulo, one of the<br \/>\nlargest cities of Brazil.<br \/>\nOn August 19th<br \/>\nand on the morning of<br \/>\n20th<br \/>\n, before the WMA\u2019s Work Group meet-<br \/>\ning, AMB organized a debating forum and<br \/>\ninvited renowned Brazilian researchers to<br \/>\ndebate the placebo and post-trial access to<br \/>\ntreatment. The event raised di\ufb00erent points<br \/>\nof view.<br \/>\nComments given on the \ufb01rst day of the event<br \/>\nserved the basis for suggestions made to Eva<br \/>\nBagenholm, President of WMA\u2019s Ethics<br \/>\nCommittee, and Otmar Kloiber, General<br \/>\nSecretary, who kindly accepted AMB\u2019s invi-<br \/>\ntation to discuss with the forum participants.<br \/>\nIt was a very productive moment, because<br \/>\nBrazilian participants could express their<br \/>\nthoughts about the Declaration.<br \/>\nOn 20th<br \/>\nduring the afternoon, the Work<br \/>\nGroup,composed of Brazilian,South African,<br \/>\nGerman,Japanese and Swedish representants,<br \/>\ngot together to debate changes that eventu-<br \/>\nally will be presented in Seoul. There were<br \/>\nalso representants of Medical Associations<br \/>\nfrom Uruguay,Canada and Portugal,as well a<br \/>\nmember of International Federation of Phar-<br \/>\nmaceutical Manufacturers &#038; Associations.<br \/>\nJohn Williams, Ethics director explained<br \/>\nto participants when previous Declaration<br \/>\nreviews, occurred each review\u2019s purpose and<br \/>\nthe need of adding notes of clari\ufb01cation.<br \/>\nNext, he described how the process of re-<br \/>\nview would be conducted: there will be no<br \/>\nchanges in the structure, just on the scope<br \/>\nand terminology; review of controversial is-<br \/>\nsues of paragraphs 29 and 30,besides enclo-<br \/>\nsuring notes of clari\ufb01cation. At that point<br \/>\ncame, up a question whether the document<br \/>\nshoud be only destined to physicians or to<br \/>\nall people that do research. After justi\ufb01ed<br \/>\narguments, it was decided that the Decla-<br \/>\nration should be destined initially to phy-<br \/>\nsicians, but other participants in medical<br \/>\nresearch involving human beings should be<br \/>\nencouraged to follow the same principles.<br \/>\nAnother aspect discussed was the use of<br \/>\n\u201cshould\u201d or \u201cmust\u201d. It was explained that<br \/>\ntranslations are complicated because not all<br \/>\nlanguages have this di\ufb00erentiation.To some<br \/>\npeople, must has a legal value and the Dec-<br \/>\nlaration of Helsinki is just a guide and not a<br \/>\ndocument with legal validity.<br \/>\nThe discussion gained more rhythm and<br \/>\nparticipation when was announced that<br \/>\nchanges would be discussed in the previous<br \/>\nparagraph 29 (version of 2004 of Declara-<br \/>\ntion) and current paragraph 32 (last version<br \/>\nof draft), which embodied one note of clari-<br \/>\n\ufb01cation. On that moment, all participants<br \/>\ngave their opinion and the placebo issue<br \/>\ntook all afternoon.<br \/>\nSome people defended that the, use of pla-<br \/>\ncebo should not happen when there is e\ufb00ec-<br \/>\ntive treatment,because in face of an innocu-<br \/>\nous substance, any new medicine would be<br \/>\nvalid. All participants agreed that the use of<br \/>\nplacebo must be extremely controlled and<br \/>\nlimited to circumstances in which there are<br \/>\nno other e\ufb00ective method.<br \/>\nThe importance of placebo in certain kinds<br \/>\nof therapeutics and this decision must be<br \/>\nsolely based on ethical principles was also<br \/>\npointed out.<br \/>\nThe \ufb01rst part of the morning of 21st<br \/>\nwas<br \/>\nopened with discussions about paragraph<br \/>\n30, which in the latest review will be the 14th<br \/>\nand will include the second note of clari\ufb01-<br \/>\ncation. Among the arguments brought up<br \/>\nabout the writing of this paragraph are: un-<br \/>\ntil when should treatment be guaranteed? Is<br \/>\nthe right endless? How to deal if the drug is<br \/>\nnot approved in the country? The remaining<br \/>\nquestion was how to include the guarantee of<br \/>\npost-trial access to treatment in the current<br \/>\nversion of the Declaration of Helsinki. In<br \/>\nthis case, they all agreed that arrangements<br \/>\nmust be detailed in the protocol.<br \/>\nAfter a small break, discussion was resumed<br \/>\nwith announcement of other proposal<br \/>\nchanges. One of them was the possibility of<br \/>\nincluding in the Declaration a note of clari-<br \/>\n\ufb01cation about children research. Changes<br \/>\ndone on the paragraph 5 met part of this<br \/>\nneed. Besides that, information might be<br \/>\nincluded in the Declaration of Ottawa,<br \/>\nwhich regulates rights of children to health<br \/>\ncare, that refers to ethical principles of Dec-<br \/>\nlaration of Helsinki.<br \/>\nAfter conclusion, representatives of the<br \/>\nWork Group, Eva Bagenholm, John Wil-<br \/>\nliams and Otmar Kloiber came together<br \/>\nduring a private lunch to consolidate the last<br \/>\nissues about the Declaration of Helsinki.<br \/>\nPaula Mobaid,<br \/>\nAMB, International Relations<br \/>\nDoH Revision meeting in S\u00e3o Paulo<br \/>\n86<br \/>\nDr. Julia Seyer<br \/>\nTo achieve the Millennium Development<br \/>\nGoals and established targets for 2015, the<br \/>\nStop TB Strategy was expanded in 2006 to<br \/>\naddress the pressing challenges posed by<br \/>\nHIV\/AIDS co-infection, TB drug resist-<br \/>\nance and limited access to adequate care.<br \/>\nOne of the strategy\u2019s chief components is to<br \/>\nengage health care providers from all public<br \/>\nand private sectors, as well as to strengthen<br \/>\nhealth systems, recognizing that in many<br \/>\nhigh-burdened countries, ill patients of-<br \/>\nten seek care outside the National TB<br \/>\nPrograms (NTP). The DOTS Expansion<br \/>\nWorking Group (DEWG), established un-<br \/>\nder the STOP TB Partnership, has moved<br \/>\nto promote the expansion of quality DOTS<br \/>\namong all relevant public and private health<br \/>\ncare providers in TB control through the<br \/>\nPublic-Private Mix (PPM) initiative.<br \/>\nThe PPM approach starts with a National<br \/>\nSituation Assessment where all relevant<br \/>\npublic and private health care providers are<br \/>\nidenti\ufb01ed and their roles analyzed in order<br \/>\nto de\ufb01ne where PPM should be imple-<br \/>\nmented and what the requirements are for<br \/>\nthis. The National TB programs will have<br \/>\nthe responsibility of funding, regulation and<br \/>\nmonitoring TB care and control. The actual<br \/>\nTB care and treatment is provided by local<br \/>\nNTP facilities or private and public hospi-<br \/>\ntals, clinics, specialists, GPs. They are called<br \/>\nnon-NTP providers.<br \/>\nThe 5th<br \/>\nPrivate-Public-Mix (PPM) sub-<br \/>\ngroup meeting in Cairo<br \/>\nThe \ufb01fth meeting was hosted by the WHO<br \/>\nregional o\ufb03ce of the Eastern Mediterrane-<br \/>\nan (EMRO) and concentrated on mecha-<br \/>\nnisms and tools to build capacities of insti-<br \/>\ntutions supporting and\/or undertaking TB<br \/>\ncare provision such as national professional<br \/>\norganizations, large hospitals, and corporate<br \/>\nsector health establishments.<br \/>\nThe conference started with an overview of<br \/>\nthe global and regional progress on PPM<br \/>\nfrom the implementation in 2002 until now.<br \/>\nTo date,over 40 PPM projects have been im-<br \/>\nplemented in 14 countries, of which 25 have<br \/>\nbeen evaluated with regards to progress and<br \/>\noutcomes. The detection rate of TB under<br \/>\nPPM increased from 10 % to 60 % and the<br \/>\ntreatment success rate is between 75 % and<br \/>\n90 %. However these \ufb01gures are misleading<br \/>\nin this context.Much data is still missing and<br \/>\nonly a small proportion of all TB patients are<br \/>\nreceiving the PPM DOTS services.<br \/>\nProject managers from NTP national level<br \/>\nreported that they are overwhelmed with<br \/>\ntheir workload. They have too many dif-<br \/>\nferent kinds of responsibilities and need a<br \/>\nstricter role de\ufb01nition. They should focus<br \/>\nmainly on organisation and less on tech-<br \/>\nnical assistance. Other stakeholders like<br \/>\nprofessional associations or care providers<br \/>\nshould be included and could o\ufb00er the lat-<br \/>\nter as well.<br \/>\nThe PPM subgroup meeting identi\ufb01ed<br \/>\nmechanisms and tools to engage institu-<br \/>\ntions, especially national professional orga-<br \/>\nnizations, large hospitals and the corporate<br \/>\nsector, and patients and communities in TB<br \/>\ncare and control.<br \/>\nThe group \u201cMobilizing professional as-<br \/>\nsociations and promoting ISTC (Interna-<br \/>\ntional Standard of TB Care)\u201d developed<br \/>\nkey recommendations for PPM subgroup<br \/>\nand NTPs on how to engage professional<br \/>\nassociations on a global and national level.<br \/>\nProfessional associations are seen as a very<br \/>\nimportant partner in developing and imple-<br \/>\nmenting the PPM strategy and communica-<br \/>\ntion and cooperation needs to be increased.<br \/>\nThey should take part in the national situ-<br \/>\nation assessment, development of regular<br \/>\noutcome reports, delivery of TB treatment<br \/>\nand their facilities should be certi\ufb01ed by<br \/>\nthe government. Ways to foster the com-<br \/>\nmunication with professional associations<br \/>\nare through TB training, CME, articles in<br \/>\nmedical journals, TB campaigns and more.<br \/>\nThe main focus is at the moment on the<br \/>\nmedical professional associations because<br \/>\nphysicians are the main persons o\ufb00ering TB<br \/>\ntreatment. It is the expectation that PPM<br \/>\nthrough professional associations can reach<br \/>\nout to public and private working physi-<br \/>\ncians. However in future other profession-<br \/>\nals like nurses or hospital managers will be<br \/>\nincluded as well.<br \/>\nDuring the UNION conference from 15-<br \/>\n18th<br \/>\nOctober the next PPM subgroup meet-<br \/>\ning will take place and the PPM strategy<br \/>\nwill be announced to the DOTS expansion<br \/>\nworking group. All participants and espe-<br \/>\ncially the WHO welcomed the WMA at-<br \/>\ntending the meeting in Cairo. Without the<br \/>\nparticipation of the physicians the PPM<br \/>\nstrategy won\u2019t be possible.<br \/>\nInformation material available:<br \/>\nGuidance on implementing PPM- en-\u2022<br \/>\ngaging all health care providers in TB<br \/>\ncontrol<br \/>\nToolkit for National situation assessment\u2022<br \/>\nGeneral guidelines and practical tools fro\u2022<br \/>\nimplementing hospital DOTS linkage<br \/>\nHandbook for using the ISTC\u2022<br \/>\nReport from the inter-regional planning\u2022<br \/>\nworkshop on PPM<br \/>\nCo-operation of WMA and the Stop TB<br \/>\npartnership \u2013 Private-Public-Mix in the \ufb01ght<br \/>\nagainst TB<br \/>\n87<br \/>\nGeneva, 14 May 2008 \u2013 Eli Lilly and Com-<br \/>\npany announced the scaling-up of an exist-<br \/>\ning partnership with the World Medical<br \/>\nAssociation (WMA) by providing a grant<br \/>\nof $998,773 to expand training courses for<br \/>\nphysicians on multi-drug resistant tuber-<br \/>\nculosis (MDR-TB). Tuberculosis (TB) is<br \/>\na preventable disease that kills close to two<br \/>\nmillion people every year and infects an es-<br \/>\ntimated nine million more. Of these, nearly<br \/>\n500,000 have multidrug-resistant TB.<br \/>\nThe purpose of this online training is to help<br \/>\nphysicians, both in the public and private<br \/>\nsector, to use the latest international guide-<br \/>\nlines and treatment protocols for MDR-TB<br \/>\ncare in their daily work.This will allow more<br \/>\nphysicians around the world to acquire the<br \/>\nbasic knowledge on standard TB manage-<br \/>\nment at a time when there is a resurgence<br \/>\nof the epidemic. A new toolkit will also be<br \/>\ndeveloped for physicians on how to manage<br \/>\nTB in the workplace. This will be produced<br \/>\nwith the World Economic Forum for use in<br \/>\nChina and South Africa.<br \/>\nThe announcement of the new four-year<br \/>\njoint partnership agreement was marked in<br \/>\nGeneva today by a signing ceremony be-<br \/>\ntween Jacques Tapiero, president of Lilly\u2019s<br \/>\nintercontinental operations and WMA<br \/>\npresident Dr. Jon Snaedal. Lilly\u2019s key part-<br \/>\nners including the World Health Organiza-<br \/>\ntion (WHO), the Stop TB Partnership, the<br \/>\nInternational Council of Nurses, the World<br \/>\nEconomic Forum and alongside Geneva-<br \/>\nbased diplomats and foreign dignitaries,<br \/>\nwere invited to the ceremony.<br \/>\nDr. Snaedal said: \u201cWe shall now be making<br \/>\nthe course more interactive with more case<br \/>\nstudies and a progressive learning pattern.<br \/>\nA TB refresher course was important to get<br \/>\nphysicians back on track regarding the basic<br \/>\nknowledge of standard TB.\u201d<br \/>\nJacques Tapiero added: \u201cWe applaud<br \/>\nWMA\u2019s commitment to developing inno-<br \/>\nvative approaches to stemming the MDR-<br \/>\nTB global burden. Given adequate health-<br \/>\ncare infrastructure and adherence to proper<br \/>\nmedication regimens, MDR-TB is not only<br \/>\ntreatable, but indeed curable. This online<br \/>\ntraining course was an important addition<br \/>\nto the already existing tools and activities of<br \/>\na larger partnership of 16 public and private<br \/>\norganizations worldwide dedicated to \ufb01ght-<br \/>\ning MDR-TB.\u201d<br \/>\nWith underwriting from Lilly, the WMA<br \/>\nover the past year has already developed<br \/>\nan online training course for physicians to<br \/>\nmore e\ufb00ectively diagnose, prevent and treat<br \/>\nmulti-drug resistant tuberculosis. Clini-<br \/>\ncal guidelines were developed and harmo-<br \/>\nnized with evidence-based material sourced<br \/>\nfrom the WHO, the International Council<br \/>\nof Nurses and the International Hospital<br \/>\nFederation. The course was tested among<br \/>\nphysicians in South Africa. The Norwegian<br \/>\nMedical Association has adapted the mate-<br \/>\nrial to a web-based format and will be pro-<br \/>\nviding CME credits to those following the<br \/>\ncourse. The German Medical Association<br \/>\nassisted in providing managerial support in<br \/>\nthe conception of the project.<br \/>\nThe online course will be expanded to de-<br \/>\nvelop a TB refresher course and a training<br \/>\ncourse on MDR-TB training. Training<br \/>\nchampions in MDR-TB treatment will be<br \/>\ncreated in South Africa, India and China.<br \/>\nThe course, already available in English, is<br \/>\nbeing translated into Spanish, French, Chi-<br \/>\nnese and Russian and will be published in<br \/>\nhandbook and CD form in addition to the<br \/>\nonline format. MDR-TB is a serious pub-<br \/>\nlic health threat in many parts of the world,<br \/>\nnotably in Sub-Saharan Africa,Central and<br \/>\nEastern Europe,mainland China,Southeast<br \/>\nAsia and in Central and South America.<br \/>\nThe recent identi\ufb01cation of extremely<br \/>\nvirulent TB and the increasing number of<br \/>\nMDR-TB cases show that the knowledge<br \/>\nand handling of TB treatment is still insuf-<br \/>\n\ufb01cient. With concrete evidence that incom-<br \/>\nplete TB treatment is responsible for the<br \/>\noccurrence of extremely drug resistant TB,<br \/>\nan ethics policy is being planned to look at<br \/>\nwhether and how patients can be encour-<br \/>\naged to complete their treatment regimen<br \/>\nand where the autonomy of a patient ends<br \/>\nin order to safeguard public health.<br \/>\nThe World Medical Association is the<br \/>\nindependent confederation of national<br \/>\nmedical associations from more than 80<br \/>\ncountries and represents more than eight<br \/>\nmillion physicians. Acting on behalf of<br \/>\npatients and physicians, the WMA endea-<br \/>\nvours to achieve the highest possible stan-<br \/>\ndards of medical care, ethics, education and<br \/>\nhealth-related human rights for all people.<br \/>\nwww.wma.net<br \/>\nThe Lilly MDR-TB Partnership was cre-<br \/>\nated to confront multidrug-resistant tuber-<br \/>\nculosis, a disease so daunting that no single<br \/>\norganization can \ufb01ght it alone. Since 2003,<br \/>\nthe public-private initiative, mobilizing 16<br \/>\npartners on \ufb01ve continents, has worked<br \/>\ntogether to share expertise in the quest to<br \/>\ncontain and conquer one of the world\u2019s<br \/>\noldest diseases. The Partnership\u2019s multi-<br \/>\npronged approach includes: community<br \/>\nsupport and patient advocacy; treatment,<br \/>\ntraining and surveillance; transferring tech-<br \/>\nnology; research; and awareness and pre-<br \/>\nvention. Additional information about The<br \/>\nLilly MDR-TB. Partnership is available at<br \/>\nwww.lillymdr-tb.com<br \/>\nContact:<br \/>\nNigel Duncan. WMA Public Relations<br \/>\nConsultant. nduncan@ndcommunications.co.uk<br \/>\nJJ Divino. Communications Manager,<br \/>\nInternational Aid Unit, Eli Lilly and<br \/>\nCompany. divinojj@lilly.com<br \/>\nLilly Commits $1MM to World Medical<br \/>\nAssociation to support Innovative<br \/>\nTuberculosis training course<br \/>\n88<br \/>\nBob Miglani<br \/>\nSenior Director, External Medical A\ufb00airs In-<br \/>\nternational, Department of the Chief Medical<br \/>\nO\ufb03cer, P\ufb01zer Inc.<br \/>\nIt doesn\u2019t take a doctor to diagnose that<br \/>\nthe healthcare systems of the world are in<br \/>\nvery bad shape. Factors such as the age-<br \/>\ning population and increasing prevalence of<br \/>\nlifestyle-related conditions like obesity are<br \/>\nplacing untenable pressure on traditional<br \/>\nmodels of healthcare provision. But while<br \/>\nmany healthcare \u201cexperts\u201d seek solutions<br \/>\nand propose reforms, those at the delivery<br \/>\nend of healthcare, namely physicians, are<br \/>\noften overlooked and excluded from health<br \/>\npolicy decision-making.<br \/>\nThe result is that physicians around the<br \/>\nworld are working within health systems<br \/>\nimposed upon them, usually without any<br \/>\nconsultation let alone involvement. De-<br \/>\nsigned with time and money rather than<br \/>\npatient care in mind, these systems restrict<br \/>\nand con\ufb01ne doctors making it increasingly<br \/>\ndi\ufb03cult for them to practice medicine as<br \/>\nthey wish. Growing frustration is lead-<br \/>\ning many healthcare professionals to take<br \/>\ndirect action as they seek to in\ufb02uence<br \/>\nhealthcare reform and policy direction for<br \/>\nthe future.<br \/>\nThroughout 2006 and 2007 German physi-<br \/>\ncians from across the country held various<br \/>\nprotests to demonstrate against new restric-<br \/>\ntive contracts being imposed on them by<br \/>\nthe government and which they felt would<br \/>\ngreatly reduce their e\ufb00ectiveness. In March<br \/>\nlast year UK junior doctors marched in pro-<br \/>\ntest against a new training system which<br \/>\nmade it impossible for them to apply for the<br \/>\nposts they wanted. In September of 2007<br \/>\nSpanish doctors undertook strikes to ask for<br \/>\nmore time with each patient (to a total of<br \/>\njust 10 minutes) and this summer,in the US<br \/>\nphysicians and nurses have also made their<br \/>\nvoices heard in major cities to advocate for<br \/>\nuniversal healthcare.<br \/>\nWhile the exact catalyst for these protests<br \/>\nmay vary, they all share a common theme: a<br \/>\ndesire to be allowed to exercise their voca-<br \/>\ntion as they wish. To be allowed to do what<br \/>\nthey do best: be doctors.<br \/>\nWhether they practice in Barcelona or Bei-<br \/>\njing, Montreal or Munich, physicians want<br \/>\nto spend their time treating patients to the<br \/>\nbest of their ability, not \ufb01lling out forms,<br \/>\nwrestling with \ufb01nancial targets or poring<br \/>\nover guidelines to determine which treat-<br \/>\nment approaches they are permitted to take<br \/>\nfor their patient.<br \/>\nAs part of its Medical Partnerships Initia-<br \/>\ntive, P\ufb01zer has been tracking the attitudes<br \/>\nand opinions of health professionals over<br \/>\nthe past few years. A series of surveys inves-<br \/>\ntigating how physicians feel about their role<br \/>\nin healthcare, developments in the quality<br \/>\nof care and the future of their profession,<br \/>\nhas been conducted in Asia, Europe and<br \/>\nthe Americas. The \ufb01ndings making salutary<br \/>\nreading not only for physicians but for all<br \/>\nthose involved in healthcare delivery, and<br \/>\nhighlight just how widely shared the con-<br \/>\ncerns and issues discussed above, are across<br \/>\nthe globe.<br \/>\nThe most recent of these surveys was car-<br \/>\nried out earlier this year among primary<br \/>\ncare physicians and specialists in 13 coun-<br \/>\ntries around the world. Research company<br \/>\nAPCO Insight interviewed 1,741 doctors<br \/>\nin Asia, Europe and North America and<br \/>\nfound some interesting trends and varia-<br \/>\ntions from region-to-region.<br \/>\nMedicine Moving in a Negative Direc-<br \/>\ntion<br \/>\nWhile across most of the globe, doctors re-<br \/>\nmain moderately satis\ufb01ed with their own<br \/>\npersonal experience of practicing medicine<br \/>\n(out of 10 Asia 7.25,Europe 6.32 and North<br \/>\nAmerica 6.94), when it comes to the bigger<br \/>\npicture and the practice of medicine overall,<br \/>\nEuropean and North American doctors are<br \/>\ngenerally negative. Over half of European<br \/>\ndoctors (51 percent) consider that the prac-<br \/>\ntice of medicine is going in a negative direc-<br \/>\ntion and in North America this \ufb01gure was<br \/>\n39 percent.<br \/>\nThe data from Asia was less homogenous<br \/>\nwith a clear split between Chinese and In-<br \/>\ndian doctors and those from Japan and Ko-<br \/>\nrea, with Australian physicians somewhat in<br \/>\nthe middle. Japanese and Korean doctors<br \/>\n(79 percent and 87 percent respectively)<br \/>\nagreed with European and North Ameri-<br \/>\ncan physicians that medicine is going in a<br \/>\nnegative direction. However, Chinese and<br \/>\nIndian doctors (78 percent and 77 percent<br \/>\nrespectively) felt medicine was going in a<br \/>\npositive direction. Australian physicians<br \/>\nwere less de\ufb01nitive with 50 percent positive<br \/>\nand 30 percent negative.<br \/>\nThe most frequently cited reasons for the<br \/>\nbelief that the practice of medicine is going<br \/>\nin a negative direction were \u201cgovernment<br \/>\nmismanagement of healthcare systems\u201d in<br \/>\nAsia (32 percent), \u201cnon-medical entities<br \/>\ninterfering in medical decisions\u201d in Europe<br \/>\n(36 percent) and \u201cbusiness aspects of medi-<br \/>\ncine\u201d in North America (42 percent).<br \/>\nWhat Physicians are REALLY Thinking<br \/>\n89<br \/>\nIs the Doctor-Patient Relationship on the<br \/>\nCritical List?<br \/>\nAs can be seen above, at the top of the list<br \/>\nwas the deterioration of the relationship<br \/>\nbetween doctor and patient. When asked<br \/>\nabout the factors which have changed the<br \/>\ndoctor-patient relationship, the majority of<br \/>\ndoctors believe this has been a\ufb00ected by pa-<br \/>\ntients:<br \/>\nexpecting to spend more time with their\u2022<br \/>\ndoctors (Asia 96 percent, Europe 72 per-<br \/>\ncent and North America 64 percent)<br \/>\nbeing increasingly concerned about being\u2022<br \/>\nable to pay for their care (Asia 93 percent,<br \/>\nEurope 62 percent and North America<br \/>\n81 percent) and,<br \/>\nspeci\ufb01c treatment expectations (Asia 84\u2022<br \/>\npercent, Europe 85 percent and North<br \/>\nAmerica 92 percent), presumably which<br \/>\nthe physician cannot always meet.<br \/>\nOther factors which physicians believe ad-<br \/>\nversely impact their relationships with their<br \/>\npatients include patients being concerned<br \/>\nthat they are not o\ufb00ered the best choices<br \/>\nfor quality care and increasing skepticism<br \/>\naround physicians\u2019 authority. In fact, the<br \/>\nsurvey found that between 47 percent (Asia<br \/>\nand North America) and 63 percent of phy-<br \/>\nsicians said that government-led clinical<br \/>\nassessments had limited the treatment they<br \/>\ncould choose on behalf of patients.<br \/>\nFrom this analysis of the doctor-patient re-<br \/>\nlationship, it is clear that patients are suf-<br \/>\nfering from the adverse e\ufb00ects of many of<br \/>\nthe unwelcome changes in healthcare that<br \/>\nhave negatively a\ufb00ected physicians. Pri-<br \/>\nmarily, this might best be summarized as a<br \/>\nloss of autonomy or outside interference in<br \/>\nmedical practice. As highlighted above,this<br \/>\nis borne out by the fact that \u201cgovernment<br \/>\nmismanagement of healthcare systems\u201d and<br \/>\n\u201cnon-medical entities interfering in medical<br \/>\ndecisions\u201d were among the most frequently<br \/>\ncited reasons for the perception that medi-<br \/>\ncine is moving in a negative direction. This<br \/>\nis further reinforced by other results of the<br \/>\nsurvey below.<br \/>\nTime is of the Essence<br \/>\nSo reducing the amount of interference in<br \/>\nclinical practice might be one way of im-<br \/>\nproving the ailing doctor-patient relation-<br \/>\nship. The survey results also highlighted<br \/>\npossible prescription for success: doctors<br \/>\nspending more time with their patients.<br \/>\nIn Europe and North America, half of<br \/>\nthe doctors surveyed (53 percent and 51<br \/>\npercent, respectively) say the average time<br \/>\nspent with patients has decreased since they<br \/>\nbegan practicing medicine. While in Asia<br \/>\nthe majority (41 percent) believe time spent<br \/>\nwith patients has remained the same.<br \/>\nThis \ufb01nding was reinforced by another<br \/>\nquestion posed in the survey: \u201cwhat would<br \/>\nyou change to improve the quality of patient<br \/>\nvisits\u201d. The most frequently quoted response<br \/>\nwas \u201cincrease time with patients\u201d with 51<br \/>\npercent of North American and 49 percent<br \/>\nof European respondents giving this answer.<br \/>\nIn Asia, 30 percent suggested this, second<br \/>\nonly to increased medical facilities.<br \/>\nTime also came to the fore when European<br \/>\nphysicians were asked to rank the signi\ufb01-<br \/>\ncance of various factors in relation to their<br \/>\njob satisfaction. \u201cHaving enough time with<br \/>\neach patient to provide care in the way I<br \/>\nwould choose\u201d was the most signi\ufb01cant is-<br \/>\nsue in Europe with the top score of 8.05 out<br \/>\nof ten.<br \/>\nBut when it comes to spending time with<br \/>\npatients,it is not just doctors\u2019desires that are<br \/>\nan issue here: the vast majority of doctors<br \/>\nworldwide (93 percent) agree that spending<br \/>\nmore time with each patient would con-<br \/>\ntribute to better health outcomes for those<br \/>\npatients, a view shared equally among Gen-<br \/>\neralists and Specialists.<br \/>\nTop 5 Unprompted Reasons Practice of Medicine Going a Negative Direction<br \/>\nReason Global<br \/>\nTotal<br \/>\nAsia<br \/>\nTotal<br \/>\nAsia<br \/>\nHigh<br \/>\nEurope<br \/>\nTotal<br \/>\nEurope High N<br \/>\nAmerica<br \/>\nTotal<br \/>\nNA<br \/>\nHigh<br \/>\nDoctor patient<br \/>\nrelationship dete-<br \/>\nriorating<br \/>\n28% 31% 50%<br \/>\nChina<br \/>\n25% 36% France 26% 27%<br \/>\nCanada<br \/>\nGeneral aspects of<br \/>\nprofession<br \/>\n25% 28% 55%<br \/>\nChina<br \/>\n24% 27% Germany 20% 26%<br \/>\nCanada<br \/>\nBusiness aspects of<br \/>\nmedicine<br \/>\n25% 19% 69%<br \/>\nKorea<br \/>\n28% 40% Germany 42% 45%<br \/>\nUS<br \/>\nGovernment<br \/>\nmismanagement of<br \/>\nhealthcare systems<br \/>\n22% 32% 70%<br \/>\nKorea<br \/>\n8% 16% Belgium 13&#038; 15% US<br \/>\nNon-medical enti-<br \/>\nties interfering in<br \/>\nmedical decisions<br \/>\n21% 8% 23%<br \/>\nAustra-<br \/>\nlia<br \/>\n36% 46% Germany 39% 44% US<br \/>\nPercentage who \u201cstrongly agree\u201d or \u201csomewhat agree\u201d with statement<br \/>\nStatement Global<br \/>\nTotal<br \/>\nAsia<br \/>\nTotal<br \/>\nAsia<br \/>\nHigh<br \/>\nEurope<br \/>\nTotal<br \/>\nEurope<br \/>\nHigh<br \/>\nN America<br \/>\nTotal<br \/>\nNA<br \/>\nHigh<br \/>\nPhysicians have lost<br \/>\ncontrol of medical<br \/>\ncare decisions to<br \/>\nother people<br \/>\n46% 38% 81%<br \/>\nKorea<br \/>\n67% 87%<br \/>\nPortugal<br \/>\n82% 85% US<br \/>\nReducing govern-<br \/>\nment involvement<br \/>\nin healthcare<br \/>\nwould be better for<br \/>\neveryone<br \/>\n68% 66% 89%<br \/>\nKorea<br \/>\n72% 85%<br \/>\nGer-<br \/>\nmany<br \/>\n70% 73% US<br \/>\n90<br \/>\nWhile it could be argued that there is lit-<br \/>\ntle that can be done about the increasing<br \/>\nnumber of patients who seek their doctors\u2019<br \/>\ntime, there is surely a better way to allocate<br \/>\ndoctors existing and increasingly precious<br \/>\ntime. The survey found that 51 percent of<br \/>\nEuropean doctors who said that they were<br \/>\nspending less time with patients said that<br \/>\nthis was because of \u201cadministrative bureau-<br \/>\ncratic requirements\u201d.<br \/>\nThere is perhaps a correlation here with<br \/>\nanother question, when European phy-<br \/>\nsicians were asked \u201cwhich experience in<br \/>\nthe practice of medicine today is the most<br \/>\nunsatisfying to you?\u201d, the most frequently<br \/>\ncited response by some margin was \u201cad-<br \/>\nministrative tasks\u201d (30 percent). Perhaps<br \/>\nEuropean doctors would be happier if they<br \/>\ncould switch their focus back to treating<br \/>\ntheir patients rather than \ufb01lling in forms.<br \/>\nIt is therefore not surprising that, another<br \/>\nbusiness-related aspect of medicine was a<br \/>\ncause of dissatisfaction:<br \/>\nFew physicians take up the profession to<br \/>\nbecome more familiar with accounting pro-<br \/>\ncedures and indeed, money matters leave<br \/>\nmost physicians distinctly de\ufb02ated. When<br \/>\nasked to state the most unsatisfying experi-<br \/>\nences in their practice, globally, 17 percent<br \/>\ncited \u201crationing care\/cost containment\u201d,<br \/>\n14 percent \u201ccompensation\u201d and 13 percent<br \/>\n\u201cpayer issues\u201d.<br \/>\nSeeking Solutions and Support<br \/>\nOver the past \ufb01ve years as our research has<br \/>\ntracked the belief among physicians around<br \/>\nthe world that they are no longer masters<br \/>\nof their own destiny, we have seen a cor-<br \/>\nresponding rise in what is termed, physi-<br \/>\ncian-activism. A variety of movements and<br \/>\norganizations have emerged in countries<br \/>\naround the world, created by and for physi-<br \/>\ncians as they aim to take their place at the<br \/>\nhealth policy table. This wave of activism is<br \/>\nre\ufb02ected in the survey, with 90 percent of<br \/>\nphysicians worldwide agreeing that improv-<br \/>\ning healthcare will require public leader-<br \/>\nship from physicians. This view was shared<br \/>\nacross all three regions: strongest in North<br \/>\nAmerica (96 percent), then Europe (90 per-<br \/>\ncent) and Asia (89 percent).<br \/>\nPhysicians in all regions, generalists and<br \/>\nspecialists, strongly agree that they should<br \/>\nspeak out about the problems facing the<br \/>\npractice of medicine. Again, agreement was<br \/>\nstrongest in North America at a staggering<br \/>\n98 percent, but Europe at 90 percent and<br \/>\nAsia with 86 percent were not far behind.<br \/>\nAn obvious place for physicians to turn<br \/>\nwhen seeking to have their voices heard<br \/>\nwould seem to be the professional organi-<br \/>\nzations and medical societies which exist<br \/>\nto support the profession. Yet member-<br \/>\nship and enthusiasm levels in our survey<br \/>\nappeared low when questions were asked<br \/>\nabout these groups. Globally only 43 per-<br \/>\ncent said they were members of any profes-<br \/>\nsional organization or advocacy group that<br \/>\nadvances the interests of physicians. When<br \/>\nquestioned about how e\ufb00ective such bodies<br \/>\nare, 82 percent responded either \u201csomewhat<br \/>\ne\ufb00ective\u201d or \u201csomewhat ine\ufb00ective\u201d.<br \/>\nWhen asked about a group which would<br \/>\nspeci\ufb01cally advocate on behalf of physi-<br \/>\ncians, enthusiasm was more evident. Three<br \/>\nquarters of physicians around the world<br \/>\nprofessed that they would join an advocacy<br \/>\norganization which aimed to educate the<br \/>\npublic about the importance of the role of<br \/>\nphysicians to public health and to also in\ufb02u-<br \/>\nence government policies a\ufb00ecting the prac-<br \/>\ntice of medicine. This hunger for support<br \/>\ncontinued when given some suggested ways<br \/>\nin which they might advance their case:<br \/>\nPercentage who \u201c strongly support\u201d and \u201csomewhat support\u201d the following ideas that<br \/>\nhave been suggested to support physicians<br \/>\nStatement Global<br \/>\nTotal<br \/>\nAsia<br \/>\nTotal<br \/>\nAsia<br \/>\nHigh<br \/>\nEurope<br \/>\nTotal<br \/>\nEurope<br \/>\nHigh<br \/>\nN<br \/>\nAmerica<br \/>\nTotal<br \/>\nNA<br \/>\nHigh<br \/>\nParticipate in train-<br \/>\ning programs to help<br \/>\nphysicians become better<br \/>\nadvocates for reform of<br \/>\nhealthcare policies<br \/>\n89% 92% 98%<br \/>\nIndia<br \/>\n79% 99% UK 93% 94%<br \/>\nUS<br \/>\nCooperate with third-<br \/>\nparties to publicize the<br \/>\nimportant role of physi-<br \/>\ncians in society<br \/>\n84% 84% 86%<br \/>\nChina,<br \/>\nIndia and<br \/>\nAustralia<br \/>\n83% 87%<br \/>\nBelgium<br \/>\n90% 91%<br \/>\nUS<br \/>\nForm a coalition<br \/>\nbetween healthcare<br \/>\nprofessionals and private<br \/>\ncompanies to defend<br \/>\nphysicians\u2019 right to make<br \/>\nindependent medical<br \/>\ndecisions<br \/>\n79% 81% 94%<br \/>\nIndia<br \/>\n71% 73%<br \/>\nFrance<br \/>\nand<br \/>\nGer-<br \/>\nmany<br \/>\n86% 90%<br \/>\nUS<br \/>\nFor each of the following problems please tell me how signi\ufb01cant the problem is to your job<br \/>\nsatisfaction. Please use a 10 point scale, where a 1 means completely insigni\ufb01cant and a 10<br \/>\nmeans extremely signi\ufb01cant problem a\ufb00ecting job satisfaction<br \/>\nStatement Global<br \/>\nTotal<br \/>\nAsia<br \/>\nTotal<br \/>\nAsia<br \/>\nHigh<br \/>\nEurope<br \/>\nTotal<br \/>\nEurope<br \/>\nHigh<br \/>\nN America<br \/>\nTotal<br \/>\nNA<br \/>\nHigh<br \/>\nProtecting my<br \/>\nmedical practice<br \/>\nfrom threat of<br \/>\nlawsuits or civil<br \/>\nactions<br \/>\n8.3 8.58 8.93<br \/>\nChina<br \/>\n7.27 7.84 Por-<br \/>\ntugal<br \/>\n7.78 7.89 US<br \/>\n91<br \/>\nA Glimmer of Hope<br \/>\nIn summary, then, this latest round in P\ufb01z-<br \/>\ner\u2019s continuing investigations into the issues<br \/>\na\ufb00ecting the medical profession, has paint-<br \/>\ned a gloomy picture for some countries. On<br \/>\na macro level, physicians in Europe and<br \/>\nNorth America are generally negative about<br \/>\nthe direction of medicine, as are those in<br \/>\nJapan and Korea. This negativity is largely<br \/>\nattributed to interference in medical prac-<br \/>\ntice by non-medical entities such as govern-<br \/>\nments and insurance companies. Physicians<br \/>\nin China and India are very satis\ufb01ed with<br \/>\nthe direction of medicine and believe their<br \/>\nrespective medical societies are serving their<br \/>\nneeds e\ufb00ectively and that they are still in<br \/>\ncontrol of medical care.<br \/>\nTaking a closer look at Asia, Indian doctors<br \/>\ntend to be more positive about the practice<br \/>\nof medicine, perhaps partly because they<br \/>\nreport little interference in their medical<br \/>\ndecisions from third-parties. At the other<br \/>\nextreme, Korean doctors are negative about<br \/>\nthe direction of medicine generally: third-<br \/>\nparty payer issues dominate their dissatis-<br \/>\nfaction and prevent them from providing<br \/>\ncare according to their medical judgment.<br \/>\nJapanese doctors express similarly high lev-<br \/>\nels of dissatisfaction with the practice of<br \/>\nmedicine; however attribute less blame to<br \/>\nthird-party payers than the Koreans. Aus-<br \/>\ntralian and Chinese doctors are more mod-<br \/>\nerate, even variable in their attitudes.<br \/>\nAcross the EU, doctors su\ufb00er from similar<br \/>\nchallenges regarding too little time with pa-<br \/>\ntients (which leads to negative health out-<br \/>\ncomes) and too much time with administra-<br \/>\ntive burdens (which also leads to negative<br \/>\nhealth outcomes), causing a decline in the<br \/>\nquality of the doctor-patient relationship.<br \/>\nConsensus also emerges in Europe that<br \/>\nhealthcare system changes will require the<br \/>\npublic leadership of physicians and they are<br \/>\nsupportive of various potential programs to<br \/>\nhelp them advocate.<br \/>\nUS doctors are subject to high levels of<br \/>\nthird-party interference, su\ufb00er burdens of<br \/>\nmanaging private practice and, therefore,<br \/>\nspend more time than they want with ad-<br \/>\nministrative burdens. Canadian doctors<br \/>\nsu\ufb00er less from these particular ills though<br \/>\nboth countries su\ufb00er from similar chal-<br \/>\nlenges regarding time management. They<br \/>\nare similarly experiencing changes to the<br \/>\ndoctor-patient relationships and agree that<br \/>\nhealthcare system changes will require their<br \/>\npublic leadership.<br \/>\nTaking a worldwide view, perhaps one of<br \/>\nthe most disturbing \ufb01ndings for the pro-<br \/>\nfession is that the long-cherished doctor-<br \/>\npatient relationship is under severe threat<br \/>\nas patients become frustrated by the time<br \/>\nthey get to spend with their physician and<br \/>\nfailure to meet their expectations around<br \/>\ntreatment.<br \/>\nAnother point of agreement and indeed,<br \/>\nhope among doctors across the globe is<br \/>\nthat in order to change today\u2019s healthcare<br \/>\nsystems and move them away from their<br \/>\nfocus on cost rather than patient care, they<br \/>\nare going to have to take a lead themselves.<br \/>\nPhysicians need to speak up and make the<br \/>\nbroader public aware of the threat facing<br \/>\nmedicine. Only by taking a strong leader-<br \/>\nship position does the profession see any<br \/>\nhope of change.<br \/>\nSo, though it may not take a doctor to diag-<br \/>\nnose the problem with healthcare today, it is<br \/>\ncertainly going to need doctors to develop,<br \/>\nadminister and manage the necessary treat-<br \/>\nment. Today the profession is faced not so<br \/>\nmuch with a case of \u201cphysician heal thyself \u201d<br \/>\nas \u201cphysician, heal healthcare\u201d.<br \/>\nAbout the Survey Methodology<br \/>\nP\ufb01zer Inc. External Medical A\ufb00airs, Inter-<br \/>\nnational, commissioned APCO Insight, a<br \/>\nglobal opinion research \ufb01rm, to conduct a<br \/>\nscienti\ufb01c probability survey with physicians<br \/>\nin North America, Europe and Asia con-<br \/>\ncerning their attitudes toward the practice of<br \/>\nmedicine. Interviewswereconductedamong<br \/>\n1,741 general practice and specialist physi-<br \/>\ncians in the United States (n=248), Canada<br \/>\n(n=95), Germany (n=138), France (n=127),<br \/>\nthe UK (n=125),Belgium (n=126),Portugal<br \/>\n(n=127), the Netherlands (n=125), China<br \/>\n(n=125), India (n=130), Korea (n=125) Ja-<br \/>\npan (n=125) and Australia (n=125). Inter-<br \/>\nviews were conducted between December<br \/>\n15, 2007 and March 1, 2008 utilizing a va-<br \/>\nriety of data collection methodologies tai-<br \/>\nlored for each country, including mail (US<br \/>\nand Canada), telephone (Germany, France,<br \/>\nUK, Belgium, Portugal, Netherlands, Japan<br \/>\nand Australia) and in-person (China, India<br \/>\nand Korea). Sample frames were selected<br \/>\nin each country to provide maximum cov-<br \/>\nerage of practicing physicians and included<br \/>\nprofessional association member and non-<br \/>\nmember lists, licensing registries, public di-<br \/>\nrectories and health organization databases.<br \/>\nThe margin of sampling error for the global<br \/>\nsample is \u00b12.3%; sampling margin of error<br \/>\nat regional and country levels are higher<br \/>\ndepending on sample size. The sample<br \/>\nwas strati\ufb01ed among the 13 countries, and<br \/>\nwithin each country, strati\ufb01ed by medical<br \/>\nspecialty (general practice and specialists).<br \/>\nThe \ufb01nal dataset was post-weighted to be<br \/>\nrepresentative of the actual distribution of<br \/>\npracticing physicians across the countries<br \/>\nand specialties.<br \/>\nBob Miglani,<br \/>\nSenior Director, External Medical A\ufb00airs<br \/>\nInternational, Department of the Chief<br \/>\nMedical O\ufb03cer, P\ufb01zer Inc.<br \/>\n92<br \/>\nDr. Analice Gigliotti<br \/>\nPresident of Brazilian Asoociation on Studies<br \/>\nof Alcohol and Drugs (ABEAD)<br \/>\nSmoking is currently the leading prevent-<br \/>\nable cause of death in the world. If nothing<br \/>\nis done, by the end of the century this ad-<br \/>\ndiction will have killed one billion people,<br \/>\nanticipating the death of half the smokers,<br \/>\nwho lose from 8 to 22 years of life. Accord-<br \/>\ning to the World Health Organization, four<br \/>\nmillion people die every year due to diseases<br \/>\ncaused directly by tobacco derivatives. It is<br \/>\nestimated that 100 million individuals died<br \/>\nin the 20th<br \/>\ncentury due to nicotine depen-<br \/>\ndence and, if the present trend prevails, this<br \/>\nnumber will be 10 times higher, reaching<br \/>\none billion deaths in the 21st century. Many<br \/>\nof these deaths are potentially preventable if<br \/>\ntobacco users quit smoking.<br \/>\nDespite all the mortality and morbidity<br \/>\ncaused by tobacco, its global consumption<br \/>\nkeeps growing. The propagated decrease of<br \/>\nconsumption of this product takes place<br \/>\nonly in some industrialized countries.<br \/>\nAmong the less favoured ethnic minori-<br \/>\nties, tobacco consumption continues to be<br \/>\nan extremely common problem. China, for<br \/>\ninstance, is responsible for great part of the<br \/>\nincrease of per capita cigarette consumption<br \/>\nin the world. Following the decrease of to-<br \/>\nbacco consumption in developed countries,<br \/>\nthe tobacco industry increased their sales in<br \/>\ndeveloping countries. In the next decades,<br \/>\n70% of the deaths caused by tobacco will<br \/>\noccur in the Third World, where the prob-<br \/>\nlems associated to tobacco consumption<br \/>\nwill share the scenario with basic health<br \/>\nproblems such as malnutrition and lack of<br \/>\nsanitation.<br \/>\nMost people are unaware of the damage<br \/>\ncaused by smoking. About 30% of all cancer<br \/>\ncases and at least 85% of lung cancers are<br \/>\ncaused by tobacco. Oral cavity, faring, lar-<br \/>\nynx,stomach and esophagus cancers are also<br \/>\nclosely associated to tobacco consumption.<br \/>\nEven the organs not directed associated to<br \/>\nthe habit of cigarette smoking \u2013 such as<br \/>\nbladder, kidney and pancreas \u2013 are more<br \/>\na\ufb00ected by cancer among smokers than in<br \/>\nnon-smokers.<br \/>\nOther fatal diseases such as Chronic Ob-<br \/>\nstructive Pulmonary Disease (COPD), pe-<br \/>\nripheral arteriopaties, aortal aneurism and<br \/>\nmyocardial infarct are also associated to<br \/>\nsmoking. Even less lethal diseases such as<br \/>\nrespiratory infections, stomach and duode-<br \/>\nnal ulcers, osteoporosis and dental problems<br \/>\nare associated to tobacco. Smoking is the<br \/>\nleading cause of coronary disease among<br \/>\nwomen.<br \/>\nTobacco also a\ufb00ects the development of<br \/>\npregnancy in smoking pregnant women.<br \/>\nConsequently, the loss of the fetus is more<br \/>\nfrequent in all phases of pregnancy, with a<br \/>\nprobability 70% higher of miscarriage. The<br \/>\nrisk of prematurity increases 40% and the<br \/>\nchildren of smoking mothers are born with<br \/>\napproximately 200 grams less than children<br \/>\nof non-smokers. They are also particularly<br \/>\nmore likely to present sudden infant death<br \/>\nand other peri and neonatal diseases. Even<br \/>\nmore alarming data shows that non-smok-<br \/>\ning pregnant women, exposed to environ-<br \/>\nmental tobacco pollution can also give birth<br \/>\nto babies with low weight. The concentra-<br \/>\ntion of seric cotinine (a metabolite of nico-<br \/>\ntine) is higher in non-smoking pregnant<br \/>\nwomen who live with smokers.<br \/>\nEnvironmental exposition to the smoke of<br \/>\ncigarettes is also harmful, being the third<br \/>\nleading cause of preventable death in the<br \/>\nworld, second to active tobaccoism and ex-<br \/>\ncessive alcohol intake. The main symptoms<br \/>\nnon-smokers exposed to environmental to-<br \/>\nbacco pollution (EPS) complain are cough,<br \/>\nheadaches and sore eyes. They also have an<br \/>\nexacerbation of rhinitis, sinusitis and asth-<br \/>\nmatic bronchitis, besides showing a higher<br \/>\nprobability of developing lung cancer. The<br \/>\nU.S Environmental Protection Agency des-<br \/>\nignated classi\ufb01ed EPS as carcinogen Class<br \/>\nA, that is, showing enough evidence of<br \/>\ncause between exposition and cancer in hu-<br \/>\nman beings.The risk of lung cancer in non-<br \/>\nsmokers exposed to cigarette smoke is 30%<br \/>\nhigher than in non-smokers who are not<br \/>\nexposed to ETS. Cardiovascular diseases<br \/>\nare also higher in passive smokers. The risk<br \/>\nof coronary disease in non-smokers exposed<br \/>\nto ETS is 24% higher than in non-smokers<br \/>\nwho are not exposed to it.<br \/>\nChildren of smokers are more easily subject<br \/>\nto develop respiratory infections and pres-<br \/>\nent worse allergic features than children<br \/>\nwho live with non-smokers.<br \/>\nIn the last decades, due to the development<br \/>\nof public awareness of the damages of to-<br \/>\nbacco and to anti-smoking governmental<br \/>\ncampaigns, a progressive decreasing preva-<br \/>\nlence of smokers can be noticed, especially<br \/>\nin some developed countries, such as the<br \/>\nUnited States, where the number of smok-<br \/>\ners stabilized in 25% of the population in<br \/>\n1993, decreasing to only 20.5% in 2007, due<br \/>\nto public health policies in the country.<br \/>\nHowever, further reducing these rates is<br \/>\nbecoming a hard task. Although in the last<br \/>\nyears a decrease in the number of adult<br \/>\nsmoking women in the United States can<br \/>\nbe noticed, more young girls are starting to<br \/>\nSmoking: A disease that starts in the brain<br \/>\nand goes to the whole body<br \/>\n93<br \/>\nsmoke, a phenomenon that is also happen-<br \/>\ning in a great number of countries around<br \/>\nthe world,as in Brazil,for instance.Nicotine<br \/>\ndependence prevalence in the United States<br \/>\nfell from 42% in 1965 to 25% in 1982, nev-<br \/>\nertheless since then these numbers change<br \/>\nwith great di\ufb03culty. This occurs because<br \/>\nof the addictive properties of nicotine that<br \/>\nresult in only 2.5% of smokers abstaining<br \/>\nfrom the drug each year.<br \/>\nThe scienti\ufb01c community made widely<br \/>\nknown the addictive characteristics of nico-<br \/>\ntine publishing, in 1988, an important re-<br \/>\nport with the following conclusions:<br \/>\nCigarette and other tobacco forms cause\u2022<br \/>\ndependence.<br \/>\nThe cause of dependence in tobacco is\u2022<br \/>\nnicotine.<br \/>\nThe pharmacological and behavioural\u2022<br \/>\nprocesses that determine the tobacco ad-<br \/>\ndiction are similar to those which deter-<br \/>\nmine the addiction to other drugs such as<br \/>\nheroin and cocaine.<br \/>\nEach cigarette contains approximately 8 mg<br \/>\nof nicotine, from which 1 mg is rapidly<br \/>\nabsorbed by the lungs. In 10 seconds the<br \/>\nsmoker feels the \u201cgood\u201d e\ufb00ects of the drug,<br \/>\nsuch as better attention and concentration,<br \/>\nthe diminishing of appetite, the increase of<br \/>\nthe alert state, the reduction of anxiety and<br \/>\ndepressive mood improvement.<br \/>\nWith the suspension of smoking, the symp-<br \/>\ntoms of the abstention syndrome reach their<br \/>\npeak in two or three days. At the end of the<br \/>\n\ufb01rst week they decrease, normally disap-<br \/>\npearing in 2 to 4 weeks. Residual symptoms<br \/>\ncan persist for even 6 months in some cases,<br \/>\nmainly the symptom of augmented appe-<br \/>\ntite.<br \/>\nThe proof that nicotine is a drug that can<br \/>\nlead to addiction is the fact that cigarettes<br \/>\nfrom which nicotine is taken arti\ufb01cially is<br \/>\noften abandoned by smokers, who change<br \/>\nto the normal ones.In fact,smokers are used<br \/>\nto regulate the concentration of nicotine in<br \/>\ntheir body, with the objective of keeping it<br \/>\nin the limits that satisfy their needs. Even<br \/>\nwhen they change their habitual brand to<br \/>\nanother one with lower nicotine content,<br \/>\ntobacco users usually try to compensate it &#8211;<br \/>\nincreasing the number, depth and length of<br \/>\ndrags, for instance &#8211; trying to compensate<br \/>\nthe changes made and keep the concentra-<br \/>\ntion of nicotine constant.<br \/>\nThe direct action of nicotine on nicotinic-<br \/>\ncolinergic receptors is distributed all over<br \/>\nthe brain. Although its direct action is ex-<br \/>\nclusively in these receptors,the \ufb01nal result is<br \/>\nfrequently a complex pattern of the indirect<br \/>\ne\ufb00ects in other transmission systems, such<br \/>\nas dopaminergic, adrenergic, serotoningeric<br \/>\nand glutamatergic.<br \/>\nThe neurons of the ventral tegmental area,<br \/>\nwhere the nicotine bonds, are projected to<br \/>\nthe nucleus acumbens, where they release<br \/>\ndopamine in large amounts, substance that<br \/>\nis associated to the gratifying sensation ad-<br \/>\ndicts feel. The bigger and faster the libera-<br \/>\ntion of dopamine in this nucleus, the higher<br \/>\nthe pleasure users get.<br \/>\nNicotine has a double e\ufb00ect in the central<br \/>\nnervous system: initially it stimulates the<br \/>\nnicotinic receptor \u2013 agonist e\ufb00ect \u2013 and<br \/>\nthen it blocks it \u2013 antagonist e\ufb00ect.To adapt<br \/>\nto the disorganisational e\ufb00ects of the drug,<br \/>\nthe brain tries to surmount the blocking ef-<br \/>\nfects of nicotine, through an increase in the<br \/>\nnumber of nicotinic receptors. On the other<br \/>\nhand, part of the abstinence symptoms is<br \/>\nmediated by desensitization in the nora-<br \/>\ndrenergic neurons of the coeruleus locus.<br \/>\nMany smokers use tobacco according to a<br \/>\nclassic cyclic model of drug addiction, in<br \/>\nwhich they search for the bene\ufb01cial e\ufb00ects<br \/>\nof nicotine, but what keeps the individual<br \/>\nsmoking is the relief of the abstinence<br \/>\nsymptoms. However, it is not only the nico-<br \/>\ntine which determines the persistence in its<br \/>\nuse. As with any other drug, the desire of<br \/>\nconsumption can be triggered by environ-<br \/>\nmental stimuli independent from organic<br \/>\nneed. That is the reason why the individual<br \/>\ncan have a \u201ccraving\u201dfor smoking, even years<br \/>\nafter the abstinence syndrome is over, when<br \/>\nthey have any contact with \u201ctriggering situ-<br \/>\nations\u201d, such as drinking and seeing some-<br \/>\none smoking, for example.<br \/>\nThere is a projection for the \ufb01rst half of<br \/>\nthe XXI century of 500 million premature<br \/>\ndeaths, \u2153 being preventable should the<br \/>\nadult individuals stop smoking. This means<br \/>\nthat a public health approach aiming to<br \/>\nstop the use of cigarettes is a fundamental<br \/>\nelement in governmental policies in the<br \/>\ncontrol of smoking. Other actions recom-<br \/>\nmended by the World Health Organization<br \/>\ninclude preventing children from becoming<br \/>\ntobacco addicts, protecting non-smokers<br \/>\nfrom the involuntary exposition to cigarette<br \/>\nsmoke; eliminating all publicity, direct or<br \/>\nindirect, of tobacco products, and control-<br \/>\nling tobacco products, including warnings<br \/>\nin tobacco products and in any publicity<br \/>\neventually residual, among others.<br \/>\nAlthough the measures of primary preven-<br \/>\ntion are fundamental,it is a mistake to think<br \/>\nthat the treatment of addicts is a minor is-<br \/>\nsue. On the contrary, approaching smokers<br \/>\nis among the best cost\/bene\ufb01t relations in<br \/>\nmedical interventions.<br \/>\nThus, to deal with such lethal pandemic,<br \/>\none most use a combination of preventive<br \/>\nmeasures to prevent children from smoking<br \/>\nand treatment measures in order to moti-<br \/>\nvate and support smokers to quit. Cessation<br \/>\nsupport has also an e\ufb00ect on prevention,<br \/>\nsince it turns smoking a less frequent and<br \/>\nless socially accepted behaviour.<br \/>\nNicotine dependence is a chronically relaps-<br \/>\ning disorder of the brain. In fact, although<br \/>\nsmokers know smoking is harmful for their<br \/>\nhealth and most of them would like to quit,<br \/>\nonly a few really try,and even fewer succeed.<br \/>\nWithout treatment,only 3 % of the smokers<br \/>\nare able to achieve six months of abstinence.<br \/>\nWith pharmacological and psychotherapic<br \/>\ntreatment, abstinence rates raise up to 25-<br \/>\n30% up to 6 months of abstinence. To stop<br \/>\nsmoking is much more complicated than<br \/>\ndeciding to stop eating avocado. Smokers<br \/>\nneed to be motivated to quit, and treatment<br \/>\nshould be widely provided.<br \/>\n94<br \/>\nIn order to increase the availability of cessa-<br \/>\ntion support, educational measures must be<br \/>\ntaken, such as:<br \/>\nthe elaboration of guidelines,\u2022<br \/>\ninclusion of diagnosis and treatment of\u2022<br \/>\ntobacco dependence in health profession-<br \/>\nals curricula,<br \/>\nprovision of counselling services on ces-\u2022<br \/>\nsation of tobacco use in national pro-<br \/>\ngrammes,<br \/>\no\ufb00ering training programs to all kinds of\u2022<br \/>\nhealth professionals.<br \/>\nEvidence based treatments should be of-<br \/>\nfered and tailored to individual preferences<br \/>\nand needs. They can be divided in wide<br \/>\nreaching treatments (with low e\ufb03cacy and<br \/>\nlow cost) and face to face treatments (high<br \/>\ne\ufb03cacy and high cost).<br \/>\n1) Wide reaching treatments:<br \/>\nTelephone help-lines (the proactive\u2022<br \/>\nones and a bigger probability of e\ufb03-<br \/>\ncacy),<br \/>\nSMS messages,\u2022<br \/>\nWeb based treatments.\u2022<br \/>\n2) Face to face treatments:<br \/>\nBrief advice (up to 3 min),\u2022<br \/>\nBasic advice (up to 10 min),\u2022<br \/>\nIntensive support (once a week or\u2022<br \/>\nmore).<br \/>\nIn general, there is a dose-response rate, in<br \/>\nwhich the higher the dose (the frequency<br \/>\nand time during consultations) the higher<br \/>\nthe abstinence rates reached.<br \/>\nIn conclusion, those evidence based treat-<br \/>\nment and preventive measures must be used<br \/>\nto decrease the prevalence of smoking. If<br \/>\nthis alert is not heard and the policies here<br \/>\nsuggested are not implemented around the<br \/>\nworld, we will face the unnecessary death<br \/>\nof hundreds of million people in the near<br \/>\nfuture.<br \/>\nReferences<br \/>\n1. American Thoracic Society. Cigarette smok-<br \/>\ning and health. Am J Respir Crit Care Med<br \/>\n1996;153:861-5.<br \/>\n2. Jha P, Chaloupka FJ. Tobaco control in develop-<br \/>\ning countries. Oxford University Press on Behalf<br \/>\nof World Bank and World Health Organization;<br \/>\n2000.<br \/>\n3. Mackay J, Eriksen M. Tobacco Atlas. WHO;<br \/>\n2002.<br \/>\n4. Peto R, Lopez AD, Boreham J, Thun M, Heath<br \/>\nC. Mortality from smoking in developed countries<br \/>\n(1950-2000). Indirect estimates from national vital<br \/>\nstatistics. New York: Oxford University Press; 1994.<br \/>\n5. Proctor N. Tobacco and the global lung cancer<br \/>\nepidemic. Nat Rev Cancer 2001;1(1):82-6.<br \/>\n6. Raw M, Anderson P, Dubois G, Hasler J, et al.<br \/>\nWHO evidence based recommendations on the<br \/>\ntreatment of tobacco dependence. Tobacco Control<br \/>\n2002; 11: 44-46.<br \/>\n7. WHO Report on the Global Tobacco Epidem-<br \/>\nic, 2008 The MPOWER package. Geneva, World<br \/>\nHealth Organization, 2008.<br \/>\n8. United States. Morbidity and Mortality Weekly<br \/>\nReport (MMWR). Cigarette smoking-attributable<br \/>\nmortality and years of potential life lost. Centers for<br \/>\nDisease Control and Prevention. MMWR Morb<br \/>\nMortal Wkly Rep 1990;42:645-9.<br \/>\n9. United States. Morbidity And Mortality Weekly<br \/>\nReport (MMWR). Trends in Cigarette Smoking<br \/>\nAmong High School Students.United States,1991-<br \/>\n2001. Centers For Disease Control And Prevention.<br \/>\nMMWR Morb Mortal Wkly Rep 2002;51(19).<br \/>\n10. United States. Morbidity and Mortal-<br \/>\nity Weekly Report (MMWR). Cigarette smoking<br \/>\namong adults. MMWR Morb Mortal Wkly Rep<br \/>\n2002;51(29):642-5.<br \/>\n11. United States Department of Health and Hu-<br \/>\nman Services (USDHHS).The health consequences<br \/>\nof involuntary smoking. A report of the Surgeon<br \/>\nGeneral. Washington DC: US Government Print-<br \/>\ning O\ufb03ce; 1986.<br \/>\n12. United States Department of Health and Hu-<br \/>\nman Services (USDHHS).The health consequences<br \/>\nof smoking: nicotine addiction. A report of the Sur-<br \/>\ngeon General. Rockville: Public Health Service, Of-<br \/>\n\ufb01ce on Smoking and Health; 1988.<br \/>\n13. United States Department of Health and Hu-<br \/>\nman Services (USDHHS). The health bene\ufb01ts<br \/>\nof Smoking Cessation. A report of the Surgeon<br \/>\nGeneral. Atlanta (GA): Centers for Disease Con-<br \/>\ntrol and Prevention; 1990; DHHS Publication No:<br \/>\n(CDC)90-8416L.<br \/>\n14. United States Department of Health and Hu-<br \/>\nman Services (USDHHS). Best practices for com-<br \/>\nprehensive tobacco control programs. Centers for<br \/>\nDisease Control and Prevention, National Center<br \/>\nfor Disease Prevention and Health Promotion, Of-<br \/>\n\ufb01ce on Smoking and Health; 1999.<br \/>\n15. United States Department of Health and Hu-<br \/>\nman Services (USDHHS). Clinical practice guide-<br \/>\nline: treating tobacco use and dependence. Public<br \/>\nHealth Service; 2000.<br \/>\n16. United States Department of Health and Hu-<br \/>\nman Services (USDHHS). Reducing tobacco use: a<br \/>\nreport of the Surgeon General. Atlanta (GA): Cen-<br \/>\nters for Disease Control and Prevention, National<br \/>\nCenter for Chronic Disease Prevention and Health<br \/>\nPromotion, O\ufb03ce on Smoking and Health; 2000.<br \/>\n17. United States Department of Health and Hu-<br \/>\nman Services (USDHHS). PHS Clinical Practice<br \/>\nGuideline, Treating Tobacco Use and Dependence;<br \/>\n2007.<br \/>\nDr. Analice Gigliotti<br \/>\nPresident of Brazilian Asoociation on Studies<br \/>\nof Alcohol and Drugs (ABEAD)<br \/>\n95<br \/>\nAbout WHPA<br \/>\nThe global organisations representing the<br \/>\nworld\u2019s nurses, pharmacists and physicians<br \/>\njoined forces in 1999, creating a unique al-<br \/>\nliance to address global health issues &#8211; the<br \/>\nWorld Health Professions Alliance. In<br \/>\n2005, they were joined by the global rep-<br \/>\nresentative organisation of the dental pro-<br \/>\nfession. Dentists, nurses, pharmacists and<br \/>\nphysicians deliver health care to individu-<br \/>\nals, families and communities regardless of<br \/>\ntheir colour, creed, gender, religion or po-<br \/>\nlitical a\ufb03liation. The World Health Profes-<br \/>\nsions Alliance, speaking for more than 23<br \/>\nmillion health care professionals worldwide,<br \/>\nassembles essential knowledge and experi-<br \/>\nence from the key health care professions.<br \/>\nThe WHPA aims to facilitate collaboration<br \/>\nbetween key health professionals and major<br \/>\ninternational stakeholders such as govern-<br \/>\nments, policy makers and the World Health<br \/>\nOrganization. By working in collaboration,<br \/>\ninstead of along parallel tracks, the patient<br \/>\nand health care system bene\ufb01t.<br \/>\nMember Organisations<br \/>\nTheInternationalCouncilofNurses(ICN)<br \/>\nis a federation of national nurses\u2019associations<br \/>\nin 129 countries, representing the 13 mil-<br \/>\nlion nurses working worldwide. Founded in<br \/>\n1899, ICN works to ensure quality nursing<br \/>\ncare for all, sound health policies globally,<br \/>\nthe advancement of nursing knowledge, and<br \/>\nthe presence worldwide of a respected nurs-<br \/>\ning profession and a competent and satis\ufb01ed<br \/>\nnursing workforce. www.icn.ch<br \/>\nThe International Pharmaceutical Feder-<br \/>\nation (FIP) is the global federation of 114<br \/>\nnational organisations of pharmacists and<br \/>\npharmaceutical scientists. Pharmacists are<br \/>\nhealth professionals dedicated to improving<br \/>\nthe access to and value of appropriate medi-<br \/>\ncine use. www.\ufb01p.org<br \/>\nThe FDI World Dental Federation (FDI)<br \/>\nis the authoritative, worldwide voice of<br \/>\ndentistry with more than 130 member asso-<br \/>\nciations in more than 125 countries around<br \/>\nthe world, representing almost one million<br \/>\ndentists internationally. Its main roles are<br \/>\nto bring together the world of dentistry; to<br \/>\nrepresent the dental profession of the world<br \/>\nand to stimulate and facilitate the exchange<br \/>\nof information across all borders with the<br \/>\naim of optimal oral health for all people.<br \/>\nwww.fdiworldental.org<br \/>\nThe World Medical Association (WMA)<br \/>\nis the global federation of national medi-<br \/>\ncal associations, representing millions of<br \/>\nphysicians worldwide. Its membership is<br \/>\nmade up of national medical associations<br \/>\nfrom around the world, directly and indi-<br \/>\nrectly representing the views of more than<br \/>\nseven million physicians. The WMA was<br \/>\nfounded in 1946 and endeavours to achieve<br \/>\nthe highest possible standards of medical<br \/>\nscience, education, ethics and health care<br \/>\nfor all people. In order to achieve this ideal,<br \/>\nthe WMA is active in the \ufb01elds of policy<br \/>\ndevelopment and the setting of professional<br \/>\nstandards. www.wma.net<br \/>\nPriorities and Actions<br \/>\nWHPA is focused on the following key pri-<br \/>\norities for improved global health care.<br \/>\nHealth as a human right<br \/>\nAs health professionals, all WHPA mem-<br \/>\nbers support and promote the principle of<br \/>\nhealth as a basic human right.This includes<br \/>\nthe right to access safe and appropriate<br \/>\nhealth care for all people of the world.<br \/>\nPatient safety<br \/>\nHealth care interventions are intended to<br \/>\nbene\ufb01t the public, but due to the complex<br \/>\ncombination of processes, technologies and<br \/>\nhuman interactions there is an inevitable<br \/>\nrisk that adverse events will happen. The<br \/>\nWHPA is working actively to improve sys-<br \/>\ntems and therefore reduce such incidents.<br \/>\nAlliance partners are also acting together<br \/>\non other issues of patient safety, including<br \/>\nthe presence of counterfeit medicines, anti-<br \/>\nmicrobial resistance and the \ufb01ght against<br \/>\nHIV\/AIDS.<br \/>\nGlobal tobacco control<br \/>\nThe WHPA encourages governments to<br \/>\nratify and implement the WHO Frame-<br \/>\nwork Convention on Tobacco Control.This<br \/>\nincludes the developing of policies that ban<br \/>\ntobacco advertising and promotion; require<br \/>\nprominent and signi\ufb01cant tobacco warnings<br \/>\non all tobacco products; ban smoking in<br \/>\npublic places and commercial airline \ufb02ights;<br \/>\nprovide public education campaigns against<br \/>\ntobacco use; and encourage tobacco farm-<br \/>\ners to shift to crop substitution.WHPA also<br \/>\npromotes an active role for health profes-<br \/>\nsionals in tobacco control, both on the clin-<br \/>\nical care level and on the association level<br \/>\nwhere advocacy is key.<br \/>\nThe WHPA Leaders\u2019 Forum<br \/>\nBetter health worldwide can only be<br \/>\nachieved through collaboration, commu-<br \/>\nnication and dialogue to explore and ex-<br \/>\nchange new approaches and methodologies.<br \/>\nOne of WHPA\u2019s important contributions to<br \/>\nthis is to bring together leaders represent-<br \/>\ning the member organisations and other<br \/>\nstakeholders in international health in a bi-<br \/>\nennial WHPA Leaders\u2019Forum, strengthen-<br \/>\ning the bond and encouraging collaboration<br \/>\nbetween the four health professions in all<br \/>\ncountries and settings.<br \/>\nThe Future<br \/>\nWHPA is dedicated to continuing its role in<br \/>\naddressing global health issues.The Alliance\u2019s<br \/>\nstrategic orientation for the future will involve<br \/>\nboth proactive work on speci\ufb01c initiatives<br \/>\nand responsive action to issues as they unfold.<br \/>\nThese issues include: ethics, equity and access<br \/>\nto health care, patient safety, tobacco control,<br \/>\nstrengthening health professionals\u2019 involve-<br \/>\nment on policy and health human resources<br \/>\nplanning. With a forward looking vision and<br \/>\ncollaborative spirit, the Alliance partners have<br \/>\ncommitted to taking an unprecedented pro-<br \/>\nactive role to deliver improved health care to<br \/>\npopulations worldwide.<br \/>\nWorking together for safe health care,<br \/>\nthe World Health Professions Alliance (WHPA)<br \/>\n96<br \/>\n(IFPMA) The International Federation<br \/>\nof Pharmaceutical Manufacturers &#038; As-<br \/>\nsociations (IFPMA) has appointed Alicia<br \/>\nGreenidge as its new Director General. She<br \/>\ntook o\ufb03ce on 2 June 2008 and succeeds<br \/>\nDr. Harvey Bale, who retired after almost<br \/>\neleven years in the position.<br \/>\nMr. Fred Hassan, President of the IFPMA<br \/>\nand Chairman and CEO of Schering-<br \/>\nPlough,said:\u201cMs.Greenidge has extensive<br \/>\nexperience working with the Geneva-<br \/>\nbased intergovernmental organizations, as<br \/>\nwell as substantive knowledge of many is-<br \/>\nsues of concern to the IFPMA.This experi-<br \/>\nence, combined with a practical approach<br \/>\nand keen mind, will equip her well for this<br \/>\nchallenging role. I am very pleased with her<br \/>\nappointment to lead IFPMA.\u201d<br \/>\nMs. Greenidge comes to the IFPMA with<br \/>\nmore than \ufb01fteen years experience in bi-<br \/>\nlateral and multilateral negotiations with<br \/>\ngovernments in the Americas, Africa, Asia,<br \/>\nPaci\ufb01c, Middle East, and Europe, working<br \/>\nlargely for the O\ufb03ce of the United States<br \/>\nTrade Representative (USTR), both in<br \/>\nWashington and in Geneva. In Geneva for<br \/>\nnearly ten years, Ms. Greenidge served for<br \/>\na period as Acting Deputy Chief of Mis-<br \/>\nsion and, for the last eight years, as Assis-<br \/>\ntant Deputy Chief of Mission and Senior<br \/>\nCounsel.<br \/>\nMs. Greenidge has gained a reputation as a<br \/>\nstrong and e\ufb00ective negotiator, but also as<br \/>\na bridge and coalition builder. She has kept<br \/>\nchannels of communication open and con-<br \/>\ntributed to many settlements and decisions<br \/>\nbefore the World Trade Organization, no-<br \/>\ntably the Public Health Declaration lead-<br \/>\ning up to and at Doha, Qatar in 2001 and<br \/>\nsubsequent agreements with regard to local<br \/>\npharmaceutical manufacturing capacity in<br \/>\ndeveloping countries, especially Africa. She<br \/>\nhas participated in deliberations concern-<br \/>\ning questions on the relationship of the<br \/>\nTrade Related Intellectual Property Rights<br \/>\nagreement (TRIPS), traditional knowledge<br \/>\nand the Convention on Biodiversity and led<br \/>\nin negotiated agreements on Least Devel-<br \/>\noped Country matters under TRIPS.<br \/>\nSince 1998, she also has interacted with,<br \/>\nand advised on issues before other inter-<br \/>\ngovernmental organizations, such as WHO<br \/>\n(including IGWG issues and the IGM on<br \/>\nvirus sharing and access to vaccines), UN-<br \/>\nAIDS, WIPO, UNCTAD and others. In<br \/>\naddition, she has engaged constructively<br \/>\nwith several non-governmental organiza-<br \/>\ntions in Geneva.<br \/>\nDuring her government service, she has<br \/>\ninteracted with industries and associations<br \/>\nrepresenting various sectors, including<br \/>\nPharmaceuticals and her activities spanned<br \/>\nacross other subjects as well, such as trade<br \/>\nremedies, dispute settlement, textiles, elec-<br \/>\ntronic commerce, investment measures,de-<br \/>\nvelopment assistance, aspects of the cotton<br \/>\nissue, bananas and services trade.<br \/>\nMs. Greenidge has a Ju-<br \/>\nris Doctorate from Boston<br \/>\nCollege, a Master\u2019s degree<br \/>\nin Public International Law<br \/>\n&#038; International Develop-<br \/>\nment Economics from the<br \/>\nAmerican University, and<br \/>\na Bachelor\u2019s degree in In-<br \/>\nternational Relations and<br \/>\nSociology from C.W. Post<br \/>\nCollege\/LIU in the United<br \/>\nStates.<br \/>\nAbout the IFPMA<br \/>\nThe International Federation<br \/>\nof Pharmaceutical Manu-<br \/>\nfacturers &#038; Associations is<br \/>\nthe global non-pro\ufb01t NGO<br \/>\nrepresenting the research-<br \/>\nbased pharmaceutical, bio-<br \/>\ntech and vaccine sectors. Its members com-<br \/>\nprise 25 leading international companies<br \/>\nand 43 national and regional industry as-<br \/>\nsociations covering developed and develop-<br \/>\ning countries. The industry\u2019s R&#038;D pipeline<br \/>\ncontains hundreds of new medicines and<br \/>\nvaccines being developed to address global<br \/>\ndisease threats, including cancer, heart dis-<br \/>\nease, HIV\/AIDS and malaria. The IFPMA<br \/>\nClinical Trials Portal (www.ifpma.org\/<br \/>\nclinicaltrials), the IFPMA\u2019s Ethical Promo-<br \/>\ntion online resource.(www.ifpma.org\/Ethi-<br \/>\ncalPromotion) and its Health Partnerships<br \/>\ninformation www.ifpma.org\/HealthPart-<br \/>\nnetships &#8211; Developing World) help make<br \/>\nthe industry\u2019s activities more transparent.<br \/>\nThe IFPMA strengthens patient safety by<br \/>\nimproving risk assessment of medicines<br \/>\nand combating their counterfeiting. It<br \/>\nalso provides the secretariat for the Inter-<br \/>\nnational Conference on Harmonisation of<br \/>\nTechnical Requirements for Registration of<br \/>\nPharmaceuticals for Human Use (ICH).<br \/>\nIFPMA Appoints Alicia Greenidge as New<br \/>\nDirector General<br \/>\nAlica Greenidge, new Director General of IFPMA and<br \/>\nOtmar Kloiber, WMA Secretary General at the WMA o\ufb03ce in<br \/>\nFerney\u2013Voltaire<br \/>\n97<br \/>\nMyriah Lesko, BSc. Pharm., BSc.<br \/>\nProjects Coordinator FIP<br \/>\nFounded in 1912,the International Pharma-<br \/>\nceutical Federation (FIP) is the global feder-<br \/>\nation of national associations of pharmacists<br \/>\nand pharmaceutical scientists. FIP has been<br \/>\nin o\ufb03cial relations with the World Health<br \/>\nOrganization (WHO) since the WHO con-<br \/>\nception in 1949 and through its 120 Mem-<br \/>\nber Organisations in 90 countries represents<br \/>\nand serves almost two million practitioners<br \/>\nand scientists around the world.<br \/>\nThroughout its almost 100 year history, FIP<br \/>\nhas expanded both literally and \ufb01guratively.<br \/>\nThe emergence of pharmaceutical care as a<br \/>\ncornerstone of the profession and the grow-<br \/>\ning recognition of the pharmacist as an<br \/>\ninvaluable contributor to health outcomes<br \/>\nhave lead FIP to become a visible advocate<br \/>\nof the role of the pharmacist in the provi-<br \/>\nsion of healthcare,while still maintaining its<br \/>\ngrounding in pharmaceutical sciences.<br \/>\nOver the past several years, FIP has worked<br \/>\ntowards advancing pharmaceutical sciences,<br \/>\npharmacy practice and more recently phar-<br \/>\nmacy education to the ultimate bene\ufb01t of<br \/>\nthe patient.This has resulted from the work<br \/>\nFIP has done internally and through mutu-<br \/>\nally bene\ufb01cial partnerships with key global<br \/>\nplayers, such as WHO. This collaboration<br \/>\nhas served to promote the role of pharma-<br \/>\ncists in the WHO healthcare agenda and<br \/>\nhas further led to some of the most signi\ufb01-<br \/>\ncant partnerships between the key players<br \/>\non the global healthcare stage.<br \/>\nFIP is focused on improving the health and<br \/>\nwell being of communities through speci\ufb01c<br \/>\nand targeted projects. FIP works within the<br \/>\nWHO International Medical Products Anti<br \/>\nCounterfeiting Taskforce (IMPACT) to ad-<br \/>\nvocate for the input of health professionals<br \/>\nin assuring the integrity of the supply chain<br \/>\nof medicines, inherently including the iden-<br \/>\nti\ufb01cation and reporting of counterfeit medi-<br \/>\ncines. The implementation of the WHO-<br \/>\nFIP Good Pharmacy Practice Guidelines<br \/>\nthrough the Good Pharmacy Practice Pilot<br \/>\nProjects is a prime example of enabling phar-<br \/>\nmacists with the opportunity to use their<br \/>\nspecialised knowledge and skills, to interact<br \/>\nwith their patients and communities in order<br \/>\nto positively in\ufb02uence health outcomes.<br \/>\nThe past several years have seen FIP bring<br \/>\non an additional focus: pharmacy education.<br \/>\nFirmly believing that in\ufb02uential scientists and<br \/>\npractitioners are the result of comprehensive<br \/>\nand quality education, FIP has created the<br \/>\nPharmacy Education Taskforce. The Task-<br \/>\nforce is dedicated to coordinating and catalyz-<br \/>\ning action to develop pharmacy education, to<br \/>\nbe accomplished through the Pharmacy Edu-<br \/>\ncation Action Plan. In March of 2008 FIP,<br \/>\nWHO and UNESCO o\ufb03cially launched the<br \/>\n\ufb01rst phase of the Action Plan, which will be<br \/>\nimplemented between 2008-2010.<br \/>\nNeverforgettingitsroots,FIPcontinuestobe<br \/>\nfully engaged in the Pharmaceutical Sciences<br \/>\nand has successfully implemented a series of<br \/>\nPharmaceutical Sciences World Congresses,<br \/>\nwhich serve as global platforms for the ex-<br \/>\nchange of information related to the pharma-<br \/>\nceutical sciences.The parallel development of<br \/>\nnumerous FIP initiatives within pharmacy<br \/>\npractice, education and the pharmaceutical<br \/>\nsciences has demonstrated that the Federa-<br \/>\ntion is able to grow with concurrent streams<br \/>\nof interest without losing ground.<br \/>\nIn 1999, FIP, the World Medical Associa-<br \/>\ntion (WMA) and the International Council<br \/>\nof Nurses (ICN) founded the World Health<br \/>\nProfessions Alliance (WHPA)(the World<br \/>\nDental Federation (FDI) came on board<br \/>\nin 2005). This unique and \ufb01rst-of-its-kind<br \/>\nalliance brings together pharmacists, phy-<br \/>\nsicians, nurses, and dentists in initiatives<br \/>\nthat focus on e\ufb00ective interaction between<br \/>\nhealth professionals, while recognizing the<br \/>\nunique values and distinctive contributions<br \/>\nthat each brings to patient care.<br \/>\nThe potential of what may come of the com-<br \/>\nmunication and interaction brought about<br \/>\nby the partnerships built within the WHPA<br \/>\nis of pinnacle value to all professions and the<br \/>\ncommunities we serve. FIP is very pleased<br \/>\nto have clear and open opportunities for<br \/>\ncollaboration with our dedicated partners in<br \/>\nhealth. The Federation believes &#8211; and advo-<br \/>\ncates to our Members &#8211; that comprehensive<br \/>\npatient care can best be achieved through<br \/>\npartnership, team work and mutual respect<br \/>\nand understanding of what each profession<br \/>\ncan contribute.<br \/>\nIt is with this philosophy of growth that<br \/>\nFIP is headed into the future: the changing<br \/>\ntides of healthcare, its delivery and the role<br \/>\nof pharmacists and pharmaceutical scien-<br \/>\ntists demand that the Federation not only<br \/>\nkeep pace but also provide solid leadership<br \/>\nto its Members and quality information and<br \/>\nsolid input to its peers in healthcare,thereby<br \/>\nempowering all to positively in\ufb02uence glob-<br \/>\nal health.<br \/>\nRepresenting pharmacists and pharmaceutical<br \/>\nscientists \u2013 your partners in healthcare<br \/>\nThe International Pharmaceutical Federation<br \/>\nKamal Midha, President FIP<br \/>\n98<br \/>\nAquina Thulare, Secretary-General of the<br \/>\nSouth African Medical Association<br \/>\nThe South African Medical Association<br \/>\n(SAMA) is an independent professional asso-<br \/>\nciationformedicaldoctorswithoutanystatuto-<br \/>\nry or disciplinary powers. SAMA is a member<br \/>\nof the World Medical Association (WMA), a<br \/>\nglobal federation of national medical associa-<br \/>\ntions representing doctors worldwide.<br \/>\nThe South African Medical Association<br \/>\nwas established on 20 September 1997, fol-<br \/>\nlowing the uni\ufb01cation of the Medical Asso-<br \/>\nciation of South Africa (MASA), founded<br \/>\nin 1927,and the Progressive Doctors Group<br \/>\n(formerly NAMDA).The name change was<br \/>\ne\ufb00ected on the 21 May 1998.<br \/>\nOn 30 April 1999 total uni\ufb01cation of the<br \/>\nmajor groupings for medical practitioners<br \/>\nwas achieved when the National Medical<br \/>\nAlliance, representing the SA Medical and<br \/>\nDental Practitioners, Society of Dispensing<br \/>\nFamily Practitioners, Family Practitioners<br \/>\nAssociation, Dispensing Family Practi-<br \/>\ntioners Association and the Eastern Cape<br \/>\nMedical Guild, a\ufb03liated to SAMA.<br \/>\nMembership to the Association is volun-<br \/>\ntary. It is also a registered trade union for<br \/>\nits members employed in the public sector.<br \/>\nAt present some 70% of doctors in both the<br \/>\npublic and private sectors are members of<br \/>\nthe association, which is registered as an in-<br \/>\ndependent, non-pro\ufb01t section 21 company.<br \/>\nThe Association\u2019s activities focus on both<br \/>\nthe professional and business aspects of<br \/>\nmedical practice.<br \/>\nOur Mission<br \/>\nTo represent doctors with authority and\u2022<br \/>\ncredibility in all matters concerning their<br \/>\ninterests in the health care environment.<br \/>\nTo promote the integrity and image of\u2022<br \/>\nthe medical profession.<br \/>\nTo develop medical leadership and skills.\u2022<br \/>\nTo provide doctors with knowledge rele-\u2022<br \/>\nvant to the demands of medical practice.<br \/>\nTo promote medical education, research\u2022<br \/>\nand academic excellence.<br \/>\nTo encourage involvement in health pro-\u2022<br \/>\nmotion and education.<br \/>\nTo in\ufb02uence the health care environment\u2022<br \/>\nto meet the needs and expectations of the<br \/>\ncommunity by promoting improvements<br \/>\nto health reform, policy and legislation.<br \/>\nObjectives<br \/>\nSAMA represents doctors in all matters<br \/>\nconcerning their interests with authority<br \/>\nand credibility in the healthcare environ-<br \/>\nment.<br \/>\nThese objectives include:<br \/>\npromoting the integrity and image of the\u2022<br \/>\nmedical profession,<br \/>\nproviding doctors with knowledge rele-\u2022<br \/>\nvant to the demands of medical practice,<br \/>\npromoting medical education, research\u2022<br \/>\nand academic excellence,<br \/>\nin\ufb02uencing the health care environment\u2022<br \/>\nto meet the needs and expectations of the<br \/>\ncommunity by promoting improvements<br \/>\nto health reform, policy and legislation,<br \/>\nencouraging involvement in healthcare\u2022<br \/>\npromotion and education,<br \/>\npromoting trust, integrity, professional\u2022<br \/>\nconduct, e\ufb03ciency and goodwill within<br \/>\nthe profession,<br \/>\nto support, improve and protect the sta-\u2022<br \/>\ntus, rights, privileges and interests of all<br \/>\nmembers,<br \/>\nto lobby Government and any relevant\u2022<br \/>\nbody on behalf of the profession,<br \/>\nto facilitate in the maintenance of stan-\u2022<br \/>\ndards of practice by members to the pub-<br \/>\nlic via continuing medical education,<br \/>\nto judiciously use all subscriptions, en-\u2022<br \/>\ntrance fees, levies and donations for the<br \/>\npursuance of the aims and objectives of<br \/>\nthe Association, while also using funds<br \/>\nentrusted for the furtherance of medicine<br \/>\nby way of bursaries, research grants and<br \/>\nsubsidies,<br \/>\nto be the guardian of the codes structure\u2022<br \/>\nfor members; setting out the practice<br \/>\nguidelines in all \ufb01elds of practice,<br \/>\nto disseminate information to members\u2022<br \/>\nin order to keep them up to date with the<br \/>\nlatest developments in our industry by<br \/>\nmeans of relevant publications; and<br \/>\nto act in an advisory capacity regarding\u2022<br \/>\nmember concerns and enquiries where<br \/>\npossible.<br \/>\nSAMA has 20 branches countrywide that<br \/>\nserve members on a more personal level,and<br \/>\nrepresent their interests and needs in that<br \/>\nparticular geographical area. Branch council<br \/>\nTheSouthAfricanMedicalAssociation(SAMA)<br \/>\nUniting doctors for the health of the nation<br \/>\nProf. Ralph Kirsch, President of the South<br \/>\nAfrican Medical Association<br \/>\n99<br \/>\nThe Nigerian Medical Association founded<br \/>\nin 1960, began as a branch of the British<br \/>\nMedical Association in 1951. It is the larg-<br \/>\nest medical association in the West African<br \/>\nsub-region with over 35 000 members from<br \/>\n36 state branches and a branch from the<br \/>\nFederal Capital Territory. 70% of doctors<br \/>\npractice in urban areas where only 30% of<br \/>\nthe population resides. The population of<br \/>\nNigeria is about 130 million. Policy deci-<br \/>\nsions are made by the Association\u2019s Nation-<br \/>\nal Executive Council (NEC), which is the<br \/>\ngoverning body. The constitution of NMA<br \/>\nis supreme and its provisions have binding<br \/>\nforce on all authorities, organs, branches<br \/>\nand members of the Association and, where<br \/>\napplicable, on any other persons.<br \/>\nWhile our Vision is to build a formidable<br \/>\nprofessional body committed to fostering<br \/>\ne\ufb00ective and e\ufb03cient health care delivery,<br \/>\nhigh ethical standards and the interest of its<br \/>\nmembers, our mission is to build a sustain-<br \/>\nable professional association of medical and<br \/>\ndental practitioners that will advance the<br \/>\ndelivery of qualitative health care services<br \/>\nthrough continuing professional develop-<br \/>\nment, advocacy, and policy development,<br \/>\nknowledge management, public education<br \/>\nmembers are elected through a democratic<br \/>\nprocess every three years to represent mem-<br \/>\nbers at the annual National Council meeting<br \/>\nof SAMA. Branch o\ufb03ces arrange their own<br \/>\nactivities such as Continuing Professional<br \/>\nDevelopment (CPD) events and regular<br \/>\nbranch meetings, and o\ufb00ers a branch peer<br \/>\nreview function when needed. Branch sup-<br \/>\nport sta\ufb00 also deals with day-to-day queries<br \/>\nfrom members, with the assistance from<br \/>\nhead o\ufb03ce. New members are encouraged<br \/>\nto contact their local SAMA branch and<br \/>\nbecome involved in SAMA activities.<br \/>\nA\ufb03liated groups<br \/>\nMembers also enjoy representation through<br \/>\nthe various a\ufb03liated groups. SAMA has<br \/>\nmore than 56 a\ufb03liated specialist and special<br \/>\ninterest groups with proportional represen-<br \/>\ntation on National Council.<br \/>\nDecision making at SAMA<br \/>\nNational Council<br \/>\nAs a representative body for doctors,SAMA<br \/>\nencourages and facilitates member partici-<br \/>\npation in decision-making through a dem-<br \/>\nocratic and transparent governance process.<br \/>\nOrdinary members can participate at local<br \/>\nlevel in the activities of the 20 branches<br \/>\nand the 56 specialists and specialist inter-<br \/>\nest groups. Branches and groups have pro-<br \/>\nportionate representation on the SAMA<br \/>\nNational Council, which meets once a year<br \/>\nwhen all elected representatives meet to dis-<br \/>\ncuss and debate issues a\ufb00ecting doctors on<br \/>\na national basis.<br \/>\nBoard of Directors<br \/>\nNational Council appoints a Board of Di-<br \/>\nrectors, which meet quarterly to discuss<br \/>\nmatters regarding the business a\ufb00airs of the<br \/>\nAssociation including policy, budget, \ufb01nan-<br \/>\ncial, economic and management issues.<br \/>\nStanding Committees<br \/>\nNational Council also appoints the members<br \/>\nof ten standing committees,which each have<br \/>\na speci\ufb01c mandate. These include human<br \/>\nrights, law and ethics, private practice mat-<br \/>\nters,public sector doctor issues,health policy,<br \/>\nand education,science and technology.These<br \/>\ncommittees meet regularly and report back at<br \/>\nthe quarterly meetings of the SAMA Board<br \/>\nof Directors, and to their peers at the annual<br \/>\nNational Council meeting.<br \/>\nSecretariat<br \/>\nA secretariat is situated in Pretoria, Gau-<br \/>\nteng with a full-time support sta\ufb00 of 55.The<br \/>\nSecretary-General is the head of the Secre-<br \/>\ntariat from where she directs and adminis-<br \/>\nters the a\ufb00airs of the Association within the<br \/>\nframework of operating policies established<br \/>\nby National Council and the Board of Di-<br \/>\nrectors. She also exercises control over all<br \/>\nmatters concerning the administration and<br \/>\nmanagement of the head o\ufb03ce and sta\ufb00.<br \/>\nIn an environment that is constantly chang-<br \/>\ning, membership of The South African<br \/>\nMedical Association (SAMA) provides doc-<br \/>\ntors with the kind of support that they need<br \/>\nin order to be able to practise medicine suc-<br \/>\ncessfully. On behalf of its members, the As-<br \/>\nsociation strives for a healthcare dispensation<br \/>\nthat addresses the challenges of healthcare<br \/>\ndelivery in South Africa.<br \/>\nThe Association provides doctors with in-<br \/>\ndividual and collective representation aimed<br \/>\nat in\ufb02uencing medical and health legisla-<br \/>\ntion, regulation and policies.<br \/>\nDr. Kgosi (TKS) Letlape,<br \/>\nChairperson SAMA, former President WMA<br \/>\nOverview of the Nigerian Medical<br \/>\nAssociation (NMA)<br \/>\nDr. Ishaq Abdul (R) handing over to the Current<br \/>\nSecretary General,Dr.Kenneth Okoro (L)<br \/>\n100<br \/>\nin collaboration with other collaborating<br \/>\npartners in health.<br \/>\nAny medical or dental practitioner regis-<br \/>\ntered under the Medical and Dental Prac-<br \/>\ntitioners\u2019Act CAP 221 Laws of the Federa-<br \/>\ntion of Nigeria (1990) and as subsequently<br \/>\namended shall have a right of membership<br \/>\nof the Association on payment of the an-<br \/>\nnual practicing fee in the said Act as may be<br \/>\nreviewed from time to time, unless other-<br \/>\nwise prescribed in the constitution.The As-<br \/>\nsociation has both governance and manage-<br \/>\nment structures with the Annual Delegates\u2019<br \/>\nMeeting (ADM) as the highest decision<br \/>\nmaking body. The management is by the<br \/>\nNational O\ufb03cers\u2019 Committee (NOC) led<br \/>\nby the President and this occupies the third<br \/>\nlevel. The NOC has seven elected members<br \/>\nwho are democratically elected every two<br \/>\nyears and has responsibilities for manag-<br \/>\ning the a\ufb00airs of the Association. The cur-<br \/>\nrent National O\ufb03cers\u2019 (2008\/2010) are: Dr.<br \/>\nProsper Ikechukwu Igboeli, President; Dr.<br \/>\nBala Mohammed Audu, 1st<br \/>\nVice President;<br \/>\nDr. O.O. Alan Taiwo, 2nd<br \/>\nVice President;<br \/>\nDr. Kenneth Johnson Okoro, Secretary-<br \/>\nGeneral; Dr. Chris Enoch, Deputy Secre-<br \/>\ntary-General; Dr. Ibrahim Abubakar Kana,<br \/>\nTreasurer; Dr. S.N.C. Anyanwu, Editor, Ni-<br \/>\ngerian Medical Journal<br \/>\nThe administrative head of the secretariat is<br \/>\nthe Secretary-General and is assisted by a<br \/>\ncore of support sta\ufb00 for the smooth running<br \/>\nof the secretariat.<br \/>\nThe Association\u2019s Journal, Nigerian Medi-<br \/>\ncal Journal (NMJ) was founded in 1964<br \/>\nwith the following aims:<br \/>\n\u2022 to provide a medium<br \/>\nfor the dissemina-<br \/>\ntion and permanent<br \/>\nrecord of the result<br \/>\nof clinical experience<br \/>\nand scienti\ufb01c medical<br \/>\nresearch, particularly<br \/>\nin Nigeria.<br \/>\n\u2022 to serve as a forum<br \/>\nfor the dissemination<br \/>\nof general information<br \/>\nand report on conference of the Nigerian<br \/>\nMedical Association among members.<br \/>\nAlthough the Association is involved in<br \/>\nmany of the government\u2019s activities,it is con-<br \/>\nsulted formally by the government only on an<br \/>\n\u2018ad-hoc\u2019 basis. It is not consulted as \u2018of right\u2019<br \/>\non health issues and has to press for its par-<br \/>\nticipation.The Association nominates eleven<br \/>\nmembers of the Medical and Dental Coun-<br \/>\ncil of Nigeria (MDCN), which regulates the<br \/>\npractice of medicine &#038; dentistry in Nigeria<br \/>\nand the curricula of its medical schools.<br \/>\nThe NMA is at present involved in in\ufb02uenc-<br \/>\ning health policy formulation in an ad hoc<br \/>\nmanner. This is done by making unsolicited<br \/>\nrecommendations to government on vari-<br \/>\nous health issues and also by making inputs,<br \/>\nwhenever invited, to some of the national<br \/>\ncommittee meetings on policy formulations.<br \/>\nThe Association holds training courses<br \/>\nfor doctors, and participates in radio pro-<br \/>\ngrammes and TV talk shows. It has several<br \/>\non-going projects including those on AIDS,<br \/>\non family planning and on Primary Health<br \/>\nCare (PHC). Project development is depen-<br \/>\ndent upon outside funding. Funding agen-<br \/>\ncies supporting the Association\u2019s activities<br \/>\ninclude UNFPA,UNICEF,WHO,USAID,<br \/>\nthe Ford Foundation, and the John D and<br \/>\nCatherine T MacArthur Foundation.<br \/>\nThe Association collaborates in speci\ufb01c<br \/>\nprojects on health issues with individual<br \/>\nNGOs and with the National Association<br \/>\nof Non-governmental Organizations on<br \/>\nHealth (NANGOH). The NMA plans to<br \/>\nmake more in-roads into the Federal Min-<br \/>\nistry of Health to ensure that it is involved<br \/>\nin all aspects of policy formulation, espe-<br \/>\ncially in the planning stages.<br \/>\nIt is also planned that the NMA continues<br \/>\nto cooperate with government in project<br \/>\ndevelopment so that the association may be<br \/>\nrepresented on the delegations to regional<br \/>\nand international health conferences.<br \/>\nThe Nigerian Medical Association (NMA)<br \/>\nis the host of the permanent secretariat of<br \/>\nthe Confederation of African Medical As-<br \/>\nsociation and Societies (CAMAS). The<br \/>\nAssociation is developing a proposal to in-<br \/>\nvolve all African Medical Associations and<br \/>\nSocieties in e\ufb00orts to improve reproductive<br \/>\nhealth and safe motherhood in Africa.<br \/>\nThe Nigerian Health System performance has<br \/>\nbeen poor, having been ranked 187th<br \/>\namongst<br \/>\n191 member states in 2000. Infant Mortality<br \/>\nrate was 97 per 1000 live births and has wors-<br \/>\nened to 110 per 1000 live births in 2005.This<br \/>\nis against the MDG \u2013 4 targeted improve-<br \/>\nment to 30 per 1000 live births by 2015. Ma-<br \/>\nternal Mortality rate was 704\/100,000 births<br \/>\nand has also worsened to 800\/100,000 births<br \/>\nin 2004 as against the MDG \u2013 5 targeted im-<br \/>\nprovement to 75\/100,000 births by 2015.Life<br \/>\nexpectancy at birth is 45 years for males and<br \/>\n46 years for females.<br \/>\nWhile budgetary provisions for health re-<br \/>\nmain grossly inadequate,other major factors<br \/>\ncontributing to the above poor health indi-<br \/>\nces include unfavourable working environ-<br \/>\nment, inadequate lack of essential medical<br \/>\nequipment, poor health seeking behaviour<br \/>\nof many Nigerians, lopsided distribution of<br \/>\nhealth facilities and very poor remuneration<br \/>\nof Medical Personnel. Lack of desired mo-<br \/>\ntivation has led to the massive brain drain of<br \/>\nMedical Professionals whose exodus from<br \/>\nNigeria became very noticeable in 1985.<br \/>\nIn deed, over 10,000 Nigerian Doctors are<br \/>\npractising outside the country.<br \/>\nIt is hoped that the above scenario will<br \/>\nchange for the better in the coming years.<br \/>\nDr. Kenneth Johnson Okoro,<br \/>\nSecretary-General<br \/>\nGroup picture of both the Immediate Past and Current Executives<br \/>\nafter the Handing Over Ceremony<br \/>\n101<br \/>\nDr. Florent Aka Kroo,<br \/>\nPresident of the NOPCI<br \/>\nLocated in the Guinea Gulf, the Republic<br \/>\nof C\u00f4te d\u2019Ivoire is a West African country,<br \/>\nindependent since August 1960 and with<br \/>\ncurrently about 18 million inhabitants.<br \/>\nThe National Order of Physicians of C\u00f4te<br \/>\nd\u2019Ivoire (NOPCI) was established in Sep-<br \/>\ntember 1960, one month after the birth of<br \/>\nthe Ivorian State by Parliament # 60-284<br \/>\nlaw of 10 September 1960.<br \/>\nThe NOPCI has two major missions, which<br \/>\nare as follows:<br \/>\nto empower all physicians who are will-\u2022<br \/>\ning to practice Medicine in the Country;<br \/>\nthey must go through a yearly registration<br \/>\nwith the National Board of Physicians;<br \/>\nto see that all physicians are respectful\u2022<br \/>\nof the principles of morality, probity, and<br \/>\ndevotion which are indispensable for the<br \/>\npractice of Medicine; the NOPCI ensures<br \/>\nas well the respect by all its members of<br \/>\nthe professional duties and the rules of<br \/>\nthe code of ethics; its defends the honour<br \/>\nand independence of the medical profes-<br \/>\nsion; it can also provide support and as-<br \/>\nsistance to its members.<br \/>\nThe NOPCI went through a long 40-year<br \/>\nperiod of lethargy. However, since 30 Oc-<br \/>\ntober 2004, it is becoming more dynamic<br \/>\nthanks to a new management team.<br \/>\nTherefore the participation index which<br \/>\nwas 15% (about 350 registered physicians<br \/>\nin good standing), is currently up to 85%<br \/>\n(about 3800 physicians out of 4500). The<br \/>\nnational ratio is 1 physician for 5000 inhab-<br \/>\nitants.<br \/>\nThe new team\u2019s e\ufb00ort is also extended out-<br \/>\nside the national area, to:<br \/>\nthe sub-regional area in relation to the\u2022<br \/>\nOrders Conference of the West African<br \/>\nEconomic and Monetary Union States<br \/>\n(WAEMUS),<br \/>\nthe French speaking area with the re-\u2022<br \/>\ncently established French-speaking Or-<br \/>\nders Conference (over 30 countries with<br \/>\nFrench as a full or partial language),<br \/>\nthe international and global arena with\u2022<br \/>\nthe NOPCI membership application to<br \/>\nthe World Medical Association (WMA).<br \/>\nThis application shall go through a vote at<br \/>\nthe General Assembly of the WMA to be<br \/>\nheld in Seoul (Korea) on 15-18 October<br \/>\n2008 and we hope it will succeed.<br \/>\nThe NOPCI is aware of its position of<br \/>\n\u201cGuardian of the Temple\u201d in Ivorian Medi-<br \/>\ncal practice. However it considers it impor-<br \/>\ntant to be informed of its members\u2019acts and<br \/>\nthoughts should they be willing to do so.<br \/>\nTherefore it is planning to establish the Ivo-<br \/>\nrian Medical Association prior to the WMA<br \/>\nGeneral Assembly of October 2008. Such<br \/>\nan initiative will bring Ivorian physicians to<br \/>\nmore representation at a global level.<br \/>\nThe C\u00f4te d\u2019Ivoire went through an eco-<br \/>\nlogical disaster in September 2006 as toxic<br \/>\nwaste was poured out in Abidjan, the eco-<br \/>\nnomic capital and its suburbs.<br \/>\nOver 100 000 inhabitants of the City were<br \/>\nconsidered victims of gas emissions, 12 of<br \/>\nthem died, 79 were admitted to care set-<br \/>\ntings, and more than 100 000 consultations<br \/>\nwere recorded.<br \/>\nIn January 2007, the NOPCI organised a<br \/>\nscienti\ufb01c workshop in order to check the<br \/>\nmedical aspects of this disaster,and its mean<br \/>\nand long term e\ufb00ects, as well in exposed<br \/>\nsubjects. It is now planning to establish a<br \/>\nnon-governmental Observatory, and needs<br \/>\ntechnical and \ufb01nancial support.<br \/>\nThe NOPCI along with the upcoming Ivo-<br \/>\nrian Medical Association is willing to be on<br \/>\nthe same wavelength as the WMA, regard-<br \/>\ning its objectives: improvement of patients\u2019<br \/>\ncare, respect of medical ethics, patients\u2019<br \/>\nrights, and sustained e\ufb00ort to ensure a post-<br \/>\nacademic training of quality.<br \/>\nThe National Order of Physicians of C\u00f4te<br \/>\nd\u2019Ivoire: presentation and perspectives<br \/>\nNational Order of Physicians of CI with CI President Gbagbo<br \/>\n102<br \/>\nBackground<br \/>\nThe Medical Association of Thailand is a<br \/>\nnon-governmental non-pro\ufb01t making so-<br \/>\ncial promotion organisation of the Medical<br \/>\nProfessions in Thailand. It was founded in<br \/>\n1921 in Bangkok. It is, at present, located<br \/>\nat the Royal Golden Jubilee Building #<br \/>\n2 Soi Soonvijai, New Petchburi Road,<br \/>\nHuaykwang district, Bangkok 10310, Thai-<br \/>\nland. CABLE Address \u201cMEDITHAI\u201d<br \/>\nTel. (66) 2 3144344, (66) 2 3188170 Fax.<br \/>\n(66) 2 3146305 Email address: math@lox-<br \/>\ninfo.co.th and http:\/\/www.mat.or.th.<br \/>\nThe present governing body of the Associa-<br \/>\ntion is composed of a President (Dr.Aurchart<br \/>\nKanjanapitak), President Elect (Pol. Major<br \/>\nGeneral Dr. Jongjate Aojanepong), Vice<br \/>\nPresident (Dr. Chatri Banchuin), Secretary<br \/>\nGeneral (Associated Professor Dr. Prasert<br \/>\nSarnvivad) with other 16 council members<br \/>\nand also Presidents of all specialty colleges<br \/>\nand faculties and invited past presidents and<br \/>\nrecognised members. The term of the com-<br \/>\nmittee will be 2 years from general election<br \/>\namongst members. The membership of the<br \/>\nAssociation at present is 23,000 out of a total<br \/>\n33,000 graduates or about 70 %<br \/>\nFunctions:<br \/>\nThe Medical Association of Thailand\u2022<br \/>\nworks towards;<br \/>\nPromoting and coordinating Medical\u2022<br \/>\nProfessions under ethical integrity;<br \/>\nPromoting relationship amongst mem-\u2022<br \/>\nbers;<br \/>\nPromoting education, research and medi-\u2022<br \/>\ncal services;<br \/>\nProviding welfare to members;\u2022<br \/>\nCoordinating and collaborating with other\u2022<br \/>\nmedical organisations both in governmen-<br \/>\ntal and in private sectors to improve better<br \/>\nstandard of medical provision and public<br \/>\nhealth to meet international standard;<br \/>\nAdvocating health promotion (exercise\u2022<br \/>\nand antismoking campaigns), prevention,<br \/>\nand medical services to public;<br \/>\nCollaborating with international health\u2022<br \/>\nand medical organizations to keep the<br \/>\nglobal standard.<br \/>\nThe Medical Association of Thailand has a<br \/>\nrole in bringing all health and medical pro-<br \/>\nviders from both governmental and private<br \/>\nsectors to work together through the elective<br \/>\nexecutive committee which is composed of<br \/>\nmembers from various sectors. The Medi-<br \/>\ncal Association of Thailand is also one of the<br \/>\nthree components forming a collaborative<br \/>\nbody from the Ministry of Public Health, the<br \/>\nMedical Council and the Medical Associa-<br \/>\ntion as a platform to oversee and overcome the<br \/>\narising problems in the Medical profession<br \/>\nand allied professions at monthly meetings.<br \/>\nThe Medical Association is also taking a role<br \/>\nin providing compromises in the con\ufb02icts<br \/>\namongst medical providers and consumers.<br \/>\nJournal of the Medical Association of Thai-<br \/>\nland is an accepted world class medical pub-<br \/>\nlication for medical education, research and<br \/>\nmedicalknow-how.Itispublishedbi-monthly<br \/>\nand distributed amongst members and medi-<br \/>\ncal institutes including medical faculties and<br \/>\nmedical libraries in the whole country.<br \/>\nThe Medical Association of Thailand is also<br \/>\ncurrently providing not only mobile teach-<br \/>\ning teams to the remote areas, but also sup-<br \/>\nports them with the professional insurance.<br \/>\nInternational Relationship<br \/>\nAt present the Medical Association of Thai-<br \/>\nland is taking more part in the international<br \/>\na\ufb00airs. One of its past Presidents (Prof. Dr.<br \/>\nSomsri Pausawasdi) has currently been elect-<br \/>\ned to the President of CMAAO (Confed-<br \/>\neration of the Medical Association in Asia<br \/>\nand Oceania with 17 member countries).<br \/>\nAlso its international relations chief o\ufb03cer<br \/>\n(Dr. Wonchat Subhachaturas) is the elected<br \/>\nChairman of the Council in CMAAO, as<br \/>\nwell the President of the Association is au-<br \/>\ntomatically a councillor in the CMAAO and<br \/>\nthe MASEAN ( The Medical Associations<br \/>\nin South East Asian Nations).<br \/>\nThe Medical Association of Thailand pro-<br \/>\nvides full support to the WMA (World<br \/>\nMedical Association) as an active member<br \/>\nand send its representatives to participate in<br \/>\nevery General Assembly Meeting and al-<br \/>\nways works closely with member countries<br \/>\nthrough e-mails and the website (http:\/\/<br \/>\nmat.or.th). Exchange visiting programmes<br \/>\nare also well ongoing within the region and<br \/>\noutside upon the invitations.<br \/>\nWonchat Subhachaturas M.D.,FRTCS<br \/>\nInternational Relations for the MAT<br \/>\nThe Medical Association of Thailand under<br \/>\nthe Royal Patronage of his Majesty the King<br \/>\nDr. Aurchart Kanjanapitak, President of The<br \/>\nMedical Association of Thailand<br \/>\nProf. Dr. Somsri Pausawasdi, Presi-<br \/>\ndent of CMAAO<br \/>\n103<br \/>\nThe Hong Kong Medical Association<br \/>\n(HKMA) was established in 1920. It is<br \/>\nthe professional body representing doctors<br \/>\nin Hong Kong, and is an independent non-<br \/>\ngovernment organization. It has a mem-<br \/>\nbership of 7,943, out of the 10,979 doctors<br \/>\nwithin a population of 7 million in the Spe-<br \/>\ncial Administrative Region of China. Hong<br \/>\nKong enjoys freedom due to the \u201cOne<br \/>\nCountry Two System\u201dpolicy and practice of<br \/>\nthe People\u2019s Republic of China.<br \/>\nThe motto of HKMA is \u201cSafe-guarding the<br \/>\nHealth of People\u201d.<br \/>\nWe have roughly half of our members work-<br \/>\ning in the public sector, and another half in<br \/>\nthe private. The issues that HKMA is con-<br \/>\ncerned with are usually important to both<br \/>\nthe private and public doctors.<br \/>\nThe professional autonomy of the medical<br \/>\nprofession is manifest by the peer-groups-<br \/>\nreview practice and self-regulatory power of<br \/>\nthe Medical Council of Hong Kong which<br \/>\nis the quasi-statutory body responsible for<br \/>\nthe setting of standards, implementation of<br \/>\nregulation and disciplining doctors.<br \/>\nWe are aiming at a better democratic rep-<br \/>\nresentation on the Medical Council as our<br \/>\nmedical regulatory body and independence<br \/>\nfrom the government.<br \/>\nThe Food and Health Bureau has been<br \/>\nconsidering health reform with Healthcare<br \/>\nFinancing Consultation. The HKMA has<br \/>\nconducted survey within the profession to<br \/>\ncollect the opinions of physicians towards<br \/>\nthe proposed health reform and healthcare<br \/>\n\ufb01nancing, especially the pros and cons of<br \/>\nmandatory medical insurance and medi-<br \/>\ncal saving. HKMA also met regularly with<br \/>\nmedical insurers to work on core elements<br \/>\nof good medical insurance scheme.<br \/>\nIn Hong Kong, we are concerned that the<br \/>\nfamily doctor concept should be better im-<br \/>\nplemented and more training opportunities<br \/>\nfor family physicians. There is a specialist<br \/>\nregister here but not a primary care regis-<br \/>\nter. We also strive to improve public-private<br \/>\ncollaboration. The HKMA proposed a pri-<br \/>\nmary care register but the medical council is<br \/>\napparently not yet ready.<br \/>\nThe HKMA has been \ufb01ghting for main-<br \/>\ntaining the right of dispensing by physi-<br \/>\ncians. Public opinion poll was done in<br \/>\n2007, conducted by the public opinion<br \/>\nprogram of the University of Hong Kong.<br \/>\nThe results showed that 3\/4 respondents<br \/>\nobjected to the separation of dispensing and<br \/>\nconsultation. However, the pharmacists are<br \/>\nstill campaigning to change the practice in<br \/>\nHong Kong to strip doctors of the rights<br \/>\nto dispense and to deprive patients of the<br \/>\nchoice of getting medicine from the doctors<br \/>\nthey consult.<br \/>\nWe had published the Good Dispensing<br \/>\nManual, encouraging members and their<br \/>\nsta\ufb00 to continually update themselves with<br \/>\ngood dispensing methods and risk manage-<br \/>\nment. Dispensing errors occurred not only<br \/>\nin the private sector, but also in the public,<br \/>\ni.e.the Hospital Authority; not only by doc-<br \/>\ntors but also by dispensers or pharmacists.<br \/>\nThe HKMA cooperates with the Medical<br \/>\nProtection Society (MPS) to assist doctors<br \/>\nin medico-legal litigation. These disputes<br \/>\noften cause immense stress and serious<br \/>\nconsequences to doctors. The secretariat<br \/>\nof HKMA will help members to contact<br \/>\nthe MPS. The soaring annual premiums<br \/>\nfor doctors become unbearable. HKMA is<br \/>\nnegotiating with MPS and the government<br \/>\nto think of ways to limit these burdens of<br \/>\ndoctors. We have established a mediation<br \/>\ncommittee to promote this \u201cwin-win\u201d me-<br \/>\ndiation approach to solve patient-physician<br \/>\ncon\ufb02icts.<br \/>\nIn the private sector,doctors su\ufb00er from un-<br \/>\nscrupulous rental increase in public housing<br \/>\nestates which cause tremendous di\ufb03culties<br \/>\nin running clinics. HKMA led our mem-<br \/>\nbers to protest against Link Real Estate In-<br \/>\nvestment Trust (Link REIT) and organized<br \/>\nrally and march by our members together<br \/>\nwith workers of other trades. Private Doc-<br \/>\ntors are also troubled by medical groups and<br \/>\nHMOs which have too much emphasis on<br \/>\ncustomers\u2019 service, marketing and commer-<br \/>\ncial elements of medical practice, but might<br \/>\nerode professional autonomy. HKMA<br \/>\nstrived to persuade the government and the<br \/>\nlegislature to regulate HMO, group practic-<br \/>\nes as well as insurance-run clinics to ensure<br \/>\nlevel playing \ufb01eld for solo practitioners.<br \/>\nIn the public sector doctors su\ufb00er from long<br \/>\ninhuman working hours, poor working en-<br \/>\nvironment, inadequate training and low re-<br \/>\nspect for professionalism from the govern-<br \/>\nment and the public. The morale has been<br \/>\nworsening and there has been sta\ufb00 exodus<br \/>\nfrom Hospital Authority, resulting in de-<br \/>\nterioration in quality service. This problem<br \/>\nwill eventually jeopardize the whole medi-<br \/>\ncal work force in the territory. The HKMA<br \/>\nis \ufb01ghting the battle together with our pub-<br \/>\nlic colleagues especially our junior members<br \/>\nwho were so demoralized. We had sent a<br \/>\nletter to WMA to see the working condi-<br \/>\ntions of junior colleagues in other NMAs.<br \/>\nOur members demonstrated together and<br \/>\nThe Hong Kong Medical Association<br \/>\n(HKMA)<br \/>\n104<br \/>\nmarched to the government house to \ufb01ght,<br \/>\nhoping to bring a brighter future for our<br \/>\nprofession and our next generation. Now,<br \/>\nthere has been some improvement in work-<br \/>\ning hours and training prospects after<br \/>\nlengthy battles, but more need to be done.<br \/>\nThe government (the Education Bureau,<br \/>\nFood and Health Bureau and University<br \/>\nMedical School) proposed to increase the<br \/>\nintake of medical students,aiming to double<br \/>\nthe number of graduates. HKMA opposed<br \/>\nand the Secretary for Education promised<br \/>\nto look into the matter from the perspective<br \/>\nof overall supply and demand of physicians<br \/>\nand also the training prospect of the medi-<br \/>\ncal graduates.<br \/>\nWe have regular exchange programmes and<br \/>\ncooperation with the Chinese Medical As-<br \/>\nsociation, while we are totally independent<br \/>\nof each other. The HKMA has 12 monthly<br \/>\nHKMA newsletters, 12 monthly CME<br \/>\nBulletins, and bi-monthly Hong Kong<br \/>\nMedical Journals. We are providers, orga-<br \/>\nnizing CME activities, as well as accredi-<br \/>\ntor of CME activities. We have an on-line<br \/>\nCME website as well as lots of cultural and<br \/>\nsports activities organized for our members.<br \/>\nThere are HKMA orchestra, HKMA choir<br \/>\nand singing group, HKMA no. one band,<br \/>\nand a HKMA charitable foundation. We<br \/>\nhave a theme song of the HKMA: \u201cWe are<br \/>\nconcerned\u201d. This year, the HKMA has or-<br \/>\nganized several concerts in theatres, as well<br \/>\nas mini-concerts in malls and streets to raise<br \/>\ndonations for needy people, patient groups<br \/>\nand the earthquake victims in Sichuan.<br \/>\nDr. Alvin Yee Shing CHAN,<br \/>\nVice President of the Hong Kong Medical<br \/>\nAssociation, Chairman of International<br \/>\nA\ufb00airs Committee, Chairman of<br \/>\nRehabilitation Committee, Central<br \/>\nCoordinator of the HKMA Community<br \/>\nNetwork, Chairman of HKMA Orchestra<br \/>\nCommittee and Choir Committee, Elected<br \/>\nmembers of the Medical Council of<br \/>\nHong Kong<br \/>\nDr.Safarli Nariman, AzMA president<br \/>\nThe Azerbaijan Medical Association<br \/>\n(AzMA) is the country\u2019s leading voluntary,<br \/>\nindependent, non-governmental, profes-<br \/>\nsional, membership medical organization<br \/>\nfor physicians, residents and medical stu-<br \/>\ndents who represent all medical specialties<br \/>\nin Azerbaijan.<br \/>\nIn 1999, Dr. Nariman Safarli and his col-<br \/>\nleagues founded the Azerbaijan Medical<br \/>\nAssociation (AzMA) and association was<br \/>\no\ufb03cially registered by Ministry of Justice<br \/>\nof Azerbaijan Republic in December 22,<br \/>\n1999.<br \/>\nSince its inception, the AzMA continues<br \/>\nserving for a singular purpose: to advance<br \/>\nhealthcare in Azerbaijan.<br \/>\nThe mission of the AzMA &#8211; is to unite all<br \/>\nmembers of the medical profession, to serve<br \/>\nas the premier advocate for its members and<br \/>\ntheir patients, to promote the science of<br \/>\nmedicine and to advance healthcare in Azer-<br \/>\nbaijan.<br \/>\nThe main aims of AzMA are:<br \/>\nto protect the integrity, independence,\u2022<br \/>\nprofessional interests and rights of the<br \/>\nmembers,<br \/>\nto promote high standards in medical\u2022<br \/>\neducation and ethics,<br \/>\nto promote laws and regulation that pro-\u2022<br \/>\ntect and enhance the physician-patient<br \/>\nrelationship,<br \/>\nto improve access and delivery of quality\u2022<br \/>\nmedical care,<br \/>\nto promote and advance ethical behavior\u2022<br \/>\nby the medical profession,<br \/>\nto support members in their scienti\ufb01c and\u2022<br \/>\npublic activities,<br \/>\nto promote and coordinate the activity of\u2022<br \/>\nmember- specialty societies and sections,<br \/>\nto represent members\u2019 professional inter-\u2022<br \/>\nests at national and international level,<br \/>\nto create relationship with other interna-\u2022<br \/>\ntional Medical Associations.<br \/>\nThe AzMA\u2019s vision for the future, and all<br \/>\nits goals and objectives are intended to sup-<br \/>\nport the principles and ideals of the AzMA\u2019s<br \/>\nmission.<br \/>\nIn 2000, the AzMA established its Per-<br \/>\nmanent Committees and the mission of<br \/>\nthe association is accomplished through its<br \/>\ncommittees as it realizes the decisions of the<br \/>\nAzMA General Assembly, studies health<br \/>\ncare delivery in Azerbaijan, and works out<br \/>\nand performs health policy and activities<br \/>\nthrough the Executive Board. The AzMA<br \/>\nThe Azerbaijan Medical Association (AzMA)<br \/>\n105<br \/>\nPermanent Committees are: Science and<br \/>\nEducation Committee, International Re-<br \/>\nlations Committee, Ethics Committee,<br \/>\nAdministration &#038; Finance Committee,<br \/>\nMembership &#038; Bylaws Committee, Pub-<br \/>\nlic Health Committee, Information &#038;<br \/>\nPublications Committee, Private Medical<br \/>\nPractice Committee, Legislative Services<br \/>\nCommittee, Public Relations Committee,<br \/>\nPhysicians Health Committee. Member<br \/>\nphysicians volunteer countless hours to par-<br \/>\nticipate in one or more of the 11 Permanent<br \/>\nCommittees which meet on a regular basis<br \/>\nthroughout the year.<br \/>\nIn 2000, the AzMA has developed special<br \/>\nmembership sections to address the unique<br \/>\ninterests and concerns of association mem-<br \/>\nbers. These sections are following- Medical<br \/>\nStudent Section, Organized Medical Sta\ufb00<br \/>\nSection, Resident Physician Section, Young<br \/>\nPhysician Section, International Medical<br \/>\nGraduate Section.Now AzMA is in the pro-<br \/>\ncess of establishing its local AzMA branches<br \/>\nin 13 regions and also assists in creation of<br \/>\nmember-scienti\ufb01c societies on specialty<br \/>\nlevel.<br \/>\nInternational Relationship<br \/>\nToday AzMA continue to work closely with<br \/>\nother medical organizations both within the<br \/>\ncountry and at an international level. The<br \/>\nfollowing are the AzMA\u2019s national and in-<br \/>\nternational a\ufb03liations.<br \/>\nNational a\ufb03liations: In 2000, AzMA be-<br \/>\ncame a full member of the National NGO<br \/>\nForum of Azerbaijan Republic.<br \/>\nInternational a\ufb03liations: The year 2002<br \/>\nyielded memorable and historical events<br \/>\nfor Azerbaijan Medical Association such as<br \/>\nmembership to the World Medical Associa-<br \/>\ntion (WMA). AzMA became a part of the<br \/>\nWMA family. AzMA president participated<br \/>\nin several General Assemblies of WMA,and<br \/>\nthese were unique chance for our association<br \/>\nto develop its relations with other member<br \/>\nNational Medical Associations and also gain<br \/>\nnew experience in di\ufb00erent \ufb01elds of part-<br \/>\nnership within the WMA family. In 2002,<br \/>\nAzMA became an associate member of the<br \/>\nEuropean Union of Medical Specialists<br \/>\n(UEMS). In 2000, AzMA was admitted as<br \/>\nmember in the European Forum of Medical<br \/>\nAssociations(EFMA) with the right for con-<br \/>\nsultation. In 2000 Azerbaijan Medical Asso-<br \/>\nciation became a full member in the Forum<br \/>\nfor Ethics Committees in the Confederation<br \/>\nof Independent States (FECCIS).<br \/>\nAzMA Membership Services<br \/>\nAs a professional organization the AzMA<br \/>\nprovides services to its members.In the Leg-<br \/>\nislative Services Committee, lawyers provide<br \/>\ne\ufb00ective advocacy and legislative represen-<br \/>\ntation for member physicians. They give<br \/>\nconsultation on related legislative matters.<br \/>\nThe committee regularly organize legislative<br \/>\nseminars for physicians, students, hospital<br \/>\nand private medical centers sta\ufb00 members.<br \/>\nAlso since 2000,the \u201cAZMED\u201dResource &#038;<br \/>\nTraining Center &#8211; organize for its members<br \/>\nregular courses on following issue: Basic<br \/>\nPrinciples of Bioethics, Medical Law and<br \/>\nHealth Legislation, English for Doctors,<br \/>\nBasic and Advanced Computer and Inter-<br \/>\nnet courses, Project proposals writing and<br \/>\nfundraising courses for Doctors, Leader-<br \/>\nship and Management for Doctors.<br \/>\nThe total number of members of the Azer-<br \/>\nbaijan Medical Association is 1250 (in-<br \/>\ncluding student membership). The admin-<br \/>\nistrative bodies of the Association are the<br \/>\nGeneral Assembly, the Councils, and the<br \/>\nExecutive board. AzMA sta\ufb00 consists of 8<br \/>\npersons, who are working on voluntary ba-<br \/>\nsis. Also working group which consists of<br \/>\n30 doctors and students actively involved to<br \/>\norganize the AzMA regular seminars,train-<br \/>\nings, conferences and work on edition and<br \/>\npublication of AzMA quarterly bulletin<br \/>\nfor members- \u201cAzMA VISION\u201d.<br \/>\nRelationship with Government<br \/>\nSince its establishment the AzMA work<br \/>\nclosely with MOH,especially on policy and<br \/>\nhealth system structure and organization.<br \/>\nIn 2001-2003 years, AzMA has been ac-<br \/>\ntively involved as Health NGO joining<br \/>\nPublic Health Workgroup of the coopera-<br \/>\ntive program of World Bank and Azerbai-<br \/>\njan Republic about \u201cEradication of Poverty<br \/>\nin Azerbaijan\u201d,In 2008,AzMA also actively<br \/>\ncooperate with MOH in National Health<br \/>\nReforms program,which \ufb01nancially support<br \/>\nby World Bank. During this year AzMA<br \/>\nconduct meetings several times with Health<br \/>\nReforms Center of MOH which have au-<br \/>\nthority to make decisions in the \ufb01eld of<br \/>\nHealth Care Policy.<br \/>\nFuture plans<br \/>\nCurrently AzMA is preparing to realize in<br \/>\nnear future its next project in Public health<br \/>\n\ufb01eld named as \u201cBe Healthy\u201d online health<br \/>\neducation for population of Azerbaijan.<br \/>\nProject goals:to make available online health<br \/>\ninformation and consultation to Azerbaijan<br \/>\ncitizens who use internet. In 2009, AzMA<br \/>\nplanning to publish a scienti\ufb01c journal\u201cAzer-<br \/>\nbaijan Medical Association Journal\u201d for Az-<br \/>\neri physicians.On 17-18 June 2009, AzMA<br \/>\nwill organize the International conference<br \/>\n\u201cCross-Cultural Aspects in Bioethics\u201d.<br \/>\nToday, AzMA members work hard to pro-<br \/>\nmote the science of medicine and to protect the<br \/>\nhealth of Azerbaijan citizens.<br \/>\nContact information:<br \/>\nE-mail: info@azmed.az<br \/>\nazerma@hotmail.com<br \/>\nWebsite: www.azmed.az<br \/>\nMeeting \u201cRole of Health Organizations in Na-<br \/>\ntional Health System\u201d with the representatives of<br \/>\nMinistry of Health, UN agencies and other In-<br \/>\nternational organizations functioning in Public<br \/>\nHealth \ufb01eld in Baku 2003<br \/>\n106<br \/>\nDr. Rosanna Capolingua, AMA President<br \/>\nAbout the AuMA<br \/>\nThe Australian Medical Association serves<br \/>\nto represent and protect the needs of pa-<br \/>\ntients in Australia. In doing so, it represents<br \/>\nthe goals of the Medical Profession. The<br \/>\nAustralian Medical Association (AMA),<br \/>\nthe country\u2019s peak health advocacy organi-<br \/>\nsation, was incorporated in 1961. Prior to<br \/>\nthis, it operated as a branch of the BMA.<br \/>\nWe currently represent more than 27,000<br \/>\ndoctors from each Australian state and ter-<br \/>\nritory and across every specialty craft group.<br \/>\nThese include salaried doctors in the public<br \/>\nsector and doctors in private practice, doc-<br \/>\ntors-in-training and medical students.<br \/>\nThe President, Vice President, Chair of<br \/>\nCouncil and Treasurer are elected annually<br \/>\nat the National Conference. The Executive<br \/>\ncommittee is made up of these o\ufb03ce bear-<br \/>\ners and two Federal councillors elected by<br \/>\nthe Federal Council. The policy setting for<br \/>\nthe organisation is performed the Federal<br \/>\nCouncil. This comprises 34 elected repre-<br \/>\nsentatives from the Australian States and<br \/>\nTerritories and each craft group (including<br \/>\nthe Australian Medical Students\u2019 Associa-<br \/>\ntion President and the Committee of Doc-<br \/>\ntors-in-Training) together with the four<br \/>\nO\ufb03ce-bearers.<br \/>\nAMA membership is discretionary. AMA<br \/>\nbranches are set up in each state and ter-<br \/>\nritory. These run independently and focus<br \/>\nprimarily on State issues, industrial repre-<br \/>\nsentation and services for members. They<br \/>\nenjoy a close, collaborative relationship with<br \/>\nthe federal Association &#8211; with all State and<br \/>\nterritory members being members of the<br \/>\nFederal AMA. The federal AMA drives<br \/>\nthe national agenda &#8211; primarily in lobbying<br \/>\nFederal Government, policy development<br \/>\nand dissemination,and maintains a national<br \/>\nmedia pro\ufb01le of the Federal President.<br \/>\nThe AMA is a strong voice in the medico-<br \/>\npolitical arena. Australians deserve a health<br \/>\nsystem that continues to improve and go<br \/>\nforwards. Government decisions on health<br \/>\ncare based on a political foundation and not<br \/>\nquality of care are not acceptable.The AMA<br \/>\nis loud and clear that it will not accept com-<br \/>\npromise to patient care. Our Association be-<br \/>\nlieves the solution is to build on the strengths<br \/>\nof our current system, using clinically-driven<br \/>\nreform to improve access to services.<br \/>\nCurrent Challenges in Healthcare for<br \/>\nthe Australian Medical Association<br \/>\nThe Australian health system ranks well in<br \/>\nthe world on many of the measures used<br \/>\nby the WHO and amongst OECD coun-<br \/>\ntries. We acknowledge that there are some<br \/>\nproblems within the system but, overall, it<br \/>\nprovides well for the vast majority of Aus-<br \/>\ntralians. There are many reasons for this<br \/>\nconsistently good performance but central<br \/>\nis the system of universal access to medical<br \/>\nservices, pharmaceuticals, free public hospi-<br \/>\ntal care and a subsidised private health in-<br \/>\nsurance scheme, which equalises premiums<br \/>\nacross the community with a \u2018community<br \/>\nrating\u2019. This is underpinned by good ac-<br \/>\ncess to highly-trained medical practitioners<br \/>\nproviding excellent patient-centred care to<br \/>\nindividuals whilst participating in continu-<br \/>\nous improvement cycles that enhance that<br \/>\nquality of medical care.<br \/>\nHowever, key challenges for health care<br \/>\ndelivery within Australia mirror the rest<br \/>\nof the world \u2013 primarily due to increasing<br \/>\ncosts of innovation and technology, an age-<br \/>\ning population, increased needs for patients<br \/>\nwith chronic and complex conditions and a<br \/>\nworkforce struggling to meet demand as the<br \/>\naverage working age increases, participation<br \/>\ntime at work reduces and morale and reten-<br \/>\ntion rates of health care professionals fall.<br \/>\nOne of the strengths of our health system<br \/>\nis that it is predominantly a primary health<br \/>\ncare delivered system with the general med-<br \/>\nical practitioner role being central as the<br \/>\nphysician, philosopher and friend or guide<br \/>\nof the patient through what is the health<br \/>\ncare maze. GPs perform roles in acute care,<br \/>\ninitiating investigations and diagnosing as<br \/>\nwell as making referrals to the other spe-<br \/>\ncialist medical and allied health providers in<br \/>\nthe system. This is an e\ufb00ective and e\ufb03cient<br \/>\nsystem but the current reform environment<br \/>\nThe Australian Medical Association \u2013<br \/>\na voice for patients and doctors<br \/>\nDr. Mukesh Haikerwal, Immediate Past Pres-<br \/>\nident AMA,Representative on WMA Council<br \/>\n107<br \/>\nsees proposals to shift some of the medi-<br \/>\ncal practitioner\u2019s responsibilities and roles<br \/>\nto other health providers including allied<br \/>\nhealth, paramedics, physicians\u2019 assistants,<br \/>\npharmacists and nurses.<br \/>\nAchieving a balance within a multi-disci-<br \/>\nplinary team is challenging. The medical<br \/>\npractitioners should provide the medical<br \/>\ncare coordination. They do work collabora-<br \/>\ntively with the various providers of health<br \/>\ncare, in a cooperative, holistic and continu-<br \/>\nous way avoiding duplication or, worse still,<br \/>\nfragmentation and neglect. Responsibility<br \/>\nand oversight as well as support for health<br \/>\nproviders by medical practitioners are cur-<br \/>\nrently markers of quality and the safety of<br \/>\nthe patient, which is paramount.<br \/>\nThere are notable exceptions to the overall<br \/>\ngood health outcomes in Australia, these<br \/>\nbeing Aboriginal and Torres Strait Islander<br \/>\nAustralians and people in regional, rural<br \/>\nand remote areas that are currently disad-<br \/>\nvantaged in terms of care provision and<br \/>\noutcomes. Aboriginal and Torres Strait Is-<br \/>\nlanders have a 17-year less life expectancy<br \/>\ncompared to non-Indigenous Australians.<br \/>\nThe AMA has entered a coalition of health<br \/>\nand welfare groups to \u2018Close the Gap\u2019.There<br \/>\nis a concerted and detailed plan of action<br \/>\nsetting out an agenda to improve health out-<br \/>\ncomes for Indigenous people and increase<br \/>\nthe number of people in the Indigenous<br \/>\nhealth workforce. A series of indicators and<br \/>\nbenchmarks for success have been detailed<br \/>\nand agreed by the coalition. AMA mem-<br \/>\nbers are also concerned about the proposed<br \/>\nNational Registration and Accreditation<br \/>\nscheme. At the moment, each state and ter-<br \/>\nritory has its own medical registration body.<br \/>\nThe Australian Medical Council provides<br \/>\nnational consistency for new entrants from<br \/>\nmedical schools and overseas. Professional<br \/>\naccreditation has always been a professional<br \/>\nresponsibility exercised by the learned Col-<br \/>\nleges. The AMA supports a system of Na-<br \/>\ntional Registration of doctors to enhance<br \/>\nworkforce mobility. The new scheme for<br \/>\nAustralia will however, be centralised, bu-<br \/>\nreaucratised and removed from where<br \/>\nmedicine is practised. At the same time the<br \/>\nnew scheme holds greater dangers with the<br \/>\npro\ufb01ciencies and standards for clinical cre-<br \/>\ndentialing and accreditation wrestled from<br \/>\nthe profession and placed into the political<br \/>\ncontrol of government.<br \/>\nThe loss of the independence of standard<br \/>\nsetting and accreditation of medical train-<br \/>\ning will serve to undermine standards and<br \/>\ncompromise quality of patient care.<br \/>\nAccess to free service in the nation\u2019s pub-<br \/>\nlic hospitals is a core component of our<br \/>\nsystem. Unfortunately, these have su\ufb00ered<br \/>\nfrom funding shortages and administra-<br \/>\ntive and bureaucratic failures. Many doctors<br \/>\nstop working in these hospitals, as they feel<br \/>\nunder-valued, unable to teach or to partici-<br \/>\npate in research. Further, they feel they are<br \/>\ncompromised in their ability to deliver care<br \/>\nto patients.<br \/>\nPublic hospitals run close to or above 100<br \/>\nper cent occupancy throughout the year and<br \/>\nthis often results in no availability for care in<br \/>\nthe hospital. Cancellation of elective wait-<br \/>\ning lists, long delays in elective and some-<br \/>\ntimes more urgent surgery, overcrowding in<br \/>\nemergency departments, ambulance bypass<br \/>\nand ambulance ramping are all symptoms of<br \/>\nbed shortages and excessive occupancy.<br \/>\nThe AMA wants two immediate measures<br \/>\nundertaken: establishing 85 per cent occu-<br \/>\npancy as a national safety benchmark; and<br \/>\nthe provision of 3,750 additional acute beds.<br \/>\nAustralia is lucky to be looking forward to<br \/>\nsigni\ufb01cantly more medical graduates. The<br \/>\nchallenge is to provide adequate high-quality<br \/>\nclinical training for these students and then<br \/>\nspecialist training places to allow them to<br \/>\npractice independently as GPs or other spe-<br \/>\ncialists.General practice and the private sector<br \/>\nand other settings will be needed to contribute<br \/>\nto providing this training environment.<br \/>\nAround 36 per cent of doctors practicing<br \/>\nin Australia at the moment have graduated<br \/>\nfrom an overseas medical school. Interna-<br \/>\ntional medical graduates are an essential<br \/>\npart of looking after patients in Australia.<br \/>\nRecently, there has been a focus on their<br \/>\nrole and the need for nationally-consistent<br \/>\nassessment processes. There is an identi\ufb01ed<br \/>\nneed to support new entrants from overseas<br \/>\nas they enter the Australian workforce.<br \/>\nThe Australian Medical Association has<br \/>\nbeen going strong and celebrates its 50th<br \/>\nanniversary in 2011. We will continue to<br \/>\n\ufb01ght for the best outcome for doctors, but<br \/>\nour fundamental concern will always be the<br \/>\nhealth and welfare that bene\ufb01t patients.<br \/>\nAMA Federal Council in Canberra in 2007. Front row, from the left, AMA Vice President<br \/>\nDr. Gary Speck, AMA Chairman of Council Dr. Dana Wainwright, Dr. Capolingua, and AMA<br \/>\nTreasurer Dr. Samuel Lees<br \/>\n108<br \/>\nThe New Zealand Medical Association<br \/>\n(NZMA) is the largest pan-professional<br \/>\nmedical representative group in New Zea-<br \/>\nland. The NZMA aims to provide leader-<br \/>\nship of the medical profession; and pro-<br \/>\nmote professional unity and values, and the<br \/>\nhealth of New Zealanders. The key roles of<br \/>\nthe NZMA are to provide advocacy on be-<br \/>\nhalf of doctors and their patients, to provide<br \/>\nsupport and services to members and their<br \/>\npractices, to publish and maintain the Code<br \/>\nof Ethics for the profession, and to publish<br \/>\nthe New Zealand Medical Journal.<br \/>\nCompletely independent, the NZMA is a<br \/>\nstrong advocate on medico-political issues,<br \/>\nwith a strategic programme of advocacy<br \/>\nwith politicians and o\ufb03cials at the highest<br \/>\nlevels, aimed at in\ufb02uencing the direction of<br \/>\ngovernment policy. NZMA representatives<br \/>\nare in regular contact with the Minister of<br \/>\nHealth, Director General of Health, Op-<br \/>\nposition party health spokespeople, and<br \/>\no\ufb03cials from the Ministry of Health, and<br \/>\nmany other agencies.<br \/>\nThe NZMA\u2019s main focus in recent years has<br \/>\nbeen the ongoing workforce issue, which is<br \/>\nthe greatest risk to New Zealand\u2019s ability<br \/>\nto provide ongoing quality health care. It is<br \/>\nnot just a crisis of the number of doctors or<br \/>\nsub-specialities, but a shortage of all health<br \/>\nworkers. The average age of doctors is in-<br \/>\ncreasing. While we acknowledge the global<br \/>\nmarketplace for health professionals \u2013 doc-<br \/>\ntors, nurses, and others \u2013 in New Zealand<br \/>\nwe have become aware that we need to be<br \/>\nsmarter in creating an environment that<br \/>\nkeeps those professionals in our country,<br \/>\nrather than has them leaving to work in<br \/>\ncountries which pay higher salaries.<br \/>\nNew Zealand is extremely reliant on over-<br \/>\nseas trained doctors. More than 42 per-<br \/>\ncent of doctors registered in New Zealand<br \/>\ntrained elsewhere in the world. For every<br \/>\n315-320 new doctors registered here each<br \/>\nyear (the medical schools\u2019 output of gradu-<br \/>\nates), between 1200-1600 doctors who<br \/>\ntrained overseas are also being registered<br \/>\n(although around half of them do not stay<br \/>\nmore than a year). It is imprudent for a \ufb01rst<br \/>\nworld country to not strive for self sustain-<br \/>\nability in medical practitioners.<br \/>\nNew Zealand is not training enough medi-<br \/>\ncal graduates. Compare us with Australia<br \/>\nwhich has doubled its medical student in-<br \/>\ntake. The NZMA has called on the Gov-<br \/>\nernment to double the number of medical<br \/>\ngraduates trained here.<br \/>\nAnother aspect of New Zealand\u2019s health<br \/>\nsystem which continues to be of great inter-<br \/>\nest to the international medical community<br \/>\nis our no-fault accident compensation leg-<br \/>\nislation.<br \/>\nThis dates back to 1966 when the Royal<br \/>\nCommission on Worker\u2019s Compensation<br \/>\n(known as the Woodhouse Commission)<br \/>\nproposed sweeping reforms. The Accident<br \/>\nCompensation Act was passed in 1972 and<br \/>\ncame into force in 1974, and remains to this<br \/>\nday, with some changes.<br \/>\nThe Woodhouse Commission proposed \ufb01ve<br \/>\ngeneral principles:<br \/>\ncommunity responsibility,\u2022<br \/>\ncomprehensive entitlement,\u2022<br \/>\ncomplete rehabilitation,\u2022<br \/>\nreal compensation,\u2022<br \/>\nadministrative e\ufb03ciency.\u2022<br \/>\nThe ACC system replaced a system of com-<br \/>\npensation which, similarly to many other<br \/>\ncountries, was expensive in legal costs, slow<br \/>\nin operation, and capricious in that similar<br \/>\ninjuries su\ufb00ered under similar circumstanc-<br \/>\nes might produce vastly di\ufb00erent \ufb01nancial<br \/>\noutcomes. The outcome was a scheme that<br \/>\nwas considered radical. The right to sue for<br \/>\ndamages for the tort of negligence causing<br \/>\ninjury was removed, and in return injury<br \/>\nwould be compensated regardless of fault,<br \/>\nincluding fault of the injured.<br \/>\nFour main factors have contributed to the<br \/>\nsystem\u2019s a\ufb00ordability.First, New Zealanders<br \/>\nbene\ufb01t from a strong social security system.<br \/>\nInjured patients, like everyone else, receive<br \/>\nfree hospital care and subsidized pharma-<br \/>\nceuticals. (Yet per capita health spending<br \/>\nwas only US$ 2448 in 2006, compared with<br \/>\nUS$ 6714 in the United States.) Thus, New<br \/>\nZealand\u2019s public health and welfare systems<br \/>\ncover many of the damages that would be<br \/>\nat issue in a U.S. medical malpractice claim,<br \/>\nleaving the ACCwith a much smaller com-<br \/>\npensation burden. Second, compensation<br \/>\nawards are generally lower and more con-<br \/>\nsistent than under a malpractice equivalent.<br \/>\nThird,the New Zealand experience suggests<br \/>\nthat even under such a system (which in-<br \/>\ncludes a legal duty of open disclosure), most<br \/>\nentitled patients never seek compensation,<br \/>\nand many may be unaware that they have<br \/>\neven su\ufb00ered an adverse event. And \ufb01nally,<br \/>\nthe New Zealand system does not incur<br \/>\nlarge legaland administrative costs.The sys-<br \/>\ntem has been very cost-e\ufb00ective, with ad-<br \/>\nministrative costs absorbing only 10 percent<br \/>\nof the ACC\u2019s expenditures compared with<br \/>\n50\u201360 percent among malpractice systems<br \/>\nin other countries.<br \/>\nSeparate and independent processes are<br \/>\navailable for responding to patients\u2019 non-<br \/>\nmonetary interests (such as the desire for<br \/>\nan apology, an explanation, or corrective ac-<br \/>\ntion to prevent harm to future patients). In<br \/>\nparticular, the Health and Disability Com-<br \/>\nmissioner resolves complaints by advocacy,<br \/>\ninvestigation,or mediation.<br \/>\nOne of the anomalies in the \ufb01rst 30 years<br \/>\nof the scheme was its handling of compli-<br \/>\ncations and undesirable outcomes of medi-<br \/>\ncal treatment. If the provider of care was<br \/>\nat fault, then this was an injury and was<br \/>\ncompensated. If it was a rare occurrence,<br \/>\nfor which the provider was not at fault (ex-<br \/>\npected in fewer than 1% of cases) then it<br \/>\nwas a medical mishap, and compensated. If<br \/>\nit did not meet either of these criteria, then<br \/>\nit was not compensated.This always seemed<br \/>\nThe New Zealand Medical Association<br \/>\nanomalous in a no-fault scheme. A review<br \/>\ncarried out in 2003 found that the require-<br \/>\nment to establish fault impacted on health<br \/>\nprofessionals by creating an overly blam-<br \/>\ning culture (rather than a culture of learn-<br \/>\ning from mistakes) \u2013 by focusing too much<br \/>\non the actions of individual health profes-<br \/>\nsionals, and by making health professionals<br \/>\nuneasy about participating in the medi-<br \/>\ncal misadventure claims process for fear of<br \/>\nthe repercussions, particularly from inter-<br \/>\nagency reporting. The consequences of this<br \/>\nincluded less focus on the patient\u2019s injury,<br \/>\nless focus on the prevention of similar inju-<br \/>\nries, confusion over the ACC\u2019s role, and op-<br \/>\nportunities to learn (and therefore improve)<br \/>\nsafety being limited.<br \/>\nThe NZMA had advocated for,and strongly<br \/>\nsupported, the amendment that came into<br \/>\nforce in April 2005 rede\ufb01ning all such oc-<br \/>\ncurrences as \u201ctreatment injury\u201d, and com-<br \/>\npensating regardless of perceived fault. That<br \/>\nprovides a much more equitable outcome for<br \/>\npatients, and helps to avoid the adversarial<br \/>\nsituation that could previously arise where<br \/>\na patient was required to assert negligence<br \/>\non the part of the doctor in order to receive<br \/>\ncompensation.<br \/>\nIn a population of four million people, in<br \/>\n2005\/2006 more than 1.2 million people<br \/>\nhad injuries treated by their local GP and<br \/>\npaid for by ACC,with ACC paying for over<br \/>\n2.3 million visits. ACC funded 2.6 million<br \/>\nphysiotherapist visits, 2.4 million visits to<br \/>\nother treatment providers and 250,000 re-<br \/>\nhabilitation services. Rehabilitation rates<br \/>\nare high: 66 % of people return to work af-<br \/>\nter three months, 84 % after six months and<br \/>\n93 % after a year. Injury prevention is a pri-<br \/>\nmary focus of ACC\u2019s work, with campaigns<br \/>\nfocused on safety at work, at home, on the<br \/>\nroad and playing sports.<br \/>\nAnother issue which has been high on the<br \/>\nNZMA\u2019s priorities is the membership of<br \/>\nthe statutory registration body, the Medi-<br \/>\ncal Council of New Zealand (MCNZ).The<br \/>\ngeneral public needs to have con\ufb01dence that<br \/>\nthe regulation of doctors is fair and open and<br \/>\ntransparent. In essence the public needs to<br \/>\nbe able to trust the medical profession, and<br \/>\nthe NZMA strongly supports this need.<br \/>\nThe Health Practitioners Competence<br \/>\nAssurance Act 2003 (which regulates all<br \/>\nhealth practitioners) took away the right<br \/>\nof the medical profession to have directly<br \/>\nelected members on the MCNZ. This can<br \/>\nbe viewed as part of a global trend to move<br \/>\naway from pure self-regulation to regula-<br \/>\ntion in partnership between the profession<br \/>\nand the public.<br \/>\nSelf regulation is a cornerstone of profes-<br \/>\nsionalism, and the NZMA has called for at<br \/>\nleast 50% of members to be elected from<br \/>\nthe profession.<br \/>\nNew Zealand has had a Primary Health<br \/>\nCare Strategy since 2001, and the NZMA<br \/>\nis fully supportive of many of its aims, such<br \/>\nas improving access to primary health care.<br \/>\nThe Government has substantially increased<br \/>\nfunding to primary care, particularly by in-<br \/>\ncreasing the level of patient subsidies with<br \/>\nconsequent improved access to general prac-<br \/>\ntice services. However, with this has come<br \/>\nattempts by the Government to impose<br \/>\ncontrols on the setting of general practice<br \/>\nfees. The NZMA has since 1938 supported<br \/>\nthe right of private sector medical practitio-<br \/>\nners, including GPs, to set and charge fees<br \/>\ncommensurate with the services they pro-<br \/>\nvide. This right has come under increasing<br \/>\nand unprecedented pressure in recent years.<br \/>\nGeneral practices are, in the main, private<br \/>\nbusinesses whose continued existence is de-<br \/>\npendent on them remaining viable.<br \/>\nThe NZMA is working with other general<br \/>\npractice organisations to assist the Govern-<br \/>\nment in achieving its health goals in pri-<br \/>\nmary care.<br \/>\nTowards the end of this year New Zealand<br \/>\nwill have a General Election. A Labour-led<br \/>\nGovernment, headed by Helen Clark, has<br \/>\nbeen in place for nine years, but political<br \/>\npolls are consistently putting the Opposi-<br \/>\ntion National Party substantially ahead.<br \/>\nThis means there may be a new government<br \/>\nin place by the end of the year. But whoever<br \/>\nis in power, the NZMA is willing to work<br \/>\nclosely with them to ensure that the health<br \/>\nsystem and the health of New Zealanders<br \/>\nremains a top priority.<br \/>\nReferences<br \/>\n1. Bismark M and Paterson R. No-Fault Com-<br \/>\npensation In New Zealand: Harmonizing Injury<br \/>\nCompensation, Provider Accountability, And Pa-<br \/>\ntient Safety. Health A\ufb00airs. 2006. 278-283.<br \/>\n2. Bismark M. Compensation and Complaints in<br \/>\nNew Zealand. BMJ. 2006 332:1095.<br \/>\n3. Accident Compensation Corporation. Review of<br \/>\nACC Medical Misadventure: Consultation Docu-<br \/>\nment.Wellington: ACC; 2003 (quoted in: Coates J<br \/>\nand Smith K.Reform of ACC Medical Misadven-<br \/>\nture. NZ Med J. 2004.Vol 117 No 1201)<br \/>\nDr. Peter Foley, Chairman<br \/>\nFrom the left Dr. Peter Foley, Chairman, Steve Chadwick, Associate Minister of Health,<br \/>\nDr. Mark Peterson, GP Council Chair<br \/>\n109<br \/>\n110<br \/>\nJe\ufb00 Blackmer, MD MHSc FRCPC<br \/>\nEthics and professionalism have long been<br \/>\npriority issues at the Canadian Medical As-<br \/>\nsociation. The Association was established<br \/>\nin 1867 and produced its \ufb01rst Code of<br \/>\nEthics in 1868, making it one of the oldest<br \/>\nsuch documents in existence.<br \/>\nThe CMA Code of Ethics is arguably the<br \/>\nmost important policy produced by the or-<br \/>\nganization. Since its original inception, it<br \/>\nhas undergone several modi\ufb01cations. The<br \/>\nlast revision, considered to be \u201cminor\u201d in<br \/>\nnature, was completed in 2004. In general,<br \/>\nmajor revisions of the document occur every<br \/>\n15-20 years, with 1-2 minor revisions in be-<br \/>\ntween.The Code is considered to be \u201chybrid\u201d<br \/>\nin nature as it is somewhere in length and<br \/>\ncontent between setting out basic principles<br \/>\nat the one end, and trying to cover all ethi-<br \/>\ncal topics and eventualities at the other. It<br \/>\nis intended to be of su\ufb03cient detail so as to<br \/>\nprovide clinicians with practical guidance in<br \/>\ndealing with complex ethical issues, but not<br \/>\nso detailed as to be behaviour-determining.<br \/>\nThe CMA Code of Ethics has been adopted<br \/>\nby all major medical bodies in Canada (with<br \/>\nthe exception of the province of Quebec,<br \/>\nwhich generally produces its own Codes and<br \/>\nregulations separate from the rest of the coun-<br \/>\ntry).For example,the provincial medical regu-<br \/>\nlatory bodies, the national educational col-<br \/>\nleges and the provincial medical associations<br \/>\nhave all adopted the CMA Code. It is to the<br \/>\nbene\ufb01t of physicians to have only one Code of<br \/>\nEthics,and not competing codes which would<br \/>\nserve as a point of confusion and potentially<br \/>\ncon\ufb02ict. This harmonization has occurred<br \/>\nthrough extensive and open dialogue and ne-<br \/>\ngotiations over the years to try and ensure that<br \/>\nthe Code meets, to the extent possible, the<br \/>\nneeds of all the stakeholders involved.<br \/>\nThe Canadian Medical Association O\ufb03ce<br \/>\nof Ethics,Professionalism and International<br \/>\nA\ufb00airs is responsible for working on poli-<br \/>\ncies, providing support and education to the<br \/>\nAssociation and its member divisions and<br \/>\na\ufb03liate specialty societies, and providing<br \/>\nsupport to the CMA Committee on Eth-<br \/>\nics. The O\ufb03ce has existed in one form or<br \/>\nanother at the CMA for many years.<br \/>\nIn 1989,the CMA increased its commitment<br \/>\nto ethics with the establishment of the Divi-<br \/>\nsion (later Department) of Ethics and Legal<br \/>\nA\ufb00airs. Work began on abortion, status of<br \/>\nthe foetus, transplantation of organs, repro-<br \/>\nductive technologies, and physicians and the<br \/>\npharmaceutical industry. In 1991 the CMA<br \/>\nrejoined the World Medical Association and<br \/>\nCMA ethics sta\ufb00 began to play a major role<br \/>\nin the ethics activities of the WMA. In 1996<br \/>\nthe CMA sta\ufb00 structure was reorganized and<br \/>\nEthics and Legal A\ufb00airs were separated.The<br \/>\nDirector of Ethics became a member of the<br \/>\nProfessional A\ufb00airs Directorate.In 2001,the<br \/>\nsta\ufb00 structure was reorganized again and the<br \/>\nDirector of Ethics became a member of the<br \/>\nResearch, Policy and Planning Directorate<br \/>\n(now titled the Research, Policy and Ethics<br \/>\nDirectorate).<br \/>\nThe O\ufb03ce is currently sta\ufb00ed by a full time<br \/>\nEthicist (with a background in basic philoso-<br \/>\nphy and ethical theory,as well as formal train-<br \/>\ning in clinical bioethics),an Executive Direc-<br \/>\ntor (who has an advanced degree in bioethics<br \/>\nand also continues to work part time as a<br \/>\nphysician) and administrative support. At<br \/>\nany point in time it is common to have stu-<br \/>\ndents or interns rotating through the O\ufb03ce,<br \/>\nas well as temporary sta\ufb00 who are employed<br \/>\nto work on speci\ufb01c projects or policies for a<br \/>\n\ufb01nite period of time.The O\ufb03ce has provided<br \/>\ntraining and experience for several students<br \/>\nover the past few years in research, policy<br \/>\ndevelopment and the practical application of<br \/>\nethical concepts and principles.<br \/>\nThe CMA Committee on Ethics meets in<br \/>\nOttawa twice a year for two-day sessions.<br \/>\nDuring this time, Committee members<br \/>\ndebate ethical issues and help direct policy<br \/>\ndevelopment in this area. With the support<br \/>\nof O\ufb03ce sta\ufb00, they assist in identifying cur-<br \/>\nrent ethical and professional issues that are<br \/>\nof importance to Association members, and<br \/>\ndecide how best to address these issues.<br \/>\nThe Committee on Ethics is the longest<br \/>\nstanding Committee at the CMA and is<br \/>\nconsidered unique in many respects.It is the<br \/>\nonly Committee that is elected by, and re-<br \/>\nports to, the General Council of the CMA,<br \/>\nwhich is considered to be the \u201cParliament\u201d<br \/>\nof Canadian organized medicine. Commit-<br \/>\ntee members are selected on a regional rath-<br \/>\ner than provincial basis, and the smaller size<br \/>\nof the Committee allows it to respond more<br \/>\nquickly to issues as they arise. In addition,<br \/>\nCommittee members are expected to have<br \/>\nsome background or expertise in the area of<br \/>\nethics as part of their membership on the<br \/>\nCommittee. Between General Council ses-<br \/>\nsions, which happen only once a year, the<br \/>\nCommittee reports through its Chair to the<br \/>\nCMA Board of Directors,and most policies<br \/>\nare discussed and approved at this level.<br \/>\nUntilthe1970stheCommitteeonEthicscon-<br \/>\ncerned itself mainly with professional issues.<br \/>\nDuring the 1970s it began addressing bioethi-<br \/>\ncal issues. During the 1980s the Committee<br \/>\npresented reports to General Council on is-<br \/>\nsues such as AIDS, as well as some amend-<br \/>\nments to the CMA Code of Ethics. Between<br \/>\n1991 and 1996 the Committee completed<br \/>\npolicies on advance directives, con\ufb01dential-<br \/>\nity, and physician-assisted dying; revised the<br \/>\nEthics and professionalism at the<br \/>\nCanadian Medical Association<br \/>\n111<br \/>\nDr. Isacio SIGUERO, President<br \/>\nThe \u201cConsejo General de Colegios O\ufb01ciales<br \/>\nde M\u00e9dicos\u201d(general medical council) is the<br \/>\nbody that brings together, co-ordinates and<br \/>\nrepresents the 52 local medical associations<br \/>\n(colegios o\ufb01ciales de m\u00e9dicos) at national<br \/>\nand international level, and for all purposes<br \/>\nit has the status of Public Law Corporation,<br \/>\nwith own legal personality and full capacity<br \/>\nto comply with its objectives.<br \/>\nSince 1898 it has been compulsory for doc-<br \/>\ntors to register as members in Spain and<br \/>\nthere is a local medical association for each<br \/>\nof the 52 Spanish provinces. The overall<br \/>\nrepresentation of this \u201cConsejo General\u201d<br \/>\ndates back to the year 1930. The Spanish<br \/>\nConstitution recognises the existence and<br \/>\nrepresentation of professional associations,<br \/>\nwith the requisite of having a democratic<br \/>\nfunctioning, like the undertaking of the<br \/>\n\u201cConsejo General\u201d, the \ufb01nal purpose of<br \/>\nthese institutions being to oversee a good<br \/>\nprofessional practice, namely the defence of<br \/>\nthe professional and patient.<br \/>\nThe \u201cConsejo General\u201d is made up of a<br \/>\nBoard and a General Assembly. The Board<br \/>\nis formed by the president, vice president,<br \/>\ngeneral secretary, vice secretary and trea-<br \/>\nsurer, all these being positions democrati-<br \/>\ncally elected every four years.The rights and<br \/>\ninterests of the corporation and profession<br \/>\nare defended through this Board vis \u00e0 vis all<br \/>\nclasses of jurisdictional, administrative and<br \/>\ninstitutional bodies.<br \/>\nThe General Assembly is integrated by the<br \/>\nBoard, by the Presidents of the 52 local<br \/>\nmedical associations, and by the national<br \/>\nCode of Ethics and the policy statement on<br \/>\nphysicians and the pharmaceutical industry;<br \/>\nand advised on CMA\u2019s brief on the revision of<br \/>\nthe Criminal Code and the \u201cJoint Statement<br \/>\non resuscitative interventions.\u201d<br \/>\nBetween 1996 and 2001 the Committee<br \/>\nrevised policies on organ and tissue dona-<br \/>\ntion and transplantation, physicians and the<br \/>\npharmaceutical industry, and, together with<br \/>\nthe Council on Health Care and Promotion,<br \/>\nviral serological status testing; and guided<br \/>\nCMA participation in the development of<br \/>\na \u201cJoint Statement on preventing and re-<br \/>\nsolving ethical con\ufb02icts involving health<br \/>\ncare providers and persons receiving care.\u201d<br \/>\nIt contributed to CMA policy development<br \/>\non assisted reproduction, health informa-<br \/>\ntion privacy, direct-to-consumer advertis-<br \/>\ning, the Charter for Physicians, the future<br \/>\nof medicine and scopes of practice.<br \/>\nRecent work by the Committee has in-<br \/>\ncluded an extensive revision of the policy<br \/>\non physician-industry interactions, the de-<br \/>\nvelopment of a new policy on ethical ob-<br \/>\nligations of physicians during a pandemic<br \/>\nand a new policy on blood borne pathogens<br \/>\nin the health care setting. Current work is<br \/>\nunderway on a major revision to the CMA<br \/>\nHealth Information Privacy Code, the issue<br \/>\nof conscientious objection by health care<br \/>\nproviders, a research ethics template for<br \/>\npracticing physicians and a project, together<br \/>\nwith the national organization of medical<br \/>\nregulators, to produce a series of clinical vi-<br \/>\ngnettes based on the CMA Code of Ethics.<br \/>\nTheissueofmedicalprofessionalismisextreme-<br \/>\nly topical in organized medicine.To re\ufb02ect the<br \/>\nimportance of professionalism, the Canadian<br \/>\nMedical Association has added the term to the<br \/>\ntitle of the O\ufb03ce (a recent development) and<br \/>\nhas also included work in medical professional-<br \/>\nism (and ethics) in one of the Key Result Areas<br \/>\nin its current strategic plan.This has helped to<br \/>\ndemonstrate in a tangible way the importance<br \/>\nof these issues within the overall structure and<br \/>\nstrategy of the organization.<br \/>\nThe CMA is the founder and Chair of the<br \/>\nCanadian Stakeholders Coalition on Medi-<br \/>\ncal Professionalism, a collection of several<br \/>\nmedical organizations from around the<br \/>\ncountry with an interest in medical profes-<br \/>\nsionalism, including educators, regulators,<br \/>\nprofessional liability insurers and others.<br \/>\nThe Coalition has been active in trying to<br \/>\nensure a consistent nation-wide approach<br \/>\nto de\ufb01ning, teaching, measuring, assessing,<br \/>\npromoting and role modelling the key as-<br \/>\npects of medical professionalism to physi-<br \/>\ncians and physicians-in-training through-<br \/>\nout the continuum of the medical life cycle.<br \/>\nCurrent e\ufb00orts are aimed at ensuring con-<br \/>\nsistency in how professional behaviours and<br \/>\ntraits are evaluated.<br \/>\nSta\ufb00 at the CMA O\ufb03ce of Ethics, Profes-<br \/>\nsionalism and International A\ufb00airs works<br \/>\nclosely with the World Medical Association<br \/>\nboth during and between WMA meetings.<br \/>\nCurrently,CMA sta\ufb00 is assisting the WMA<br \/>\nwith the drafting of new policies in medical<br \/>\nprofessionalism (including professionally-<br \/>\nled regulation, professional autonomy and<br \/>\ncon\ufb02ict of interest) and revision of current<br \/>\nWMA policies (including telemedicine and<br \/>\nhealth human resources). The relationship<br \/>\nbetween the CMA and WMA has always<br \/>\nbeen a close one, as evidenced by the fact<br \/>\nthat John Williams has served as the direc-<br \/>\ntor of ethics for both organizations, and the<br \/>\nauthor of this paper recently completed a<br \/>\nsecondment at the WMA o\ufb03ce where he<br \/>\nassisted with policy development and coor-<br \/>\ndination in ethics and professionalism.<br \/>\nThe \u201cConsejo General<br \/>\nde Colegios O\ufb01ciales de M\u00e9dicos\u201d<br \/>\n112<br \/>\nThe Slovak Medical Association (SkMA)<br \/>\nis an a\ufb03liation of professional medical and<br \/>\npharmaceutical societies and also regional so-<br \/>\ncieties of physicians, nurses and pharmacists.<br \/>\nSkMA is a non-pro\ufb01t, non-governmental<br \/>\nassociation representing more than 22 000<br \/>\nmembers. The tradition<br \/>\nof SkMA goes back to<br \/>\nthe 19th century. On 3<br \/>\nJanuary 1833 a group of<br \/>\nyoung medical students<br \/>\nestablished the Slavonic<br \/>\nMedical Association as<br \/>\na self-learning medical<br \/>\nsociety. Following the<br \/>\nfounding of Czechoslo-<br \/>\nvak republic there was<br \/>\nin place local medical<br \/>\nsocieties in Ko ice and<br \/>\nBratislava (1919-1920)<br \/>\nand various professional<br \/>\nassociations, which from<br \/>\n1949 comprised the or-<br \/>\nganisational units of<br \/>\nthe Czechoslovak Medical Association, and<br \/>\nfrom 1969 separate Czech and Slovak Medi-<br \/>\ncal Association. After the establishment of<br \/>\nindependent Czech and Slovak republics in<br \/>\n1993, the Slovak Medical Association con-<br \/>\ntinued to work on an autonomous basis.<br \/>\nMain activities:<br \/>\nEducation (Continuing Medical Educa-\u2022<br \/>\ntion, Non-institutional life-long Educa-<br \/>\ntion)<br \/>\nPublications of Medical Journals (co-op-\u2022<br \/>\neration with professional medical societ-<br \/>\nies, editors and publishers)<br \/>\nInternational Activities and Contacts,\u2022<br \/>\nMedical ethics<br \/>\nHealth care legislation, Quality of health-\u2022<br \/>\ncare development<br \/>\nMembership service, awards approval,\u2022<br \/>\npublic relations<br \/>\n1. Education<br \/>\nOne of the main missions of the Slovak Medi-<br \/>\ncal Association is the organisation of scienti\ufb01c<br \/>\nevents and scienti\ufb01c congresses, conferences,<br \/>\nsymposiums and other professional meet-<br \/>\nings with domestic and foreign participation,<br \/>\nto support the involvement of own experts<br \/>\nin similar events abroad and to publish and<br \/>\nsupport the issue of professional magazines<br \/>\nand publications. On basis of a mutual agree-<br \/>\nment among the statutory representatives of<br \/>\nthe Slovak Chamber of Physicians, the Slo-<br \/>\nThe Slovak Medical Association<br \/>\nProf. MUDr. Peter Kri\u0161t\u00fafek,<br \/>\nCSc. President<br \/>\nMUDr. Irina \u0160ebov\u00e1, CSc.<br \/>\nMPH, Scienti\ufb01c Secretary<br \/>\nrepresentatives from the di\ufb00erent profes-<br \/>\nsional sections through which doctors are<br \/>\nrepresented according to the modality and<br \/>\nform of professional practice they under-<br \/>\ntake: hospitals, urban and rural primary<br \/>\ncare, pensioners, in training, public admin-<br \/>\nistrations, with unstable employment, and<br \/>\nown private medical practice or as employ-<br \/>\nee. The task of these sections is to provide<br \/>\nguidance in matters of their speciality and<br \/>\nto undertake studies and proposals.Togeth-<br \/>\ner, the Board, local Presidents and sections\u2019<br \/>\nrepresentatives form the General Assembly,<br \/>\nwhich is the top governing authority of the<br \/>\n\u201cConsejo General\u201d.<br \/>\nThe \u201cConsejo General\u201d and the 52 local<br \/>\nmedical associations form what is known as<br \/>\n\u201cOrganizaci\u00f3n M\u00e9dica Colegial (OMC)\u201d.<br \/>\nThis body represents all registered doctors<br \/>\nin Spain, acting as safeguard for the core<br \/>\nvalues of the medical profession: deontol-<br \/>\nogy and code of ethics.<br \/>\nThe \u201cConsejo General\u201d is o\ufb03cially respon-<br \/>\nsible for representing the OMC before the<br \/>\nGeneral Administration of State and the<br \/>\npublic agencies related with or dependent<br \/>\non it, as well as for coordinating the profes-<br \/>\nsion at the di\ufb00erent organisational levels.<br \/>\nTo quote a few examples, the work of the<br \/>\n\u201cConsejo General\u201d is today centred on vari-<br \/>\nous questions of professional and social in-<br \/>\nterest that include the study of medical de-<br \/>\nmography to try and correct the de\ufb01cit in<br \/>\ndoctors and carry out a suitable planning of<br \/>\nhuman resources, even controlling the o\ufb03-<br \/>\ncial recognition of foreign medical quali\ufb01-<br \/>\ncations,fostering training and accreditation,<br \/>\nusing its own Council o\ufb03cially recognised<br \/>\nby the Government.<br \/>\nOther facets of its work include professional<br \/>\nand social promotion of doctors and their<br \/>\nadaptation to scienti\ufb01c and professional<br \/>\nchanges, as well as permanent and accred-<br \/>\nited professional development. It also has a<br \/>\nsocial Foundation to assist the needs of doc-<br \/>\ntors and their families, this being one of the<br \/>\nmost important works of the health sector.<br \/>\nThrough its \u201cConsejo General\u201d, the OMC<br \/>\nis present at almost all international medical<br \/>\norganisations, at which it provides its expe-<br \/>\nrience. These actions imply bene\ufb01ts for the<br \/>\nprofessional practice, for the patient \u2013 end<br \/>\nreceiver of such actions and true central hub<br \/>\nof the National Health System \u2013 and \ufb01nally<br \/>\nfor society as a whole.<br \/>\nDefending the values of the medical profes-<br \/>\nsion and rights of doctors and the patients,<br \/>\nthe \u201cConsejo General\u201d is now undertaking<br \/>\nactions in favour of prescriptions being an<br \/>\nact that is the exclusive competence of the<br \/>\ndoctor being the only professional who,con-<br \/>\nsidering his training and quali\ufb01cations, can<br \/>\nassure a safe and e\ufb03cient quality treatment<br \/>\nfor the patient; without waiving collabora-<br \/>\ntion with other health professionals, to as-<br \/>\nsure the quality of the health care process.<br \/>\n113<br \/>\nvak Medical Association, the Slovak Medical<br \/>\nUniversity, the Association of Private Physi-<br \/>\ncians and the Association of Medical Facul-<br \/>\nties in Slovakia, the Slovak Accreditation<br \/>\nCouncil for Continual Medical Education<br \/>\n(SACCME) was established in May 2004.<br \/>\nThe SACCME provides credits for CME ac-<br \/>\ntivities, as well as with the implementation of<br \/>\na quality control mechanism (standard partic-<br \/>\nipants satisfaction questionnaire). 250 credits<br \/>\nover a 5-year period were proposed, 150 from<br \/>\nthem are obtained from external educational<br \/>\nactivities (passive or active participation,auto-<br \/>\ndidactic tests in medical journals,publications,<br \/>\npresentations, teaching) and 100 credits are<br \/>\nreceived for professional performance and for<br \/>\nself-teaching.<br \/>\n2. Publications<br \/>\n17 medical journals (mainly in the Slovak<br \/>\nlanguage with English summaries):<br \/>\nMedical Monitor (6\/year),\u2022<br \/>\nRevue of Nursing and Laboratory Methods\u2022<br \/>\n(4\/year)<br \/>\nActa Chemotherapeutica (6\/year)\u2022<br \/>\nHead and Neck Diseases (4\/year)\u2022<br \/>\nClinical Immunology and Allergology\u2022<br \/>\n(4\/year)<br \/>\nSlovak Physician (12\/yars)\u2022<br \/>\nUrology (2\/year)\u2022<br \/>\nPractical Gynaecology (4\/year)\u2022<br \/>\nHaematology and Transfuziology (4\/year)\u2022<br \/>\nAtherosclerosis, Clinic,Treatment (3\/year)<br \/>\nLaboratory Diagnosis (4\/year),\u2022<br \/>\nSurgical News (4\/year)\u2022<br \/>\nSlovak Radiology (4\/year)\u2022<br \/>\nCardiology (4\/year)\u2022<br \/>\nPediatricon (4\/year)\u2022<br \/>\nRespiro (4\/year)\u2022<br \/>\nGeriatria (4\/year)\u2022<br \/>\nAccupunctura Bohemo-Slovaca (2\/year)\u2022<br \/>\nSlovak Sexulogy (2\/year)\u2022<br \/>\nMicrobiology and Epidemiology News\u2022<br \/>\n(4\/year)<br \/>\nFarmacoeconomics and Drug\u00b4s Policy\u2022<br \/>\n(4\/year).<br \/>\n3. International activities and contacts<br \/>\nThe Slovak Medical Association is a mem-<br \/>\nber of World Medical Association (WMA),<br \/>\nEuropean Forum of Medical Associations<br \/>\nand WHO (EFMA\/WHO), Union of<br \/>\nEuropean Medical Specialists (UEMS),<br \/>\nCouncil for International Organizations<br \/>\nof Medical Sciences (CIOMS). Interna-<br \/>\ntional cooperation is supplied also directly<br \/>\nby means of various SkMA professional<br \/>\nsocieties and their colleagues in European<br \/>\nUnion or abroad.<br \/>\nIn co-operation with WMA representatives<br \/>\nthe Slovak version of the Medical Ethics<br \/>\nManual was \ufb01nalised and will be distrib-<br \/>\nuted among our members. The SkMA sup-<br \/>\nport all ethical, social and environmental<br \/>\nactivities of the WMA. On 19 September<br \/>\n2006, the SkMA and Slovak Association of<br \/>\nPharmaceutical Companies (SAFS) signed<br \/>\nan agreement concerning ethical principles<br \/>\nco-operation between the medical profes-<br \/>\nsion and the pharmaceutical industry.<br \/>\nFrom 2007, the SkMA has representation<br \/>\non the EFMA\/WHO committee (Irina<br \/>\nSebova-liaison o\ufb03cer). On 1-3 April 2009,<br \/>\nwe will be organising the Annual Confer-<br \/>\nence of EFMA\/WHO in Bratislava. Pro-<br \/>\nposed topics: CME\/CPD, Palliative Care,<br \/>\nCreation of quality standards, Seniors Care.<br \/>\nThe good co-operation between the SkMa<br \/>\nand the UEMS was con\ufb01rmed on 19 March<br \/>\n2006 in Brussels by the signing of an agree-<br \/>\nment between the European and Slovak ac-<br \/>\ncreditation councils for CME (EACCME<br \/>\nand SACCME). The institutions declared<br \/>\nthat they are interested in co-operation in<br \/>\n\ufb01eld of CME accreditation through a formal<br \/>\nagreement aimed to foster the interchang-<br \/>\ning of experiences and the implementation<br \/>\nof a formal system mutual recognition of<br \/>\nCME credits.The SkMA was the organiser<br \/>\nof UEMS Meeting (Board and Council) on<br \/>\n11-13 October 2007 in Bratislava. One of<br \/>\nthe most important documents adopted at<br \/>\nthis Meeting was the Bratislava Declaration<br \/>\non E-Medicine.<br \/>\nOf growing importance are activities<br \/>\nwith regard to international contacts with<br \/>\nCIOMS, as well as membership of profes-<br \/>\nsional SkMA societies in partnership with<br \/>\nEuropean or non-European organisations.<br \/>\nThe SkMA co-operates very closely and in-<br \/>\ntensively with the Czech Medical Associa-<br \/>\ntion.<br \/>\n4. Health Care Legislation, Quality<br \/>\nof Healthcare Development<br \/>\nThe public Health System in Slovak repub-<br \/>\nlic is under the jurisdiction of the Ministry<br \/>\nof Health, which is responsible for manag-<br \/>\ning national health policy. The SkMA acts<br \/>\nas an opponent in discussions on health<br \/>\ncare legislation proposals from Minis-<br \/>\ntry of Health, proposes the nomination of<br \/>\nthe Main Experts, the Consultants for the<br \/>\nDrug Categorization Commissions and<br \/>\nthe Members of the Medical Performance<br \/>\nCatalogue Committees.<br \/>\nIn co-operation with other medical institu-<br \/>\ntions and professional associations submits<br \/>\nSkMA suggestions or projects for improve-<br \/>\nment of healthcare quality.<br \/>\n5. Membership service, awards<br \/>\napproval, public relations<br \/>\nThe SkMA has 87 professional societies ac-<br \/>\ncording to specialization or \ufb01eld of particular<br \/>\ninterests and a total of 48 regional societies<br \/>\nor alliances according to geographic loca-<br \/>\ntion independent from profession. Mem-<br \/>\nbership in the SkMA is voluntary. Main ex-<br \/>\necutive bodies of the SkMA in place of the<br \/>\nRepresentative Plenary Meetings are the<br \/>\nPresidium, Supervisory Board and Execu-<br \/>\ntive Secretariat. The Presidium of SkMA,<br \/>\nelected for 4 years period, encompasses 13<br \/>\nmembers including the President, Scienti\ufb01c<br \/>\nSecretary and two Vice-Presidents.The Su-<br \/>\npervisory Board has 3 members including<br \/>\nthe chief of Administration and is sta\ufb00ed<br \/>\nwith 19 full time employed persons headed<br \/>\nby the Director of Secretariat.<br \/>\nThe o\ufb03cial residence of SkMA is the House<br \/>\nof Medical O\ufb03cers (Domus Medica, Dom<br \/>\nzdravotn\u00edkov) with a Congress o\ufb03ce, De-<br \/>\npartment of membership service, Economic<br \/>\ndepartment and Auditorium.<br \/>\n114<br \/>\nKorean Medical Association<br \/>\nThe WMA General Assembly Seoul 2008<br \/>\nThe year of 2008 is very signi\ufb01cant in the<br \/>\nhistory of Korean Medical Association<br \/>\n(KMA), as it celebrates its 100-year anni-<br \/>\nversary. Modern medicine was introduced<br \/>\nin Korea in the year of 1884 by an American<br \/>\nmissionary physician. During a relatively<br \/>\nshort period,Korea has made rapid progress<br \/>\nin medical science and the practice.<br \/>\nIn 1908, KMA was established in Seoul and<br \/>\nsoon became the national organization repre-<br \/>\nsenting all medical doctors in Korea.In spite of<br \/>\nmany di\ufb03cult situations occurred in the Ko-<br \/>\nrean peninsula,KMA has made uni\ufb01ed e\ufb00orts<br \/>\nto promote health of the people.Through the<br \/>\nperiod of Japanese occupation, Korean War,<br \/>\nrapid economic development, and advance to<br \/>\nthe democratic society, KMA has always been<br \/>\nfor the people to secure health and happiness,<br \/>\nenhancing the standard of medical science and<br \/>\neducation, and participating actively to the<br \/>\ndecision-making process. With the devotion<br \/>\nand support of physicians in care for people,<br \/>\nthe government could achieve the universal<br \/>\nhealth insurance policy in 1989 only 12 years<br \/>\nafter the launch of the national health insur-<br \/>\nance program.<br \/>\nKMA\u2019s e\ufb00orts to enhance international<br \/>\ncooperation contributed to the drastic im-<br \/>\nprovement of the standard of health care<br \/>\nand now it reached the highest standard<br \/>\nakin to the advanced countries in OECD.<br \/>\nThe number of members has increased into<br \/>\n90,000 physicians today and the roles and<br \/>\nresponsibilities of KMA become more and<br \/>\nmore important in observance of medical<br \/>\nethics and provision of continuous medical<br \/>\neducation: training and certi\ufb01cation of spe-<br \/>\ncialists, introduction of malpractice insur-<br \/>\nance program.<br \/>\nIn this October, KMA is privileged to host<br \/>\nthe WMA General Assembly Seoul 2008.<br \/>\nThe Organizing Committee was launched<br \/>\nin September 2006 as the o\ufb03cial decision-<br \/>\nmaking body for KMA and is spearheaded<br \/>\nby Dr. Tai Joon MOON, the President<br \/>\nEmeritus and Dr. Soo Ho CHOO, the<br \/>\nPresident of KMA. Dr. Dong Chun SHIN<br \/>\nserves as secretary general of the commit-<br \/>\ntee. To make the Assembly successful and<br \/>\nmeaningful, KMA has been working very<br \/>\nhard. We have organized the scienti\ufb01c ses-<br \/>\nsion under the theme of \u201cHealth and Hu-<br \/>\nman Rights\u201d to cover health equity, health<br \/>\nfor under-privileged people, health prob-<br \/>\nlems from environmental perspectives and<br \/>\nmedical ethics and human rights, and so on.<br \/>\nAs keynote speeches, UN\u2019s activities and<br \/>\nstrategies for protecting human rights and<br \/>\nan overview on WMA\u2019s policies and history<br \/>\nof health and human rights will be present-<br \/>\ned and discussed.<br \/>\nTo commemorate the meaningful centen-<br \/>\nnial anniversary, KMA is planning a photo<br \/>\nexhibition on the sidelines of the Assembly<br \/>\nshowing historic highlights of development<br \/>\nof medical sciences from the late 19th<br \/>\ntill<br \/>\npresent days in front of the main meeting<br \/>\nhall of Shilla hotel during the Assembly.<br \/>\nTour programs will include beautiful sites of<br \/>\nSeoul city. We expect excellent weather in<br \/>\nOctober and you will enjoy the unique at-<br \/>\ntractiveness of Seoul where tradition meets<br \/>\nmodern vitality.<br \/>\nKMA would like to welcome you all to Seoul<br \/>\nand we are honored to share important dis-<br \/>\ncussions with you and exchange friendship<br \/>\namong leaders of organized medicine of the<br \/>\nworld during the Assembly.<br \/>\nBo-kyung Kang,<br \/>\nInternational Relations<br \/>\n32nd<br \/>\nKMA Scienti\ufb01c Congress Korea launch of universal health care<br \/>\ninsurance<br \/>\nThe hosting of the 12nd<br \/>\nCMAAO Meeting<br \/>\n115<br \/>\nThe roundtable \u201cHigh Quality Healthcare<br \/>\nin Europe,\u201d organized jointly by the Coun-<br \/>\ncil of European Dentists (CED) and the<br \/>\nStanding Committee of European Doctors<br \/>\n(CPME) on the 11th<br \/>\nof September,in Brus-<br \/>\nsels, provided one of the \ufb01rst opportunities<br \/>\nfor stakeholders to discuss the Commis-<br \/>\nsion\u2019s recent proposal for a Directive on Pa-<br \/>\ntients\u2019 Rights in Cross-Border Healthcare.<br \/>\nThe event under the patronage of Othmar<br \/>\nKaras, MEP, brought together Commission<br \/>\no\ufb03cials and MEPs to exchange views with<br \/>\nthe main organisations of European health<br \/>\nprofessionals and patients on the proposed<br \/>\nDirective, as well as on the wider institu-<br \/>\ntional and political framework for cross-<br \/>\nborder healthcare in Europe.<br \/>\nEU Commissioner for Health and Con-<br \/>\nsumers,Androulla Vassiliou,opened the de-<br \/>\nbate with a keynote presentation. She con-<br \/>\n\ufb01rmed the continued commitment of the<br \/>\nCommission to dialogue and cooperation<br \/>\nin the process leading to the adoption of the<br \/>\nproposed Directive on Patients\u2019 Rights in<br \/>\nCross-Border Healthcare with those most<br \/>\ndirectly a\ufb00ected by it: the health profession-<br \/>\nals and the patients.<br \/>\nDuring the debate, all representatives, those<br \/>\nof the health professionals as well as the<br \/>\npatients, welcomed the directive and reiter-<br \/>\nated the need to enshrine patients\u2019 rights of<br \/>\naccess to safe and high quality healthcare<br \/>\nthroughout the EU in a legal document.<br \/>\nCPME President Dr.Michael Wilks point-<br \/>\ned out, among other issues, the necessity of<br \/>\ngood information systems for both patients<br \/>\nand physicians that support cross-border<br \/>\ncare.<br \/>\nCED President Dr. Orlando Monteiro da<br \/>\nSilva noted that quality is de\ufb01nable but very<br \/>\ndi\ufb03cult to measure. \u201cWe must focus on<br \/>\nthe three main principles of strategy, high<br \/>\nquality and e\ufb03ciency, doing the right thing<br \/>\nright.\u201d<br \/>\nThe moderator,Dr.Matthias Wismar of the<br \/>\nEuropean Observatory on Health Systems<br \/>\nand Policies, concluded that there is a con-<br \/>\nsensus among the panellists on the need for<br \/>\nthis directive.<br \/>\nOthmar Karas, MEP (EPP), played a lead<br \/>\nrole in negotiating an agreement between<br \/>\nthe European Parliament and the Council<br \/>\nunder the Austrian EU Presidency in 2005,<br \/>\nleading to the exclusion of health services<br \/>\nfrom the Services Directive. Other speakers<br \/>\nincluded DG SANCO Head of Unit Ber-<br \/>\nnard Merkel, MEPs Bernadette Vergnaud<br \/>\n(PES) and Holger Krahmer (ALDE), and<br \/>\nDr. Anders Olauson, President of the Euro-<br \/>\npean Patients\u2019 Forum.<br \/>\nClaudia Ritter, Director \/ Brussels<br \/>\nO\ufb03ce,CED, Council of European Dentists.<br \/>\nwww.eudental.eu<br \/>\nLisette Tiddens-Engwirda, Secretary<br \/>\nGeneral,CPME, Standing Committee of<br \/>\nEuropean Doctors. www.cpme.eu<br \/>\nContents<br \/>\nEditorial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75<br \/>\n179th<br \/>\nWMA Council Meets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76<br \/>\nHuman Resources for Health, Kampala . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82<br \/>\nHealth \u2013 a global overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82<br \/>\nAn alternative to better global health . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83<br \/>\nThe new revision process of the International Classi\ufb01cation of Diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84<br \/>\nDoH Revision meeting in S\u00e3o Paulo. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85<br \/>\nCo-operation of WMA and the Stop TB partnership \u2013 Private-Public-Mix in the \ufb01ght against TB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86<br \/>\nLilly Commits $1MM to World Medical Association to support Innovative Tuberculosis training course . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87<br \/>\nWhat Physicians are REALLY Thinking . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88<br \/>\nSmoking: A disease that starts in the brain and goes to the whole body . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92<br \/>\nWorking together for safe health care,the World Health Professions Alliance (WHPA) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95<br \/>\nIFPMA Appoints Alicia Greenidge as New Director General . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96<br \/>\nRepresenting pharmacists and pharmaceutical scientists \u2014 your partners in healthcare . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97<br \/>\nThe South African Medical Association (SAMA). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98<br \/>\nOverview of the Nigerian Medical Association (NMA). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99<br \/>\nThe National Order of Physicians of C\u00f4te d\u2019Ivoire: presentation and perspectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .101<br \/>\nThe Medical Association of Thailand under the Royal Patronage of his Majesty the King . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .102<br \/>\nThe Hong Kong Medical Association (HKMA). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103<br \/>\nThe Azerbaijan Medical Association (AzMA). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .104<br \/>\nThe Australian Medical Association \u2013 a voice for patients and doctors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .106<br \/>\nThe New Zealand Medical Association . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .108<br \/>\nEthics and professionalism at the Canadian Medical Association . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .110<br \/>\nThe \u201cConsejo General de Colegios O\ufb01ciales de M\u00e9dicos\u201d . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .111<br \/>\nThe Slovak Medical Association . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .112<br \/>\nKorean Medical Association.The WMA General Assembly Seoul 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .114<br \/>\nCross-border healthcare:<br \/>\nDebate between the EU institutions, health professionals<br \/>\nand patients on the draft directive launched<\/p>\n"},"caption":{"rendered":"<p>wmj19 No. 3, September 2008 Editor in Chief Dr. P\u0113teris Apinis Latvian Medical Association Skolas iela 3, Riga, Latvia Phone +371 67 220 661 peteris@nma.lv editorin-chief@wma.net Co-Editor Dr. Alan J. Rowe Haughley Grange, Stowmarket Su\ufb00olk IP143QT, UK Co-Editor Prof. Dr. med. Elmar Doppelfeld Deutscher \u00c4rzte-Verlag Dieselstr. 2, D-50859 K\u00f6ln, Germany Assistant Editor Velta Poz\u0146aka wmj-editor@wma.net [&hellip;]<\/p>\n"},"alt_text":"","media_type":"file","mime_type":"application\/pdf","media_details":{},"post":727,"source_url":"https:\/\/www.wma.net\/wp-content\/uploads\/2016\/11\/wmj19.pdf","_links":{"self":[{"href":"https:\/\/www.wma.net\/fr\/wp-json\/wp\/v2\/media\/3572"}],"collection":[{"href":"https:\/\/www.wma.net\/fr\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/www.wma.net\/fr\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/www.wma.net\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wma.net\/fr\/wp-json\/wp\/v2\/comments?post=3572"}]}}